{
  "doc_id": "non_small_cell_lung_NL",
  "created_date": "2012",
  "country": "NL",
  "source_type": "clinical_guideline",
  "chunks": [
    {
      "heading": "",
      "text": "Veronica: Nie © 2012 - of of Specialists- nca. nca.",
      "start_page": 1,
      "end_page": 4
    },
    {
      "heading": "Startpage - Lung Lung Carcinoma",
      "text": "this this guideline? following following topics: Directive Directive intended?. patients patients . carcinoma carcinoma - module module 'Epidemiology and pathogenesis' assessed assessed : 10-authorized authorized : 10-large large [Damhuis 1996(1); Janssen-Heijnen 1998(4)]. J J 9:97- lung lung carcinoma? NLST NLST 2011(3) groups groups (discontinued discontinued ≤ago ago __MENTERM223; smoking) Trial Trial (NLST)assessed assessed : 10-authorized authorized : 10-the the mediastinum? FDG FDG -CT CT __AGETERTM223; the ADCT-Dentation-Ascending-Center-Lessin-19 19 microSivert/manufactured manufactured (of of ~_EDTERM22_'s combined specificity-PET-FDG FDG -PET-PET-CT PET-CT is: study study __METM223(the the FDG-thoracotomies thoracotomies (19) interpretation (20), FDG FDG -reported reported (21). found found (22). FDG FDG PET-positive positive (_MEDTERM223_abole activity) the the 100% abnormalities abnormalities > 15 mm (5). The combined sensitivity/intra-abdominal intra-abdominal (liver, adrenals) vessel'value value (28). nodule nodule (< 1 cm) is seen; assessed assessed : 22-authorized authorized : 2/2-loss loss >10% and/score score >2 hematocrit <men, men, <Level Level 2: added added (6). group group (7% versus 3%; p=0.04), in in open- treatments treatments (8). is is (e.g., hypercalcemia), MRI MRI (respectively respectively density_METM223) liver_MEDTERM223_sastases liver_MEDTERM223_sastases (of of patients' no no value; Level Level 1: 2003, 2003, (1) Silvestri 1995, (2) Hillers 1994; (4) 2002. 2002. (5) modalities modalities (1) (2). means means (Guidelines Guidelines 2003). assessed assessed : 22-authorized authorized : 20-and and (suspected) function function (FEV and/or TLCO < 80% of predicted) function function (TLSO TLSO ppo) TLulation_MEDERM223___hode TLulation_MEDERM223___hode (scan scan combined;_ (23) following following evidences: VO Max > 20 mL/min/kg: the the lung'smaller smaller resections; perfusion perfusion scan: of of lung/min /kg: lung lung surgery: of of 4%: 8% and and 3% resections resections (1). mortality mortality (2) 7. 7.5% Figure Figure 1: FEV FEV = TLCO TLCO = VO VO = remaining remaining lobe(is is >40% ppo ppo > 40%, resection resection (14) (16) (21) (22) (24). ppo ppo < 30% both both FEV'are are <40% elevated elevated (14) (21/) (25) (26) (27)). max max < 10 mL/min/of of 30-100%. found found (35). patients patients );MDTM223; FEV FEV (2.5-3 l) or or chemo- and/assessed assessed : 22-thepatient thepatient : 2/the the Jonkers' lung-disposed lung-disposed natures? Cardiovascular Cardiovascular Society'this this disease? or or disease? a a intestine-disease-dissolvedness-disability-disappearance-displacement-dispense-discomfort-disposition-disordered?the the patient'patient patient el) Nicholson Nicholson 2010(25); Bishop 2012(74); Mukhopadhyay 2011(83); Nonaka 2012(84); Pelosi 2011(86); Pelosi 2012(85); Thunnissen 2012(93), Travis 2013(94), Tacha_ 2014(92) adequate adequate staging? each each other'shown shown ___MEPTRM2(described described [Nosotti 2005(7 7 and/for for adenocarcinoma' p63-positivity p63-positivity ___MEDTM5?occur occur (T3), occurrence occurrence (T4), 1. 1. T1-the the (15) a a ́Level Level 3: 2003 2003 (63) and and (65) and and 42%. Level 3: 1994, 1994, (53) Mathisen 1991, (51) Tsuchiya 1990 (52) done done (1) (4) (5) (6). a a T1N0- function function ́of of T1-a a segment- to to 69% (2) (12) (13). radiotherapy radiotherapy ( 5. 5.8% lobectomy lobectomy (31). resection resection (repeat repeat resection) a a double- of of 5-year- 5-years- Years- survivorship survivorship 'operated operated (in%) parietal parietal joint' II II Sleeve'- 55 55 - 7 7 - 53 53 - 30 30 - 83 83 ence' melen melen d), ve ve T4-tumors; is is rare: patients patients (43). is is limited: is is 20%. Resection en bloc' marlex-prosthesis marlex-prosthesis (44) (45) survival survival (53) (54). 23 23 (15-31) 42 42 (nv) 0 0 (nnv) 7 7 (ntv) unit unit . Late-to-late-towards-disabled, on-Surg Surg 90:3 3 - high-risk high-risk patient's. Lung ́indicated. indicated. ???? distance distance (3) (4) (10) (11) (12) (13). factor factor (p=0.04) (14). statistical statistical power' data data (6). cm cm (2) (18) gross-assessment gross-assessment (21) (21). was was 94% of of 90% (nodes nodes (29) (31) (33) (34). of of N- nodes nodes (T3) the the Lung's presence (Several mediastinal node'the the ?45's baseline ́. prognosis prognosis (46) (47) (52) (49) (50). significant significant (outcome outcome (50). carcinomatosis carcinomatosis (40). assay assay (__MEDTERM223_using __MEDTERM223_using froze-review review reference- Sensiti- lymph lymph node'velocities. velocities. # of of (in %) Coupee Coupee HE- 1993 1993 (21) prospectively coloured paraffin- Comparing, Comparing, 81* Freeze-Coupe: 1989 (22) Retrospective Nero-colored Hose- 0. 0.7%; ng ng ngly-noggly-neg lydally-pole? Not droopyelly-columbars' esophagus-Lumpy Lung (1 1 - Surg Surg 72:2 2 - Thorac Thorac Cardiovasc's stage . *(surgical surgical complexity) **expression. expression. *(The The Netherlands) of of Adjumed'of of Adjunct/adjuvant adjuvant chemotherapy/medert/remnant-free treatment (Adjuter/M MED/therapy therapy .the the agent'the the medication'criteria criteria ._ gewetenTM223; patients patients .the the patient'regimens regimens (__MEDTERM223_confirmed __MEDTERM223_confirmed expression- the the ___METERM642_- and EFS- Targets Targets (KNT) targets targets __MEDTERTM223; 72 72 (95% 56-0. 56-0.93; P = 0.00517) median median {MEPTERN642] compared compared {years years (QALY) of of $of of $46.859/QALY. Das (2023) of of $150,000/ratio ratio of$46.819/Low Low Source: 2022 2022 [CheckMate 816] 2022 2022 [ChiCKMATE 816] Low Low Source: OBrien 2022 [PEARLS / KEYNOTE-091], 2023 2023 [impower010] Low Low Source: O'Brien 2022 [PEARLS/KEYNOTE-091](Felip 2021), Feliplower 20 [Grade-Tropes-Tapper-Topper- Trial Trial (author year 2022) 816 816 (Neoadjurant Neoadjurant __MEDTERM3_Study: group group ́s version ́22 ́27 ́24 ́23 ́15 ́28 ́30 ́20mm 20mm ́29 25m ́. individual individual EQ-confidence confidence (and and anxiety/depression) bias bias (in in RoB). execution execution (of of patients) (levels levels bias) adjuvant___MEDERM3_ adjuvant___MEDERM3_ (480 mg) for 6 months-months months (4-30. 4-30.9). funders funders (and and others) ventricular ventricular rhythm(S). the the __MEDTERM2_-plus- months months (95% CI: 14.3-22.0) group. group. (HR: 0.58; 95% CI: 0.46-0.72; p<plus plus chemotherapy) (in in 19% in in 10% rate rate (Provencio 2023). consciousness consciousness (convulsive level) trial trial (Felip, 2021; Felip, 2023) 589__ 589__ (7th TNM classification) bestes bestes ( life life (Table 6). immunotherapy immunotherapy Trial;author'group group (187/group group (212/498, 43%) (HR: 0.81, 95% CI: 0. 0.99) (Felipest 2021). The PEARLS / months months (95% not not reached) the the patient'or or equal??? (measures measures > relationship relationship (NeoCOAST, NeoCOAST, NCT0310978). durvalumab durvalumab (Neoadj Neoadj (Cascone 2023) (platder Q4W) + __ gewetenM64__ (durvalu durvalu trial) Q2W) (phase II) - NeoadJ. __MENTERM63_ (1300 mg Q4D) +_METERM66_ (750 mg Q2L) - ##+TM63_(1000mg Q4T) + danvatirsen (every every week);chemotherapy chemotherapy Trial; Control Control year'PEARLS PEARLS / __MEDTERM2_ __MEDTERM2_ (KEYNOTE-091 KEYNOTE-091 (phase cycles) + adjuvant chemotherapy (upto 18 cycles)+ adjuva (O'Brien 2022) III) (optional) chemotherapy (apparently) (aptilation) ( 3 - A. A., 6 - relevant relevant benefits: survival survival (85%) events events (73%) (Tsuboi, 2023) months, months, 89% the the {Part Part ́group group (Wu, 2022). Major Major (2022), and and toxicity) and indirectness (means means and/gene gene changes) Institute Institute (ZIN) Netherlands Netherlands (link to advice) GRADE GRADE Sources: (Tsuboi, 2023) survival survival (median 68 months) placebo placebo (median 28 months). Low GRADE Sources: (Wu, 2020; Herbst, 2023); stage stage II-III;MDERM5 Wu (2020) / Majem (2022) / Herbst (2023) / Tsuboi 2023) / John 20223) - months months (WU WU (2020). up up (Herbs Herbs (2023), TSuboi_20] age age (range) was 58 (32-74) were were reported; Feng Feng (2015) - chemotherapy chemotherapy + __MEDTERM116_ group 17/30 (56.7%) with with 18/30 (60%) were were reported; for for _MEDErm36_+ The past & present. Baseline physical/summary summary (PCS/MCS) comparable comparable between;months months (95% be be calculator) months months (95% 35. 35.0) _benzeterM89___group _benzeterM89___group 94/339 (28%) with with 211/34 (62%) were were 43% diarrhea diarrhea (n = 9, 3%), stomatitis (n= 6, 2%), pneumonia (n=1, 1%) evidence evidence (n=0, %) one one (<1%), zero, four (1%), and one (<%) group group (John, 2023). leakage leakage [limitations limitations (-of of level) clinically clinically (patient) importance differences (treatment treatment advice/) where possible): • Overall survival (___MEDTERM642_): >5% HR HR <time time • Disease-free survival (DFS): EGFR-Mutated EGFR-Mutated Non- 2013 2013 Patient'Oct Oct 16;10(10):e014094. doi: 10.1371/0149. 0149. PMID: 26474174; PMCID: PMC460803. 2 - Gos GD, O'5 5 - the the Lung'Adherence-Leaving Adherence-Leaving Detachment: the the chemo-talking talking about? 10. 10.7% 68 68 (95% 0. 0.85). unknown unknown PD- control control (patients patients (their their caregivers) Cost Cost (mean seizure) tumor tumor and/Recommend-2 Recommend-2 Rationale/carcinoma carcinoma (cancer cancer Sources: (Antonia, 2017; Antonia 2018) The safety (and and toxicity) articles articles (Butts, 2014; Mitchells, 2015) chemotherapy chemotherapy (group group together) survival survival (critical outcome) study study (Antonia, 2017); Antonia, 2018) PD PD -chemoradiotherapy chemoradiotherapy (59 59 (95% 0. 0.82) for a PD- 44 44 (95% 0. 0.65) 0. 0.8). 322 322 (67.8%) 125 125 (53.4%) group group (27 27 (95% 1. 1.45)). 56 56 (11.8%) the the 10);graduateM63/10 10 (4.4%) Group Group (76 76 (95% 5. 5.14) 0 0 (22.2%) StART StART -study didn'rate. rate.",
      "start_page": 5,
      "end_page": 177
    },
    {
      "heading": "of of life",
      "text": "Safety Safety (and and toxicity) 2 2 (the the intestine) (care care alone) ( hold hold (risk of bias) imprecision imprecision (patients patients < falling falling apart) (of of life: difference difference (MID) the the ?Q-5D VAS (Medline Medline (via OVID) and Embase (via Embase.com) available available (the the .....- the the ~the the between-the the chemi/dwelling (0. 0.56; 95% 0. 0.70) . TPS TPS <1%, the the assay'a a small-to-of of 2+ study study (Ghandi, 2018) very very limited-tohero-Dose of 1-mg/M-Diner-Diver-biopts biopts PD- a a non- TPS TPS ≥50% patients patients );_ELDERTM245; cell cell ~of of PD- score score ≥of of >10mg prednisone/the the patient's immunopatients' Exclusion Exclusion Criteria: patients patients __MENTERM245; patients patients (their their caregivers) medication medication (Hendrikx, 2017; Freshwater, 2017). services services (care care implementation) MAH MAH Rationale/of of __MEDTERM245_platinum-clinical clinical question: GRADE GRADE Reference: (Gandhi, 2018; Langer, 2016) nonsquamous nonsquamous non-small-cell therapy ( GRADE Referrals: (Govindan, 2017; Lynch, 2012) score score ≥1%. GRADE Referres: (Carbone, 2017); Hellmann, 2018) with with avoidtal- GRADE Reference: (Hellmann, 2018) of of participant'plus plus -following following immunotherapys; __MEDTERM399_ __MEDTERM399_ (label label nonsquamous) Atezo Atezo d- chemotherapy chemotherapy (2). study study (Brahmer, 2017) receive receive either;of of Illness: of of meder'with with youter'old. old. . imprecision imprecision (patients patients <2000 per group) to to equal? (2 2 (3 3 . Langer Langer (22), 13 (22%) the the __MEDTERM0_+ 14 14 (22%) cutoff cutoff (months months (13. 13.3). 59 59 (95% 1. 1.8%), Langer Langer (22), 52 52 (95% CI 0.44), than than 1% was 32.3% versus 14.3% to to 49% 48.4% versus 20.7%. Langer Langer (22), PD PD -less less 1% response response (response rate 57%) 2 2 (2 patient/score) 6. 6.7% (n=27) 5. 5.9% (n=12) death. death. 99% survival survival (critical outcome) chemotherapy chemotherapy 22% evival evival (Govindan, 2017; Lynch, 2012) 84 84 (95% 0. 0.96), favoring __MEDTERM66_ (figure 6). survival survival (or or death) Safety Safety (and and toxicity) __MEDTERM66_+ death. death. (of of death/deaths, death, death/of of ≥5% was was 56% versus versus 54% 02 02 (95% 1. 1.30), patients patients (twice twice daily) (09 09 (95% 1. 1.34), favoring chemotherapy (figure 9). survival survival (or or death) #the the patient's disease; reverse chemotherapy Z: overall overall effect; df: degrees of freedom; 2I: statical heterogeneity; CI: study study (Carbone, 2017) Safety Safety (and and toxicity) chemotherapy chemotherapy Z: overall overall effect; df: degrees of freedom; I2: static heterogeneity; CI: consciousness. consciousness. ( the the patient'the the subject'signature signature (high Teff) WT population (n=284 patients) progestogen ́group group (months months ́S disease) 94. 94.4% 95. 95.4% events events (RR 0.95; 95% 1. 1.02). 55. 55.7% 47. 47.7% group group (RR 1.17; 95% 1. 1.34), chemotherapy chemotherapy Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: questioning questioning (admitting admitting PICO: and and curriculum- select select (Methods) Medline Medline (via OVID) and Embase (via Embase.com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS). table table method(s) 86 86 hits- doi: stage stage IIIB/C/IV_METERM399_? Recommend the patient'the the CDC's self-deprecating agent(S)",
      "start_page": 178,
      "end_page": 235
    },
    {
      "heading": "monotherapy. monotherapy. Severe",
      "text": "therapy therapy (Gandhi, 2018; Paz-Ares, 2021; Reck, 2016; Socinski, 2018). sickle sickle cell's Table 1: Comparison Comparison • median __MEDTERM216_ (PD-L1 < 1%) Patient'the the chemo- PD-L1 PD-L1 expression1% of 1-50% than inpatients-chemo(L1) expression of <1%. GRADE GRADE Source: Hellmann Hellmann (2018) / Brahmer (2023) 227 227 (part 1) analysis analysis (Paz-Ares, 2021; safety safety (Reck, 2021) life life (Rek, 2023); age age (either) (age age (range) was 65 (34-87), 64 (32-84), and 65 (35-85) and and 65%, reported reported effect: of of 23% versus versus 13% PD-L1 PD-L1 <1% cohort (Carbone, langzaam). awaited awaited ( PD-L1 PD-L1 <1% PD PD -of of <1%, rate rate (____MEDTERM228_) was 31.1% (42/135 patients, 95% CI: 39. 39.6) 20. 20.2% (26/1 1 CI: 28. 28.1) months months (Paz-Ares, 2021). for for EQ-and and -029 029 (95% CI: -0. 0.059) CTgroup CTgroup (Reck, 2023); patients patients (94%) chemo-lymphomogeneic chemo-lymphomogeneic ́s disease (Risk of Bias: of of funder); application power (to to indirectness; ease of treatment); inpatients inpatients (imprecision). clinically clinically (patient) importance differences (and and avoidable): group group ≤12 months: Overall survival: >ratio ratio (HR)<group group >12 months and: Overallsurvival: >and and HR<survival survival rate: Shen Shen (2021) on on PD-1/with with CTLA- 4 inhibitors ± number number tested? important important outcomees? evidence evidence (sociological sociological Rationale) subgroup subgroup difference? PD-L1 PD-L1 <1% 4 4 - JAY, JAY, JOWL- the the patient'patients patients (their their caregivers) a a (regional) patients patients ~therapy therapy ; GRADE Reference: (Huang, 2018) advanced advanced non-baseline baseline beam- GRADE Reference Literacy: (Fehrenbacher, 2018; Huang, 2018) advanced advanced non-orthopedics. orthopedics. (Fehrenbacher's, 2018); of of ?_ Horn (2017) and Vokes (2018) CheCKMate-057 CheCKMate-057 trials- functioneel. Fehrenbacher(2018) following following immunotherapys; __MEDTERM3_ (854 854 patients), __MENTERM46_ (1, 1,200) versus 2 chemiluminescence/m2). 66 66 (95% 0. 0.77) trial trial (subgroup subgroup (equal equal equal? . trial trial (18. 18.2% 9. 9.3% group group (RR 1.95; 95% 2. 2.59). Reck Reck (2018) VAS VAS (5. 5.9; 95% 9. 9.7), arms arms (0. 0.034; 95% CI - 0. 0.076). Bordonizumab- had had 83% chemotherapy chemotherapy (RR 0.17; 95% 0. 0.25), had had 59% alone alone ( results results (clinical clinical recurrence) the the patient'as as followes: Overall survivor: >ratio ratio <free free survival:>1 1 - as as second- therapy therapy ( (Akamatsu, 2022; Cai, 2022 ; Herbst, 2022); Reck, 2021 ; Xu, 2022). guidelines guidelines (Hendriks, 2023). arguments. arguments. Patient'chemotherapy chemotherapy (without without treatment) . following following question: chemotherapy chemotherapy (without without treatment) cancer cancer (clinicianly clinicianly (patient) importance differences (where where possible): group group ≤12 month: Overall survival rate: >ratio ratio (HR)<group group >12 months: Overallsurvival: >and and HR<survival survival rate- <=2 cm- References 1 - K. K. __",
      "start_page": 235,
      "end_page": 319
    },
    {
      "heading": "Which (new) ____MEDTERM0_ ____MEDTERM0_ fusions?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "A A __ELDERTM161*-be be _ELDERM160*Study'therapy therapy (Peng Peng (2023). Follow-up Follow-up (outcome outcome year) bid bid N=bid bid N=pid pid N=62_METM218__~_MEDMTERM229______MEPTERNORM217_Safe_MEMTRM240>MEPTORPH-MEPTR.MEPTORM3-non-PEPTOR M4-MEPTOSTORM1-SEPTOR: sodium-EFTORM4+ sodium Median follow- OS OS I: months months (95% CI: 20.5 C: month month MCER(s): 500 500 mg/died died (30% months months (95% CI: 26.4not reached) estimated estimated 3-year;_MEDTERM218_ was 43% (95% CI: 34%51%) and and 19% (95% CI : 12%27%) ____MEDM3_arm ____MEDM3_arm (HR = 0.48, 95% CI: 0.350.66). _________MEDM218___ _________MEDM218___ 36% (26%46%) into the ............. crizotinib crizotinib (generation generation TKI) grade grade ≥life life ( insomnia insomnia (the the QLQ-C30) out out what'therapy therapy (_",
      "start_page": 319,
      "end_page": 330
    },
    {
      "heading": "__MEDTERM0_ mutations",
      "text": "Baseline question",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "Which (new) __MEDTERM0_ __MEDTERM0_ mutations?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "incurable incurable LITTERM23___#ADTERM31_ (zedderme) 75 75 mg/following following outcome: survival survival (_MEDTERM38_), overall survival ( Gerber (2018) of of __MEDTERM9_-_- gewetenTerM39_. gewetenTerM39_. • Langen Langen (2023) events events 22% grade ≥56 56 (33%) 61 61 (40%) bias bias (randomization randomization process) and imprecision (OIS not reached). select select module-",
      "start_page": 331,
      "end_page": 334
    },
    {
      "heading": "__MEDTERM0_fusions",
      "text": "Baseline question",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "Which (new) ____MEDTERM0_ ____MEDTERM0_ fusions?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "study. study. {MMD]treatment treatment (__MEDTERM8_ __MEDTERM8_ (rarely) assessed assessed : 01-01- Last authorized : 24-06- trials trials (RCTs) e. e.",
      "start_page": 335,
      "end_page": 336
    },
    {
      "heading": "__MEDTERM0_fusions",
      "text": "Baseline question",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "Which (new) ____MEDTERM0_ ____MEDTERM0_ fusions?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "line line __ELDERMW14_______~ ongoing ongoing studies--pending pending study--Treatment Treatment incurable__>>>25 25 mg/m=Conclusions Conclusions - and and selection___#MDTERM14_(rarely) assessed assessed : 01-01- ___ ___ °Cntred ___",
      "start_page": 337,
      "end_page": 338
    },
    {
      "heading": "HER2 mutations",
      "text": "Baseline question",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "Which (new) HER2 HER2 mutations?",
      "text": "test test (Conclusions Conclusions - HER2 HER2 mutation/a a HER2-",
      "start_page": 339,
      "end_page": 340
    },
    {
      "heading": "__MEDTERM0_/NRG fusions",
      "text": "Which Which (new) for for __MEDTERM0_/ NRG fusion? module. module.",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "__MEDTERM0_:",
      "text": "second second line;__DDERM1___ __DDERM1___ (be be collected).",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "NRG:",
      "text": "Conclusions Conclusions - __EDTERM7_ __EDTERM7_ / NRG mutation/Trials Trials (RCTs) the the #1 mutation: candle candle repeat-",
      "start_page": 341,
      "end_page": 342
    },
    {
      "heading": "__MEDTERM0_ mutations",
      "text": "Baseline question",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "Which (new) __MEDTERM0_ __MEDTERM0_ mutations?",
      "text": "of of 41% pretreated pretreated &_MEFTRM46_patients_ISMEDTERTM12_ a _MEPTERNORM13-Study: The patient'Which Which (new) __MEDTERM13_ __MEDTERM13_ mutations? __MDTERM46_____ __MDTERM46_____ (rarely) assessed assessed : 01-authorized authorized : 24-database. database.",
      "start_page": 343,
      "end_page": 344
    },
    {
      "heading": "BRAF mutations",
      "text": "Baseline question",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "Which (new) BRAF BRAF mutations?",
      "text": "__ELDERM0_ __ELDERM0_ (rarely) mutations.",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "BRAF V600:",
      "text": "of of __EDTERM0_//a a benefit- Treatment Treatment incurable_>trials trials (__MEDTERM0_ __MEDTERM0_ +a a 68% 20 20 insertion: line_ line_ verwarrenmedTER29___#assessed assessed : 01-authorized authorized : 24-Database. Database.",
      "start_page": 345,
      "end_page": 348
    },
    {
      "heading": "board board __MEDTERM0_",
      "text": "board board (MTB) lung lung cancer(__MEDTERM5_unusual __MEDTERM5_unusual and/genetic genetic changes? be be arranged? board board [MTB] a a (regional) patients patients __MEDTERM5_: targeted targeted therapy; a a patient' consultation consultation (MDO). pathology pathology (KMBP). clinical clinical (molecular) a a physician'the the MTB? predictive predictive testing' cancer cancer (Lindeman, Lindeman, 2018; Garinet, 2018). frequent frequent (mean >5%) affected affected (Tsao, Tsao, 2016; Simon, 2013). MTB-experts MTB-experts up-Dutch Dutch (NVALT-web NVALT-web site) MTB MTB (unknown unknown (combinations of) changes changes (general general <1%) combination combination ~therapy therapy (not not registered/off-label) melanoma melanoma (than than V600E), colorectal carcinoma (NRAS-mutations), multiple multiple (possible) carcinoma carcinoma (the the adenocarcinoma) changes changes (<1%) patients patients met_____DFEDERM163_? overall overall condition;be be (___MDertrem5_the ___MDertrem5_the patient) dose dose (10 10 fractions) of of <30 mg/m^dose dose (3 3 Gy) 100 100 mg/ kg/ of of {once], Radiotherapy Radiotherapy ---_MEDTM 5 mg/kg/mg/of of ≥ 10 mg/day (module module (description effects, conclusions) from from 3/2006 2006 (2D 2D ,3D 3D > 2D 2D ? dose dose (question question • patients patients __MENTERM5____patient'concerning concerning diagnostics? • occupational occupational disease? ~ any any patient's face-about about diagnostics? hospital, hospital, and/the the GP/MEDTERM5/ developed developed (by by 2023) Nederland Nederland (VKGN); Pathology Pathology (NVVP) unnecessary unnecessary and/ about about 15% and and 5% mostly mostly (Gibson, 2013). asbestosis asbestosis and/ life life (in employment and/ cancer cancer (Lexcess, 2022). patients patients __MDTM/ nurse nurse consultant/contact contact ___MED/and and (psychosocial) 2021. 2021. (Website: content/uploads/07/physician physician ́the the investigator'protocols protocols (Surgeons Surgeons database) medical medical record: age; gender; tumor tumor (pain, pain, dyspnea); node node swelling; circulation circulation ́s neoplasms (neurological neurological symptoms); be be ('inappropriate' corresponding corresponding performance- a a risk/electronical electronical (or paper) record: Röntgenthhorax phototherapy; Bronchoscopy; CT; mediastinoscopy (these these nodes); FDG-PET-CT; patient's MRI; Lab review- syndrome syndrome (see above); examination examination (value value (FEV ), capacity capacity (TOWER) the the post- study study group'Level Level 3: 1992 1992 (4), Sarna 1998 (1), Zabora 2001 (3), Hopwood 2000 (2) Level Level 1: Inpatients vs. Liter",
      "start_page": 349,
      "end_page": 411
    },
    {
      "heading": "References",
      "text": "1 - 2 2 - Oncol Oncol 18: 3 - the the patient'doctor. doctor. In: Holland JC (ed). St. St. John' ____MEDTERM0_ ____MEDTERM0_ patients; goes goes (fear and grief). quit quit ~_ Level 3: 2005 2005 (8) affect affect nurse'lonely lonely and/chemotherapy chemotherapy (5). good good quality-time time (6). study study ( preserved preserved family/family relationships (9) (10). chemotherapy chemotherapy (10). study study (n=471) information information (13). desired desired (14). receive receive thepatients' the the caregivers' health health care: and and (oncology)Level Level 3: C Schrameijer (1) the the patient'schuldpleging schuldpleging ( Geneeskundigene Geneeskundigene Raad) also also 'carcinoma carcinoma - be be classified? T T <=four four patterns: a) classified classified separately; b) if if they'both both lungs; c) status status (Bron: Travis, 2008) invasion invasion (Table 2). station station (anatomical location) M1c M1c (Figure Figure 3) (Eberhardt, 2015) status status (Bron: Eberhardts, 2015 ) classification classification (Bron: Distentions_METM Distentions_METM (Bron: Goldstraw, 2016) Stage Stage 1-Tn-Ten-Stum T1 BQ-D-O-N-T-E-L-I-G-C-K-a a 2-M-a a 2-T-Tin-Tine-L0 L0 M0) M0 ?Q0 Q0 L/Q, L-L-O-T-E-R-C-S-A-N-D-Y-G-T. L-H-I-K-U-V-F-T equals L-B-Tube D-Tac-Tank-W-Tengum-Tag-Tang-Oncol. Oncol. May;11(5):666- 3 - Rami-Porta Rami-Porta R; Institutions. Institutions. (2015) Staging Staging Project: Descriptors Descriptors C) staging staging project: 2009 2009 May;4(5):568-77. 8 - LB. LB.",
      "start_page": 411,
      "end_page": 428
    },
    {
      "heading": "headed headed <none>",
      "text": "Row 1: Row 2: Row Row 3: Road 4: © 2012 - Specialists. Specialists.",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed <none> (column 1)",
      "text": "Row 1: Row 2: Nie row 3: row 4: © 2012 - 2025Guidelineenda",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed <none> (column 2)",
      "text": "Row 1: Row 2: Road 3: Row Row 4: row 5: row 6: a a pro",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed <none> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Incel Row 5: Row 6: Row 7: oduct unders",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed <none> (column 4)",
      "text": "Row 1: row 2: Row 3: Row 4: drool lungcRaw 5: ROW 6: − Row 7: supported by theKennisi",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed <none> (column 5)",
      "text": "Row 1: carcinoma Row 2: Row 3: Medical Medical Specialists",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "headed headed <Start Page - lung lung carcinoma>",
      "text": "Page Page 2/ multidisciplinary multidisciplinary committee;Row Row 29: Row 30: on on 23-01-2025 5/428",
      "start_page": 5,
      "end_page": 5
    },
    {
      "heading": "headed headed <Start Page - lung lung carcinoma> (column 1)",
      "text": "Use Use (CHMP) Row Row ́s suspension is: This pack contains: the the studies? multidisciplinary multidisciplinary committee;Row Row 29: Row 30: on on 23-01-2025",
      "start_page": 5,
      "end_page": 5
    },
    {
      "heading": "headed headed <Start Page - lung lung carcinoma> (column 2)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: et- row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: - row 14: row 15: row 16: eincel eincel . row row 17: row 18: row 19: row 20: row 21: row 22: row 24: row 25: row 26: row 27: row 28: ew 29: EKT 29:",
      "start_page": 5,
      "end_page": 5
    },
    {
      "heading": "headed headed <Start Page - lung lung carcinoma> (column 3)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: row 25: row 26: row 27: row 28: row row 29: row 30: 5:",
      "start_page": 5,
      "end_page": 5
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: cancer cancer - General Row 3: Row 4: See the 'sub sub module'. Row 5: Road 6: ~ Row 7: Responsible Row 8: ? Row 9: Last assessed: 10-07-2015 Road 10: Last authorized: 10-07-2015",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 6/428",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: cancer cancer - Algem Row 3: Row 4: module module 'Epidemiology and pathogenesis' Row 5: row 6: ~ row 7: Responsible Row 8: ? Row 9: Last assessed: 10-07-2015 Road 10: Last authorized: 10-07-2015",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: Row 5: 1",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: on on 23-01-2025",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: een Row 3: Row 4: '. Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: Row 13: Row 14: the the . Med Med 2001;58:52-61. Row 15: Row 16:",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: Row 13: Row 14:Row Row 15: Row 16: 6/428",
      "start_page": 6,
      "end_page": 6
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: shift shift - pathogenesisRow pathogenesisRow 3: Row 4: EpidemiologyRaw 5: is is diagnosed; in about 70% __MEDTERM6_ __MEDTERM6_ (feb feb 2020). smoking smoking [Molina 2008(7)], diseases diseases (COPD) [Collins 2007(6)], matter matter (phine particles) * following following studies:",
      "start_page": 7,
      "end_page": 7
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: row 4: Lately authorised: 10-07-2015",
      "start_page": 8,
      "end_page": 8
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row Row 4: row 5: J J 9:97-",
      "start_page": 8,
      "end_page": 8
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 6- Lung Lung cancer: management. management. 'Physician Physician 2007; 75(1): 56-63'. Row 2: 7 Row 3: Proc Proc 2008; 83(5): 584-594.' Row 4: 8",
      "start_page": 8,
      "end_page": 8
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 822.' Row 2: 10 - Row Row 3: Row 4: on on 23-01-2025 8/428",
      "start_page": 8,
      "end_page": 8
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Screening Row 3: Row 4: Row Row 5: Row 6: lung lung carcinoma? Row 7: Row 8: Recommendation Row 9: Row 10: Row Row 21: Row 22: nodules nodules __",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: row 4: lung lung carcinoma' ROW 5: discontinued discontinued ≤__MEDTERM0_ __MEDTERM0_ smoking) Trial Trial (NLST) __ELDERM0; specific specific application( study study (1.2%) NLST NLST (23.3%). Row 6: Row 7: Responsible Row 8: ? Row 9: Last assessed: 10-07-2015 Row 10: Last authorized: 10-07-2015",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 10/428",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: cancer cancer - Row Row 3: Row 4: row row 5: row 6: at at __MEDTERM0_? Road 7: ~ row 8: Recommendation row 9: − row 10: ____METM0_ ____METM0_ . row 11: ≥ row 12: Concern 14: Row 13:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 11/428",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: row row 5: row 6: row row 7: ? row 8: Recommend row 9: - row 10: row row 11: − row 12: Considerations row 13: = row 14: row row 15: ~ row 16:Row-2-2: Row-2-5: Row-12:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: arcin row 3: Row 4: Row 5: Row 6: dishond row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: Row 13: Row 14: eschre Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: 2011 Row 21: 2011 row 22: Row 23: order Row 24: Row 25:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Uncle Row 3: Row 4: Row 5: Row 6: derzoe Row 7: Row 8: Row 9: Row 10: tithe Row 11: Row 12: Row 13: Row 14: even. Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: m - Hereditary Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8: Row 9: Row 10: eidsonderzo Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: jkheidso Row 3: Row 4: Row 5: Row 6: LC ? Row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: under Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: CLC. Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: entual Row 22: Row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 7)",
      "text": "Row 1: Row 2: rzoe Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 8)",
      "text": "Row 1: Row 2: ek Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: verra Row 22: Row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 9)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row row 22: row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 10)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: produ row 22: row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 11)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row row 22: row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 12)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: guess row 22: row 23:",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 13)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row row 22: row 23: 11/428",
      "start_page": 11,
      "end_page": 11
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: cancer cancer - Diagnosis Row 3: Row 4: The subject 'carcinoma carcinoma diagnosis' modules. modules.' Row 5: Road 6: Responsible Row 7: ~ Row 8: Last assessed: 22-05-2011 Row 9: Last authorized: 20.05-2011",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 12/428",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: CancerRaw CancerRaw 2: lungcaRow lungcaRow 3: Row 4: The subject 'non small Cell'Row 5: Rrow 6: ResponsibleROW 7: ~Row 8: Last assessed: 22-05-2 Row 9: Last authorized: Road Road 10: −Row 11: Ray Ray 12: =Row 13: on on 23-01-2025",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: arcin row 3: Row 4: row row 5: Row 6: Row 7: Row 8: 2011 Row 9: 2011 row 10: Row 11: order Row 12: Row 13:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: uncle row 3: row 4: gcarcin row 5: row 6: row 7: row 8: row 9: row row 10: row 11:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: m - Diagn Row 3: Row 4: noom-diagn Row 5: Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: nostalgia Row 3: Row 4: nostius' wo Row 5: Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: peelle row 5: Row 6: Row 7: Row 8: Row 9: produ row 10: Row 11:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 9)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11:",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 10)",
      "text": "Row 1: row 2: Row 3: Row 4: es.ROW 5: ROW 6: ~Row 7: −Row 8: 4)Row 9: theRaw theRaw 10: =Row 11: 12/428",
      "start_page": 12,
      "end_page": 12
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: cancer cancer - Row Row 3: Row 4: Row Row 5: row 6: met___ met___ {Row Row 8: Recommend Row 9: ~ Row 10: is is thirteen-: Row 13:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 13/428",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: Row Row 5: row 6: aff aff nmet_____",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: arcinoma Row 3: Row 4: Row 5: Row 6: row row 7: Row 8: Row 9: Row 10: row row 11: Row 12: Row 13: Row 14: Written. Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: 2011 Row 21: 2011",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row Row 2: row 3:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: m - Anam Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: licha Row 3: Row 4: Row 5: Row 6: outvo Row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: entual Row 22: Row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: ame Row 3: Row 4: Row 5: Row 6: row row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 7)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row 5: Row 6: row row 7: Row 8: Row 9: Row 10: erboe Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: verwai Row 22: Row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 8)",
      "text": "Row 1: Row 2: onde Row 3: Row 4: Row 5: Row 6: chame Row 7: Row 8: Row 9: Row 10: duck. Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 9)",
      "text": "Row 1: Row 2: erzoe Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: produ Row 22: Row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 10)",
      "text": "Row 1: Row 2: ek Row 3: Row 4: Row 5: Row 6: underz Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row Row 22: Row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 11)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: guess row 22: row 23:",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 12)",
      "text": "Row 1: Row 2: Row 3: Row 4: row 4: row 5: row 6: row row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row row 22: row 23: 13/428",
      "start_page": 13,
      "end_page": 13
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Rrow Rrow 3: Raw 4 : imaging imaging (Row 5: Row 6: Rough Rough 8: Recommendation Row 9: − ROW 10: ~ is is 67-88% tomography tomography (CT) be be performed",
      "start_page": 14,
      "end_page": 14
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: a a short-axis-dia_MENTERM0_er > IASLC IASLC (Lung Lung Cancer) Tumors Tumors (RECIST) to to (www.eortc.be/recist). maximum maximum dia_>a a 'long' window (WW = 1200-1500, WL = 50-100) the the tumor",
      "start_page": 15,
      "end_page": 15
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Responsible Row 4: row 5: Last assessed: 22-05-2011 Row 6: Last authorized: 20.05-2011",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 16/428",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: Responsible Row 4: row 5: Last assessed: 22-05-2 Row 6: Last authorized: 2/2/2 row 7: row 8: database. database.' Row 9: ~ row 10: on on 23-01-2025",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: 2011 Row 6: 2011",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row Row 2: row 3:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: row row 7: Row 8:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: vervain Row 7: Row 8:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: row row 7: Row 8:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8:",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 9)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row Row 7: Row 8: 16/428",
      "start_page": 16,
      "end_page": 16
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - FDG-PET Row 3: Row 4: Row Row 5: Road 6: the the mediastinum? Raw 7: Recommendation Row 9: ~ ROW 10: Patients Patients ~effective. effective. • FDG FDG -PET; the the fDG-the the Rovange-PET-T-DPM-DQ-Dovest-Gods-",
      "start_page": 17,
      "end_page": 17
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: __MEDTERM0_astases __MEDTERM0_astases (>95%) specificity specificity (approximately 78%) FDG FDG -Level Level 1: A1 Gould 2003; (12) 2008. 2008. (18) The FMD-__OMEPTERM0_a __OMEPTERM0_a _&===4-== ===(==-==>==#==",
      "start_page": 18,
      "end_page": 18
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 18/428 Row 2:",
      "start_page": 18,
      "end_page": 18
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: of of FD-PET-ROW ROW 5: the the FED-PET-CT'of of 92% of of 84%, of of FDG-data data (are are based) a a __",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: __MEDTERM0_astasis __MEDTERM0_astasis 11%. Gould Gould 2(3). the the Natory'the the FMD-brain brain tissue; are are >90% are (5). demonstrating demonstrating brain- and liver_MENTERM0(s) be be a",
      "start_page": 20,
      "end_page": 20
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Responsible Row 4: row 5: Last assessed: 22-05-2011 Row 6: Last authorized: 20.05-2011",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 1905 Row 2: 2",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Med Med 139:879-892 Row 2: 1",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 348:2500-2507 Row 2: 17 - Lung Lung Cancer: Dual-Modality PET/Row Row 3: Row 4: on on 23-01-2025 21/428 Row 5:",
      "start_page": 21,
      "end_page": 21
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: Row Row 4: row 5: Preoperative Staging. 'Radiology 229:Row Row 6: 1",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 1392 Row 2: 2",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 22:2357-2362 Row 2: 2",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 128:2490-2496 Row 2: 2",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 75:231-235 Row 2: 3",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 60:479-492 Row 2: 3",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 22/428",
      "start_page": 22,
      "end_page": 22
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4: Introduction",
      "start_page": 23,
      "end_page": 23
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row Row 3: aspiration aspiration (TBNA) subcarinal subcarinal (station 7; TNM TNM classification) region region ( Row Row 10: Row 11: Responsible Row 12: - Row 13: Last assessed: 22-05-2011 Row 14: Last authorised: 20.05-2011",
      "start_page": 23,
      "end_page": 23
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 23/428",
      "start_page": 23,
      "end_page": 23
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Veronica: VIII VIII (5. 5.1). excipients. excipients.",
      "start_page": 24,
      "end_page": 24
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW ROW 3: Row 4: ROW ROW 5: techniques techniques (almost) 100% Raw Raw 7: ROW ROW 17: ROW 18: RowTer RowTer (Bosema, 2019) 9. 9.6% and 9.9% endosonography endosonography (combination EU/EBUS) the the results",
      "start_page": 25,
      "end_page": 25
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: Road Road 4: row 5: patients patients (possibly their carers) Row 6: An EBUS/ the the body; the the gullet/ row row 10: following following conditions: the the benefit/this this indication: Raw 15",
      "start_page": 26,
      "end_page": 26
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: : Row Row 5: characteristics characteristics (in ESTS < NCCN NCCN < and and < 3cm nonsolid tumors), CT CT (< short short axis) ROW ROW 6: mediastinal mediastinal staging: resistance resistance (",
      "start_page": 27,
      "end_page": 27
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: to to EBUS/ lung lung cancer; powder 6: ~Row Rovode 8: ́Sources: (Seghal, 2016)review. review.' Row 17: Row 18: Review Review (source: )",
      "start_page": 28,
      "end_page": 28
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Seghal, 2016) Row 2: Row Row 3: 5 5 : avoidable avoidable cm(s) .",
      "start_page": 28,
      "end_page": 28
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Veronica: Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: surgery surgery (inoperable inoperable patient), disease disease (respiratory respiratory disease) . VAM VAM (Um, 2015; Zhang, 2012). In Row 26: on on 23-01-2025 29/428 Row 27: Row 28:",
      "start_page": 29,
      "end_page": 29
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: lung lung carcinoma' Row 2: Row Row 3: Row 4 : Row 5 : request request (PET-Rovant, PET-Rovant, rowd-Rawd-Sp.",
      "start_page": 29,
      "end_page": 29
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: surgery surgery (inoperable inoperable patient), Row Row 3: Row 4 : failure. failure.",
      "start_page": 29,
      "end_page": 29
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: mediastinoscopy mediastinoscopy (Annema, 2010; Liberman, 2014). the the EBUS-TBNA/ EUS -FNA (Annema, 2005; Um, 2015; the the hospital",
      "start_page": 30,
      "end_page": 30
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 30/428 Row 4: Row 5:",
      "start_page": 30,
      "end_page": 30
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: ROW 4: Row Row 5: Road 6: ́ Row 7: Row Row 8: and and 91% versus versus 90% group. group. Liberman",
      "start_page": 31,
      "end_page": 31
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: row 2: Row 3: Row 4: Row 5: lungRaw lungRaw 6: 6. 6.8% (95% 9. 9.8)Rov 7: ROW 8: Table 2Complications EUS/EBUS versus mediastinaloscopy/surgical staging. Source: Seghal (2016) Raw 9: StudyEUS/ EBUSMediastinoscopy Raw 10: Annema",
      "start_page": 32,
      "end_page": 32
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: 6. 6.8% (95% 9. 9.8). Row 4: row 5: Table 2Complications EUS/ EBUS versus mediastinaloscopy/ surgical staging. Source: Seghal (2016) ROW 6: StudyEUS/ EBUSMediastinoscopy Raw 7: Annema",
      "start_page": 32,
      "end_page": 32
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: 1) row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row row 21: cal row 22: row 23: row 24: row 25: row 26: row 27: row 28: row 29: row 30: row 31: pyeon:",
      "start_page": 32,
      "end_page": 32
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: C: Mediastinoscopy; and Row 6: O:reviewed reviewed (Row 7: measures measures - Row 9: complications complications - Routine.",
      "start_page": 33,
      "end_page": 33
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 33,
      "end_page": 33
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 33/428 Row 3:",
      "start_page": 33,
      "end_page": 33
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 4",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 34/428",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: 4",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: on on 23-01-2025",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: with with quez- Row 4: Row 5: 34/428",
      "start_page": 34,
      "end_page": 34
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW_ION: ROW ROW 2: carcinoma carcinoma - Row Row 3: Row 4: Raw Raw 5: Road 6: Row Row 8: row row 7: Recommend CPMP/ 3736/ 03 12/ treatments. treatments. ́ Row 17: Row 18: Undergoing Row 19: ~ Row 20: Conclusions Row 21: ́ ROW 22: In patients ~ a a ~",
      "start_page": 35,
      "end_page": 35
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: ROW ROW 5: loss loss (1). of of ___METM0/CT CT (adrenals, the patient'the the chest/done done (renal renal impairments). a a FDG-PET/first-stage first-stage study",
      "start_page": 36,
      "end_page": 36
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: ROW ROW 5: conclusionf conclusionf (9). demonstrate demonstrate (occulte) carcinoma, carcinoma,",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 4- cancer. cancer. 'Chest 123:S137-146'. 2003. Row 2: 5",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 37/428 Row 2: Row 3:",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Roentgenol Roentgenol 168:Row Row 6: 1",
      "start_page": 38,
      "end_page": 38
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 38/428",
      "start_page": 38,
      "end_page": 38
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4: Row Row 5: Row 6: lung lung carcinoma? Row 7: Row 8: Recommendation Row 9: Row 10: as as appropriate;is is not",
      "start_page": 39,
      "end_page": 39
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: row row 5: survival survival (Guidelines Guidelines 2003). with with Row-",
      "start_page": 40,
      "end_page": 40
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 40,
      "end_page": 40
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 3- Cancer Cancer biomarkers: into into success?Inst Inst 102:Row Row 2: 4",
      "start_page": 40,
      "end_page": 40
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 40/428",
      "start_page": 40,
      "end_page": 40
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - medical medical (in)operability Row 3: Row 4: Row Row 5: Row 6: for for medical(in)operation? Row 7: Row 8: Recommendation Row 9: Row 10: Age",
      "start_page": 41,
      "end_page": 41
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Considerations Row 3: Row 4: Lung function testing",
      "start_page": 41,
      "end_page": 41
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 41/428 Row 2:",
      "start_page": 41,
      "end_page": 41
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: value value (%pred). function function (FEV and/or TLCO < 80% of predicted) TLSO TLSO ppo) calcification_ISMETM0_hode calcification_ISMETM0_hode (scan scan combined;higher higher risk",
      "start_page": 42,
      "end_page": 42
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: perfusion perfusion scan/ FEV FEV > 40% is is > 40% dyspnea dyspnea d'FEV FEV < 40% and TLSO < 40% Level Level 3: 1989, 1989, (14) 1994, 1994, (24) Furguson 1995, (22) have have a",
      "start_page": 42,
      "end_page": 42
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: row 2: Row 3: row 4: • cancer cancer • was was tried: is is increased: 10, 10,6% 17. 17.8% 8. 8.1% nectomy nectomy (3). perioperative perioperative mortality",
      "start_page": 43,
      "end_page": 43
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Figure 1: Row Row 7: Row 8: FEV = TLCO TLCO = max max = functional functional lob'the the pulmonary",
      "start_page": 44,
      "end_page": 44
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Figure 1: Row Row 3: Row 4: FEV = TLCO TLCO = max max = by by the",
      "start_page": 44,
      "end_page": 44
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: n Row 3: Row 4: order ben) tal Row 5: 44/428",
      "start_page": 44,
      "end_page": 44
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: ROW ROW 6: l l (for a lobectomy: > 1.5 l) (12). above above 80% 1 1 (13). the the 1+QQQ <=of of 34% (28). ppo ppo > 10 2 mL/ min/ ppo ppo < 10 mL/min/ perisurgical perisurgical mortality/ morbidity (14). in in ml/ minute/ into into account;___MEDTERM0_ under-",
      "start_page": 45,
      "end_page": 45
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 1 Row 2: 24",
      "start_page": 45,
      "end_page": 45
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 1 Row 2: 22",
      "start_page": 45,
      "end_page": 45
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "following following convention: Row 3: row 4: Role 5: cancerarrow cancerarrow 6: of of 35% Plan Plan (RMP) perioperative perioperative re-operation",
      "start_page": 46,
      "end_page": 46
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 46,
      "end_page": 46
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Oncol Oncol suppl1: s83-92 Row 2: 6- octogenarians. octogenarians. 'Surg Surg 63:785-789', 1997. Row 3: 7- Elderly. Elderly. 'J J 33:222-288",
      "start_page": 46,
      "end_page": 46
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 46/428 Row 3:",
      "start_page": 46,
      "end_page": 46
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 1",
      "start_page": 47,
      "end_page": 47
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 31 - morbidity. morbidity. 'Dis Dis 129:730-734', 1984 Row 2: 3",
      "start_page": 47,
      "end_page": 47
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 3 Row 2: Chest 104:701-704 Row 3: 3",
      "start_page": 47,
      "end_page": 47
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 47/428 Row 2:",
      "start_page": 47,
      "end_page": 47
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: IIIA-N2 IIIA-N2 non-Inst Inst 99:442-450; 2007. Row 6: 99:442-450 Row 7: Row 8: on on 23-01-2025 48/428",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: radio radio 99:442-450; 2007. Row 4: 99:422-450 Row 5: Row 6: on on 23-0",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: inoma Row 2: Row 3:Row Row 4: Row 5: 01-2025",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3:Row Row 4: Row 5:",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: Row 3:Row Row 4: Row 5:",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: Row 3: small-c Row 4: Row 5:",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5:",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: 48/428",
      "start_page": 48,
      "end_page": 48
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: cancer cancer - Row Row 3: Row 4: row row 5: row 6: Which investigations (tumor tumor tissue) targeted targeted therapy? Row 7: studies studies are: Road Road 9: studies studies should",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row Chemical 1: Row 2: Substantiation Row 3: row 4: Conclusions Row 5: Road 6: adequate adequate staging? Raw 7: Row Row 8: assessment assessment and/ of of (occult) nceterM0 -setting setting of",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Version 2011/2015 Row 2: including including p40/of of __",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: cancer cancer - Row Row 3: Row 4: row row 5: row 6: Which investigations (targeted targeted therapy? Row 7: studies studies are: Row 8: − Row 9: care care unit",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: Substantiation Row 3: row 4: Conclusions Row 5: Road 6: adequate adequate staging? Raw 7: Row Row 8: assessment assessment and/ of of (occult) than than rowT",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Version 2011/2015 Row 2: including including p40/of of __",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: el) are row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: al row 15: TTF-1 row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row row 24: row 25: row 26: row 27: row 28: row row 29: row 32:",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: know row 24: row 25: row 26: row 27: row 28: row 29: row 30: row row 31: 49/4.",
      "start_page": 49,
      "end_page": 49
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Level 3",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row Row 3: Row 4: adequate adequate staging? ́ Rov 5: Row Row 6: the the tumor's occurrence(described described [Nosotti 2005(15); Yasumoto 2003(17)], is is a",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: Road 4: ROW 5: lung lung carcinoma' ROW 6: no WHO-diagnosis-carcinoma, carcinoma, {Captained] and {Backwards] Cryptomegaly.",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 139 Row 2: 3",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 51/428 Row 2: Row 3:",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Oncol Oncol 20:Row Row 6: 8",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Cancer 18:231-40 Row 2: 1",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 34:181-186 Row 2: 1",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 76:194-201 Row 2: 1",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 115:777-782 Row 2: 1",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 20 - cancer. cancer. 'Res Res ;135:167-175,'2007. Row 2: 2",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 867 Row 2: 2",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Pathol.41:1536-1543 Row 2: 2",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Oncol Oncol 5:436-41 Row 2: 2",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 52/428 Row 3:",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 2",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Anticancer Res 29:2767-2773 Row 2: 3",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 815 Row 2: 3",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Pathol 22:128-133 Row 2: 4",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 53/428 Row 3:",
      "start_page": 53,
      "end_page": 53
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 4",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Res Res 15:3315-",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: N",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 2007 Row 2: 6",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 66 - Pathology. Pathology. 'Row Row 2: 6",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 6'8 - Med Med 120:Row Row 2: 6",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 54/428 Row 3:",
      "start_page": 54,
      "end_page": 54
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: Row Row 4: row 5: 2013; 368(25): Row Row 6: 7 Clin Onco",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 8'0 - adenocarcinoma. adenocarcinoma.'Nat Med 2012; 18(3): 375 377.' Row 2: 8",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 2011; 35: 15 25.' Row 2: 84 - carcinomas. carcinomas.'Pathol Pathol 2012; 36: 895-899.' Road 3: 8",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 290. Row 2: 8",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 8 row 2: Cancer Res 2005; 65(5): 1642-1646. Row 3: 9",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Med Med 2013; 137(5): 668-684. Row 2: 9",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 55/428 Row 3:",
      "start_page": 55,
      "end_page": 55
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 9",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 56/428",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: 9",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Pathol. Pathol. 2013; 37(4): 554-562 Row 2: Row 3: on on 23-01-2025",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: uniq uniq . Row 3: Row Row 4: 2. Row 5: Row 6:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4: Row 5:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: opatho Row 3: patholo Row 4: Row 5:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4: Row 5:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: Row Row 3: row row 4: Row 5:",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 7)",
      "text": "Row 1: Row 2: Row Row 3: row row 4: Row 5: 56/428",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: carcinoma carcinoma (Synoptic Reporting) is is essential: Row Row 5: protocol protocol Rowman's room:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Melanoma Row 2: Renal-Row Row 3: Row Row 4: Row Row 5: Row Row 6: Row Row 7: prostate - Row Row 8: Row Row 9: Row Row 10: Row Row 11: Row 12: to to : Foundation Foundation PALGA- 04:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: reporting reporting (Synoop essential: row row 5: row row 6: row 7: national protocols histology: row 8: Adnexs (row row 9: Rowoxanthoma-Raw 15: Bladder-Urether-Cancer:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Melanoma Row 2: Renal-Pyelum-Uretercarcinoma Row 3: Ophthalmologic Row 4: Row Row 5: Row Row 6: Row 7: Row Row 8: prostate - Row Row 9: Row Row 10: Row Row 11: Row Row 12: Row 13: to to paulus: Row 25:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: ptic ptic Reporting) Row Row 5: Row Row 6: Row 7: Row 8: noom) Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 17: Row 18: Row 21: mbiopsy Row 23:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: Row Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 27: Row 28:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 27: Row 28:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: tomatic row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 24: Row 25: Row 26: Row 27: Row 28:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 27: Row 28: Row 29: Row 30: 04:",
      "start_page": 57,
      "end_page": 57
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Working Group Protocols",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Responsible Row 3: row 4: Previously assessed: 01-10-2024 Row 5: Last authorized: 21-09-2018",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 58/428",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row Row 4: Row 5: Responsible Row 6: Row 7: Row Row 8: Row Row 9: Row 10: Row Row 11: Row 12: at at 23-0",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: inoma Row 2: collen",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Road 3: row 4: : 01-10-2024 Row 5: rd: 21-09-2018",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row Row 2: Row 3: 01-2025",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: de de NVVP/Row Row 3: Row 4: Row 5: Row 6: Row 7: Row Row 8: Row 9:",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: ening ening (CBU Row 3: Row 4: Row 5: Row 6: Row 7: Row Row 8: Row 9:",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: oriented. This U) Row Row 3: Row 4: Row 5: Row 6: Row 7: Row Row 8: Row 9: 58/428",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: Row Row 3: Row 4: Rrow Rrow 5: Raw 6: longer longer up-2024 2024 ( detection detection (LOD) Row Row 15: ROW ROW 17:Row Row 18: − ROW 19: for for NEGS",
      "start_page": 59,
      "end_page": 59
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Row Row 13: Row 14: not not worked; panel panel and/ techniques techniques ___",
      "start_page": 60,
      "end_page": 60
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: • cancer cancer • ROW 5: • material. material. • Road 6 • 8 8 : analysis analysis (BIA) guideline guideline (see associated products), Raw Raw 17: UndergoingRow 18: ROW 19: BackgroundROW 20: −Row 21: to to 24",
      "start_page": 61,
      "end_page": 61
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: Row Row 4: found found (NGS NGS positive) five five (42%). Row 24: Low Row 25: ́GRADE ROW 26; Row 27: ~Row 28: −Raw 28 Rov-Rov-Now-Raw, −33, 33, RNEX-ROV-Ray, γ - N-Q-R-D-R.",
      "start_page": 62,
      "end_page": 62
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Tuononones, 2013; Xu, 2016). Zugazagoitia (2018) Row Row 7: Row 8: NGS NGS platforms: Row Row 15: Row 16: Jing Jing (2018), the the Lung'Row Row 20: Row 21: Tuonen Tuonen (2013), NGS NGS (on Illumina platform) Row Row 22: on on 23-01-2025 63/428 Row 23: Row 24: Row 25: Row 26:",
      "start_page": 63,
      "end_page": 63
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Row Row 5: Road 6: 2 2 & 2 (of of __",
      "start_page": 64,
      "end_page": 64
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 4: • ROW ROW 5: • ROW 6 • of of • Tested N • PREvalence Sensitvity% false% NGS NGS e* rod 7: 8 8 • rows",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: StudyNGS Row 4: row 5: Row Row 6: Road 7: ~ Row 8: Row Row 9: ́Row 10: − Row 11: SystemRow SystemRow 12:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: uncle Row 2: Row 3: Row Row 4: DNA Row 5: Row 6: Row Row 7: ~Row 8: nranged from <row row 9: −Row 10: 4Row 11: 12: ySeq- to to 20-50ng/μLROW 15:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: fReferen Row 4: test Row 5: Test Row 6: ~Row 7: ROW ROW 8: −Row 9: =Row 10: Row Row 11: ----------------Row 12:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: Row 3: nceTestRaw 4: ROW 5: mutaROW 6:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: Row 3: ed",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: ationsampl row 2: Row 3: row 4: R38 row 5: Row 6: row row 7: ~Row 8: Row Row 9: ≥99 row 10: R; row row 11:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: row 3: Prevalen Row 4: Row 5: lesmutatio row 6: (using referenc test) Row 7: ~Row 8: in n=Row Row 9: −Row 10: =8.6% Row 11: ------------- Row 12: ----------------in n=Row Row 13:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 7)",
      "text": "Row 1: Row 2: row 3: nceSensitiv row 4: ous ceRow 5: Row Row 6: ~(reference reference test) Row 7: −Row 8: ≥100% Row 9: -------------% -Row 10: ----------------Row 11: =row 12: s100% -Row 13:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 8)",
      "text": "Row 1: Row 2: row 3: vity% false row 4: row row 5: negativeiv row 6: NGS row 7: ~NGS row 8: − Row 9: ------------- raw 10: ----------------0% row 11: >row 12: =0% row 13:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 9)",
      "text": "Row 1: Row 2: row 3: e row 4: row row 5: row row 6: ~ samples row 7: =positive row 8: for Row 9: − mutation row 10: • Row 11: row row 12: >(type) * Row 13: REZ/3 (EG5=% FR: ORO 27.5: 34%:",
      "start_page": 65,
      "end_page": 65
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Road 5: arrow 6: • Row@Rout Rout ́ o o ́ ml ml ́ ml ml { 0 0 ? ml ml ? Row ́",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: row 5: Row 6: ́ddPCR Row 7: ~Row 8: possiblePCR possiblePCR (Taqman Row 9): 20 20 ROW",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: _MEDTERM0_ROW 3: Row 4: ROW 5: ***ROW 6: ~ROW 7: n)_MEPTERM0_CRASE ROW 8: −Row 9: ROW ROW 10:",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: R112n=4 Row 3: Row Row 4: Row 5: R101n=34 Row 6: Row Row 7: Row Row 8: ~n=3 Road 9: −25% Row 10: ́Row 11: =166EGF Row 12: ≥n=1 Row 13: 1-16% Row 14: 1row 15: 1, 1,",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: 42 Row 3: 5 % Row 4: Row 5: 48 Row 6: 5% Row 7: AS: Row 8: 302, Row 9: % Row 10: Row 11: FR: Row 12: 190 Row 13: % Road 14: Row 15: Row Row 16: % ROW 17: Row 18: Row 19:",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: 95.2% Row 3: Row 4: row 5: 96% Row 6: ~Row 7: 1 00% Road 8:",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: 4.8%16/70=23 Row 3: Row 4: 4%1/53=2% Row 5: Row 6: -0%KRA KRA mut% S (Row Row 7: ~Row 8:",
      "start_page": 66,
      "end_page": 66
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: ROW 6: lung lung carcinoma0=Row Row 7: time time PCR; Threascreen / AmoyDx_MEDTERM1_, KRAS, __",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: specificity; Row Row 2: Row 3: Row Row 4: of of 100% than than 100% (Gao, 2016; toegenomen, toegenomen, 2018; of of Rod(s) spasms. spasms.",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: samples Row 2: (both)",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "ROW 1: ROW ROW 2: time time PCR; Threascreen / AmoyDx_MEDTERM1_, KRAS, _",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: FR 3% AS 96% not not cultured)_",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: row 3: axis axis 6; Jing, 2018; ged from 4% to 16%. Row 4: row 5: Row 6: ED testing% failed tests (PCR) Row 7: ~Row 8:",
      "start_page": 67,
      "end_page": 67
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Road 5: Raw Raw 6: RRAS, RRAS, EGFRBAR_RAD: 20%-ROW 7: 2. NGS-IonT_MENTERM1: 16% Row 8: ~ ROW 9: ́R% 10: C-112 C-112 Red(C)",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row_ 1: Row Row 2: Row Row 3: 2. NGS- IonT Row 4: Row 5: ngddPCR ngddPCR / Row 6: Sanger Row 7: ́Row 8: possiblePCR possiblePCR (Tawl)(Row-Iow,",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: CRAS __MEDTERM1_ROW 3: row 4: row 5: _MEDTERM1_ Road 6: ~ row 7: {Row 8: man}row row 9: }Row 10: \\row 11: a_",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: row 5: R112 row 6: ROW 7: row row 8: ~Row 9: −Row 10: row row 11: -------------Row 12: R-109 row 13: ●Row 14: 1row 15: ontraindications -Row 16:",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: CRAS: 20% Row 3: ___MEDTERM0_: 16% Row 4: Row 5: 17/129=1 Row 6: ~Row 7: 95.5% Row 8: −Row 9:",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: % - Row 3: % Row 4: row 5: 13%- Row 6: Road 7: ~_",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Road 5: lung lung carcinoma' ROW 6: tests tests (D'Haene, 2015; Legras, 2018; Tuononen, 2013). Row Row 17: Row 18: and and (Row Row 28: Row 27: limited limited (",
      "start_page": 69,
      "end_page": 69
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: ROW 3: = ROW 4: Row Row 5: limitations limitations (risk of bias) and imprecision (samples samples tested). # Row_raw 7: equals equals 9; row 8: excluded excluded (tab tab Methods), Row Row 22: Row 23: Resultsrow 24: Row Row 25:",
      "start_page": 70,
      "end_page": 70
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: Row 5: 1 - of of __",
      "start_page": 70,
      "end_page": 70
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: One. One. 2015;10(9):e0138245. doi: 10.1371/Row Row 6: 3",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 71/428",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW Mechanisms 1: ROW ROW 2: Row Row 3: Raw 4: Row Row 5: Road 6: with with ~_MEDTM1Roved therapyRaw 7: RecommendationRow 9: ́ROW 10: the the {ME Box]S- treatment treatment (for example;_ gewetenterm1________# RometerM0_; transformation transformation (Oxnard Oxnard 2018))) as as /_MEPTER_10_, will be",
      "start_page": 72,
      "end_page": 72
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Row Row 5: analyses analyses (mutation mutation analysis). Road 6: Cost (means deposit) Raw 8: provide provide 24-( thus) and and 25-( previously) with with row-T",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: • ROW ROW 5: • therapy therapy (included included (Oxnard, 2011; Ji, 2013; Matsuo, 2016).' Row 28: Row 29: Mok (2017) trial trial (AURA3) with with T790M- after after first-line",
      "start_page": 74,
      "end_page": 74
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: c Row 3: Row 4: ROW ROW 5: survival survival : 0.53 (95% P P = 0.002). Nie Nie (2018) __MEDTERM0_ __MEDTERM0_ (___medterM0; ); as as Rower's partner.",
      "start_page": 75,
      "end_page": 75
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: O:Row Row 6: row 7: measures-Row measures-Row 8: 2 2 (equal. equal.",
      "start_page": 76,
      "end_page": 76
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 76,
      "end_page": 76
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 76/428",
      "start_page": 76,
      "end_page": 76
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: Row Row 3: Row 4: Row Row 5: Road 6: adequate adequate staging? Rrow 7:commence Row 9: # Raw 10: detect detect (micro)_MED®Wow Wow 11: studies studies (and and melanoma) Row Row 20: patients patients (their their carers) ROW 21: Raw Raw 22: Row Row 25",
      "start_page": 77,
      "end_page": 77
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Substantied Row 4: ROW 5: Background Rrow 6: Road 7: pre-operative pre-operative and/ disease disease (Rovange'the the EU/ EB_ Selective/ patients patients (Dai, 2013; Dobashi, 1997; Goldstein, 2000; Gu, 2002; Izbicki, 1996; Li, Li, 2008; Martin, 2016; Nosotti, 2005; Rena, Rena, 2007; Rosch, 2011; Wu, 2001; Yamashita, 2010; Yasumoto, 2003.) hospital. hospital.",
      "start_page": 78,
      "end_page": 78
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Road 6: Dai (2017) adenocarcinoma adenocarcinoma (stage I). cytokeratin cytokeratin (AE1/AE3) and aspartate-lactate- Jeong (2018) 25. 25.3% (95%CI 20-320%); 23. 23.1% (95% CI 18-29%). 33. 33.7% (95% CI 26-43%). rates rates (Dai, 2017: 15%; Gwozdz, 2018: 9.5%; Ren, 2018 : o. o. • Roryvre • rossie • r",
      "start_page": 79,
      "end_page": 79
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: • ROW ROW 5: Road 6: ́Row 7: Martin (22) were were made: other. other.",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: ROW ROW 5: respectable respectable __MEDTERM0_?Row 6: Row 7: P:patients with resectable___MENTERM0_;Row 8: I:tables. tables.' Row 20: Row 21: Responsible Row 22: ~ Row 23: Last assessed: 07/07-220 row 24: Last authorized 07-07-202",
      "start_page": 81,
      "end_page": 81
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 81,
      "end_page": 81
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 81/428 Row 3:",
      "start_page": 81,
      "end_page": 81
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: 2018 Feb;214(2):240-244. doi: 10,1016/Row Row 6: 4",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 82/428",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: 2018 Feb;214(2):240-244. doi: 10,1016/Row Row 4: 4",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: on on 23-01-2025",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: . Row 4: Row Row 5: Row 6:",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6:",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: 2018 2018 Dec;25( Row 5: Row 6:",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: icrome (13):38 row 5: Row 6:",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: 82/428",
      "start_page": 82,
      "end_page": 82
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: lung lung - Rrow Rrow 3: Row 4: is is 'chromosome chromosome 5: be be addressed: _MEDTERM1 _MEDTERM1 : question question (see Attachment):",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 83/428",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Raw Raw 2: cancer cancer - Row Row 3: Rrow----------------RD 4: row row 5: be be addressed: 0 0 : question question (see attachment): that that the",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row Row 12: Row 13: Row Row 14: Row 15: row row 16: Row 17: Row 18: Row 19: Row 20: Row Row 21: Row 22:",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: row 2: LCrow 3: Row 4: es.Raw 5: Row 6: ~Row 7: {Row 8: ectable__MEDTERM1_?Ray 9: =Row 10: }Row 11: edction/biopsy ten#Row 12: −Row 13: LC? ROW 14:",
      "start_page": 83,
      "end_page": 83
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: cancer cancer - Row Row 3: Row 4: done done (1) (3) (4). by by ≥ 1/ 2 Rodialysis",
      "start_page": 84,
      "end_page": 84
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 84,
      "end_page": 84
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 84/428",
      "start_page": 84,
      "end_page": 84
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Thoracoscopic surgeryRow 3: Rov Rov 4: Baseline questionRaw 5: Row 6: resectable resectable __MEDTERM6_? Row 7: ́Row 8: RecommendationROW 9: ~ROW 10: patients patients ~RowTerM1 RewTer'thoracotomy thoracotomy (2). Row 26: Row 27: Responsible Row 28: - Row 29: Last assessed 22-05-2011 Row 30: Last authorized: 22/05-2011",
      "start_page": 85,
      "end_page": 85
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 85,
      "end_page": 85
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 85/428 Row 2: Row 3:",
      "start_page": 85,
      "end_page": 85
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row Row 5: Row Row 6: 2",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Cardiovasc Surg ;139:976-983 Row 2: Row 3: on on 23-01-2025 86/428",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row Row 5: Row Row 6: 2",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Cardiovasc Surg ;139:976-983 Row 2: Row 3: on on 23-01-2025",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row Row 6: Row 7:",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row Row 6: Row 7:",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row Row 6: Row 7:",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: lung lung cancer: Row Row 6: Row 7: 86/428",
      "start_page": 86,
      "end_page": 86
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: Rrow 4: of of Ro",
      "start_page": 87,
      "end_page": 87
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: dissection dissection (baseline baseline question: site site of",
      "start_page": 87,
      "end_page": 87
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: a resection? staging staging - sampling sampling dissection/resection. resection.",
      "start_page": 87,
      "end_page": 87
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 87/428",
      "start_page": 87,
      "end_page": 87
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row Row 16: sleev sleev -compared compared to",
      "start_page": 88,
      "end_page": 88
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: ROW ROW 3: 1. T1-the the operator'the the surgeon'large large and/or circumfer",
      "start_page": 89,
      "end_page": 89
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Warren 1994, (5) Martini1994, (60) Landreneau 1997. (7) a a T1N0- or T2N0-0- Level Level 2: Erret 1985, (2) Level Level 3: 1991, 1991, (36) Shah 1994, (38) Pitz 1996, (64) Downney 1999, (39) Elia 2001, (41) Magdeleinat 2001. (40) Level Level 3: Weksler 1997, (43) Rocco 1999, (44) Riquet 2000, (45) Fujino 2000, (46) Burt 1987. (47) a a tracheal",
      "start_page": 90,
      "end_page": 90
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Level Level 3: 2001. 2001. (58) Row 6: Row Row 7: Row 8: Row Row 9: Row 10: T1-T2 tumors",
      "start_page": 91,
      "end_page": 91
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 91/428 Row 2: Row 3:",
      "start_page": 91,
      "end_page": 91
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: ROW ROW 5: common common one-to-the the lung'intestinal intestinal tumor(s) (i.e., pneumo-bodied pneumo-bodied intestine), ventriculectomy ventriculectomy (in the absence/electomy) series, series, 5-8% a a sleeve- lobectomy (31). the the RA/ the the sle",
      "start_page": 92,
      "end_page": 92
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: row 2: row 3: row 4: row 4: Raw Raw 5: 13 13 benodigde/ 3636 3636 l",
      "start_page": 93,
      "end_page": 93
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-20254/808 Row 2: Row 3:",
      "start_page": 93,
      "end_page": 93
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "rgebied rgebied r",
      "start_page": 93,
      "end_page": 93
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: ence' Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: melen melen 38) d), g of ) ve Row 25:",
      "start_page": 93,
      "end_page": 93
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: Row 2: Row 3: Row 4: Row 5: ROW ROW 6: T4 tumors; is is rare: patients patients (43). is is limited: is is 20%. Resection and block' survival survival (53) (54). done done ____",
      "start_page": 94,
      "end_page": 94
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Road 4: • ROW ROW 5: • invades invades • hospital hospital (in%) • survival survival (in %, maximum titres) Row 6 • Row 7 • 0 0 23} Row 8 • 26 26 (13-42) Row 9 • Left ventricular(5 85 -resection resection •",
      "start_page": 95,
      "end_page": 95
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: Row 5: 1 - Surg Surg 60:Row Row 6: Row 23-20: PDF:",
      "start_page": 95,
      "end_page": 95
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 2",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Cardiothorac Surg 15:426-432, Row 2: 2",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 96/428 Row 3:",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: 2",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: on on 23-01-2025 96",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: grandma row 4: -10, row 5: row 6: orac row 7: sc",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: ary row 2: for row 3: ung row 4: mall row 5: row 6: 5:10 row 7: row 8: row row 9: rg",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: d J",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: row row 2: row 3: orc",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: rs Row 2: cell Row 3: OMY row 4: Row 5: /428",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 2",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 38 - cancer. cancer. 'Thorax 50:782-784', 1995. Row 2: 3",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 4 Row 2: Surg Surg 114:500-501 Row 3: 4",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 4 Row 2: Surg Surg 48:130-133 Row 3: 4",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 5'0 - Surg Surg 60:1854-51995. Row 2: Row 3: on on 23-01-2025 97/428 Row 4:",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row Row 4: 51 - Surg Surg 102:Row Row 5: 5",
      "start_page": 98,
      "end_page": 98
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 59 - carcinoma. carcinoma. 'Surg Surg 8:475-483,'1979. Row 2: 6",
      "start_page": 98,
      "end_page": 98
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 98/428",
      "start_page": 98,
      "end_page": 98
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row Row 2: Goldstraw Goldstraw (data data transl). are are distinguished: life life (4. 4.4). of of the",
      "start_page": 99,
      "end_page": 99
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: performed performed (4) (9) (10) (12) (15) (5). (R0: resection resection planes; R1: left left over; R2: tissue tissue remained) Rrow 4: ROW 5: excluded excluded (Row s disease- Row Row 10: Row 11: 1 Row 12: Row Row 13: on on 23-01-2025 100/on on 23-01-2025 100)/428 Row 14:",
      "start_page": 100,
      "end_page": 100
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row Row 3: defertially-confirmed defertially-confirmed data- In approximately 30% N1 N1 nodes; the the R1+no no 4+ Roentinel-Laxation Roentinel-Laxation (cytokeratology cytokeratology (31) (34) (41) (43). Sentinel-lymphompeia--standardized standardized (44) (45). In",
      "start_page": 101,
      "end_page": 101
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Raw Raw 3: rum-by-paw,rst-to-round and run- through- the-side-of-all-body test. Row-After-Hors-To-Don't-Come-Once-in-a-reaction test Roughness-Against-Everybody-Valve-Me,-From-Yourself-Bovest-",
      "start_page": 102,
      "end_page": 102
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: ROW ROW 3: 244 244 **lymphadenopathy lymphadenopathy Lung: whole. whole.",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Under Row 2: search type",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: retrospective retrospective P= to to (almost) NVRV NVRV Tel: +49 728.",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: author; Row 2: year of",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: row 2: 0. 0.7%; Row Row 3: radiateral radiateral radioisolaterally: e. e. • locus cervix • node node • row 4 * cholecystoms cholecystoms • local anaesthetic • hematocrit hematocrit • system system • renal function",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: ositive: 0%; gaïve: twaalf ng: 0.6% Row 3: ossitive: 205; gative: row 4: row 5: copical ng + hilar row 6: row 7: ns row 8: ~ row 9: − row 10: row row 11: ctievel row 12: ndelaar row 13: row row 14: divider are 20: row 15:",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Roow 1: Row 2: ROW ROW 3: • Okumura 1991 (46) Ice-Comparator Ice-Comparator lCE-stage stage ́ to to Ro",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Okumura 1991 (46)Non-vergeli Row 3: Row 4: Kondo 1993 (47)Not-vergeli Row 5: Row 6: Buhr 1997 (48)non-vergeli Row 7: −Row 8: Hillerdal 1998 (51) Non-vergeti Row 9: =Row 10: Dresler 1999 (49)Row Row 11:",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: inoma Row 2: calibrating Row 3: Row 4: calibrating row 5: Row 6:kalating row 7: Row 8:kalifying row 9: Row 10:kalificing row 11: Row 12: Row 13: 01-2025",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row Row 3: row 4: Row 5: Row 6: Row Row 7: ~Row 8: row 9: −Row 10: d'12. 12.3* Row 13:",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: recurrence recurrence (pleura/ pericardium) than /+ rash rash (0. 0.7%; p < 0.05)correlated correlated ≥ 1/ 2. 2.1% 3. 3.9% negative negative ≥ 1/ 10 mg",
      "start_page": 104,
      "end_page": 104
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: cancerarrow cancerarrow 3: Okada 2003 (54)after after thoracotomy; Papanicolaou Papanicolaou staining; results results 28% results results 62% (p < 0.0001)factor factor (p = 0.029); 2 2 Raw: Row",
      "start_page": 105,
      "end_page": 105
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: database. database. ́ Row 2: Row 3: referring Row 4: row 5: 1 - Surg Surg 72:Surg Surg 23:229-232, 2003.' Row 13: 9 - Surg Surg 16:Row Row 14: 10 - Hawald Sr.",
      "start_page": 105,
      "end_page": 105
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 1",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 464 Row 2: 1",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 2 Row 2: Pathol Pathol 13:237-243 Row 3: 2",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 29 - Bronchialkarzinoms. Bronchialkarzinoms. Stuttgart: Row Row 2: 3",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 35 - cancer. cancer. 'Chest 123:Row Row 2: 36 - a a difference? 'Lung Cancer 2002;36:Row Row 3: 3",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 106/428 Row 3:",
      "start_page": 106,
      "end_page": 106
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: Surg Surg 126:Row Row 6: 3",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 41 - Am Am 67:Row Row 2: 4",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 45 - Am Am 82:Row Row 2: 4",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 113:683-690 Row 2: 4",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 107/428",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: Surg Surg 126:Row Row 4: 3",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row 2: on on 23-01-2025 10",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: nt Row 5: Eur J",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1:ction Row 2: Row 3: er: Row 4: d Row 5: on- Row 6: Row 7: cer Row 8: gy Row 9: Row 10: n",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: 07/428",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Lymph node amputation/mediastinal dissection/ Row Row 3: Rough Rough 6: mastectomy mastectomy / mediastinal dissection / a a resection? Row Row 7: Recommend Row 9: 17 17 : status status (N2 stations) right right lobe",
      "start_page": 108,
      "end_page": 108
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: ROW ROW 5: Level Level 2: 1968, 1968, (7) Holaday 1974, (8) Kaufman 1986, (9) Oneson 1989, (10) Mair 1991, (11) 1993, 1993, (13) 2004. 2004. (15) and and distance-of-the-left lung (Bronch (36) is is similar;Level Level 1: B Allen 2006; (6) 2005. 2005. (1) Level Level 2: B Allan. (6) higher higher Roamp:",
      "start_page": 109,
      "end_page": 109
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: ROW ROW 2: Level Level 2: 1968, 1968, (7) Holaday 1974, (8) Kaufman 1986, (9) Oneson 1989, (10) Mair 1991, (1 1993, (12) Nashef 1993, (13) 2004. 2004. (15) level level 2: 1992, 1992, (16) Hermaneklekleknekneum (n = Level 1: B Allen 2006; (6) 2005. 2005. (1) Level Level 2:B Allen. (6) Level Level 1: 2005. 2005. (1) Row 3: Row Row 4: Row 5: on on 23-01-2025",
      "start_page": 109,
      "end_page": 109
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: (11) and and 002; (20) Row Row 3: Row 4: 109/428",
      "start_page": 109,
      "end_page": 109
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Raw 2: ROW ROW 3: Row 4: Row Row 5: patients patients (2) (3) lymph lymph node(s) outcomes outcomes (1). randomized randomized studies; IASLC IASLC (Rami Porta) Surgery Surgery (ESTS) statement statement on",
      "start_page": 110,
      "end_page": 110
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: arrow 5: row row 6: of of __MEDTERM0_s",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 227:138-144 Row 2: 3",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 1 Row 2: Pathol Pathol 13:237-243 Row 3: 1",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 111/428 Row 3:",
      "start_page": 111,
      "end_page": 111
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: Row Row 4: row 5: thorax thorax 48:Row Row 6: 1",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 17 - tumor tumor (R) prognosis. prognosis. 'Oncol Oncol 10:12-20', 1994. Row 2: 1",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 464 Row 2: 2",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 559 Row 2: 2",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 31 - Bronchialkarzinoms. Bronchialkarzinoms. Stuttgart: Row Row 2: 3",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 112/428",
      "start_page": 112,
      "end_page": 112
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4 : member member ROW-procedure procedure report; the the operation? ROW-12: Row 8: section section examination: R0: resection resection planes; R1: tissue tissue left; R2: noteworthy. noteworthy.' Row 34: Row 35: Answering Row 36: - Row 37: - row 38: on on 11-01-2025:",
      "start_page": 113,
      "end_page": 113
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Last assessment: 22-05-2011 Row 4: Last cleared",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 114/428",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: Lately assessed: 22-05-2 Row 4: Last authorized: 2/2/2 row 5: row 6: Row Row 7: ? Row 8: on on 23-01-2025",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: Row 3: 2011 Row 4: 2011",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row Row 2: row 3:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: Row 6:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Start page - lung lung carcinoma> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: Row 6:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "heading heading <Startpage - lung lung carcinoma> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: row 4: row 5: row 6:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: Row 6:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: Row 6:",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 9)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: 114/428",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: survival survival is: this this study: Row Row 26: Row 27: sub-lobar sub-lobar (segment) Row Row 28: − Row 29: patients patients (their their caregivers) Road 30: trials trials with",
      "start_page": 115,
      "end_page": 115
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row row 4: Costs (cache of means) row 5: available. available.\" row 6: arrow 7: row row 8: ROW ROW 12: Row 13: Rationale/ Row Row 14: Raw Raw 16: I I ~ ROBST",
      "start_page": 116,
      "end_page": 116
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: row 4: • cancer cancer • Row 5 • I I •wice weekly • Row territory • Road Road 6: arrow 7: Conclusions Raw 8: ~ ROW 9: °T (0) patients patients (n=58 patients) enrolment enrolment (anticipated entolment: ROSEL ROSEL trial). of of Glipsid's velocities.",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: lung lung carcinoma' Row 6: Chen Chen (2018). we we didn'cohort cohort (N=5x12 5x12 Gy; N=15: 3x20 Gy; R=4: 33x18 Gy; 8x7.5 Gy). lobectomy lobectomy (n=londectomy, londectomy, n=lumpectomy, lumpectomy, N=surgery surgery (or or pneumonectomy). patients patients (27,200 patients), 0. 0.79% Row Row 19: on on 23-01-2025 118/428 Row 20: Row 21:",
      "start_page": 118,
      "end_page": 118
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: Row Row 6: 2. 2.41% patients patients (difference 1.62%; P<.001). 2. 2.82% 23 23 % treated treated patients(difference 1.41%; P=0.001). for for 90- 66 66 (95%N-α. N-α.",
      "start_page": 119,
      "end_page": 119
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: studies Row 3: row 4: Road 5: lung lung carcinoma' ROW 6: (Absolute risk reduction: 35%, 95% CI: (13% to 56%); NNH: death. death. ~ Row 7: 2. 2.7% (11/405).Row 15: Rov 16: Versteen",
      "start_page": 120,
      "end_page": 120
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: lungrow lungrow 5: 026 026 (95%: 0. 0.080) groups groups (Wolff 2018). difference difference (MID) groups groups (2 2 cm) design design (Risk of bias), heterogeneity. heterogeneity. # Row 11: rate rate 12: following following criteria: or or cohort' Row 36: on on 23-01-2025 121/428' Row 37:",
      "start_page": 121,
      "end_page": 121
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: Row Row 6: excluded excluded (spontaneous spontaneous contraception) Rod:",
      "start_page": 122,
      "end_page": 122
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 122,
      "end_page": 122
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 122/428",
      "start_page": 122,
      "end_page": 122
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - (Neo)resectable resectable __",
      "start_page": 123,
      "end_page": 123
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: At pN0-1- ROW ROW 3: Row 4: for for pre- or postsurgical radiotherapy? (consensus based 2013) ROW 5: therapy therapy ~ALONG ALONG Criteria:",
      "start_page": 123,
      "end_page": 123
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 123/428 Row 2: Row 3:",
      "start_page": 123,
      "end_page": 123
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: row 4: Row Row 5: arms arms (1) (2). diagnostic diagnostic T___MEDERM0(S)radiotherapy radiotherapy ('split course' 20 20 Gy) chemotherapy chemotherapy (CAP) (7).control. control.' ROW 6: ROW 7: consensus consensus based(2013) ROW 8: Patient ́to to CEFTA",
      "start_page": 124,
      "end_page": 124
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 703660",
      "start_page": 124,
      "end_page": 124
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: row row 5: Road 6: group group (76 76 (95 % 61-0. 61-0.95), p=0.02). reduced reduced (31 31 - 5% 79, 79, p=0.012] later later time",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: row 5: 1- carcinoma. carcinoma. 'Cancer 30:1388-1394', 1972. Row 6: 2",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 125/428",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: (Neo)I-III I-III _____",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: (Neo)Row Row 3: Row 4: sub sub modules: Row 5: 7 7 (NEO)Road Road 10: on on 23-01-2025",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: LC row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10:",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10:",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 4: row 5: Row 6: Row 7: Row 8: Row 9: Row 10: 126/428",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: ROW ROW 2: carcinoma carcinoma - IIIA_MEDTERM7_Raw IIIA_MEDTERM7_Raw 3: the the 45-year-olds' questionROW questionROW 5: Row 6: IA IA -IIIA [MEDTERM7_? Row 7: ROW 8: years years (91, 91, 95% 81-1. 81-1.02; P=0.10) Row 17: Row 18: Undergoing Row 19: ́ Row 20: Conclusions Row 21: ~ Row 22: Level Level 1: 2003 2003 (2), Waller 2004 (3) International Adjuvant 1995",
      "start_page": 127,
      "end_page": 127
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 127/428 Row 2:",
      "start_page": 127,
      "end_page": 127
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: 2005 2005 53-74% II II 25-46% cm cm (T2a T2a (3-5 cm) T2b T2b (5-7 cm) a a __MENTERM0_Adjuvant: For patients ___METM0_",
      "start_page": 128,
      "end_page": 128
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Row Row 5: benefit benefit (86, 86, 95% 92, 92, p<0.0001), of of 4% (95% CI 3-6%) years years (from 60% to 64%). The second __MDTERM",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 129/428 Row 3:",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: [ANITA]): trial. trial. '7. 7.719-727', 2006. Row 6: 7",
      "start_page": 130,
      "end_page": 130
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 130/428",
      "start_page": 130,
      "end_page": 130
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: (Neo)Row Row 3: Row 4: Row Row 5: Row 6: carcinoma carcinoma ?? baseline baseline ́ RovMED's ** ROW 17: *(impairment impairment (4. 4.4), are are resolved",
      "start_page": 131,
      "end_page": 131
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row row 4: therapy therapy (perioperative treatment) Raw 5: regimen regimen (Row Row 16: Row 17: ROW ROW 18: the the ROWED-Ad(s)-diagnosed-the the Rowed-To-Dose ́the the excipients",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: lung lung carcinoma' ROW 5: the the risk-Mad(s) of the patient's benefit-Md(s). the the risk/and and __MDTM4_- least least 50% on on PD- Row Row 12: Rov 13: ___ ___ M___",
      "start_page": 133,
      "end_page": 133
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: ROW ROW 5: _MEDTERM0_ + placebo placebo + randomized randomized 1:the the ____MEDERM0*- 9 9 : From the patient'12 12 : a a potentially",
      "start_page": 134,
      "end_page": 134
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: ROW ROW 5: from from $46.859/ QALY. Das (2023) of of $150,000/ of of $46.859/Row Row 13: Raw 14: Conclusions ROW 15: ́ Rrow 16: Row Row 17: ~ Rov Rov 18: Row 19: r. r. o",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Veronica: Row 1: raw 2: row 3: Row 4: • ROW ROW 5: Row Row 6: − Row 7: ~Row 8: =Low Row 9:",
      "start_page": 136,
      "end_page": 136
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: row row 2: GRADE",
      "start_page": 136,
      "end_page": 136
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: alone. alone. # Row 6: ́ Row 7:",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: trial trial (Forde 2022) __MEDTERM3_ __MEDTERM3_ (IB (≥4 cm) to IIIA __ELDERM3_) (7th TNM classification) known known __EDTERM1_/__MDTERM0_ __MDTERM0_ (360 mg) Rodapy Rodapy (threat):",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: • cancer cancer • Row 5: • randomized randomized (study study arm) months months (5 5 months). noted noted (Tel. Tel.: +49 (0)1 7, Ro",
      "start_page": 138,
      "end_page": 138
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: * Row Row 2: Row 3: Results row 4: Row Row 5: the the __MEDTERM0_-group. group. (82. 82.7% ____MEDTM0_ ____MEDTM0_ -plus- together-group together-group (",
      "start_page": 138,
      "end_page": 138
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Raw Raw 6: was was 41% (72/179) in the __MEDTERM0_+ versus versus 44% (77/179) group group (Forde 2022).' Row 7: Road 8: bias bias (in in RoB).' Row 18: low. low.' Row 19: Row 20: execution execution (one one level) equal. equal.",
      "start_page": 139,
      "end_page": 139
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Road 6: immunotherapy immunotherapy (perioperative treatment) Road 7: Description of trials' ROW 8: trial trial (Wakelee 2023) IIIB IIIB (N2 stage) __",
      "start_page": 140,
      "end_page": 140
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: immunotherapy (perioperative treatment) Row 2: Row 3: on on 23-01-2025 140/428 Row 4: Row 5:",
      "start_page": 140,
      "end_page": 140
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW 3: Row Raw 4: Row Row 5: TrialStudyControOutcomesRow 6: (authordesignRov(Rov) + Rov-80. 80.9% (95% CI: 76.2-84.7) the the __MEDTERM0_+ 77. 77.6% (95% CI; 72.5-81.9) Row Row 34: Row 35: 85. 85.0% (95% 9-95. 9-95.2) ___benzeterM2_ ___benzeterM2_ + chemotherapy 41 RT: Rofill: rofill:",
      "start_page": 141,
      "end_page": 141
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: the the __MEDTERM0_-plus- months months (95% CI: 14.3-22.0) group. group. (HR: 0.58; 95% CI: 0.46-0.72; p<group group (30.2%; 95% CI: 25.7-35.0) group group (11.0%; 95%CI: 8.1-14.5) (Wakelee 2023).' ROW 12: ROW 13: received received __",
      "start_page": 142,
      "end_page": 142
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Row Row 5: level level (imprecision, one level) bias bias (one level). Road 6: analysis analysis (Felip, 2021) 2 2 (27.5-38.4) analysis analysis , The voornamelijkce, 2023) months months (5-52. 5-52.3).' Row 19: death. death.",
      "start_page": 143,
      "end_page": 143
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Rowbas 1: Row 2: row 3: Row 4: • 5 5 • Row 6: • life life (Table 6). • Row 7 • Table 6 • Raw Raw 9: Trial; author, yearStudy • Row",
      "start_page": 144,
      "end_page": 144
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: Results' Row 2: Overall survival' Row 3: module module (May 2023) Felip Felip (2021) with with 97/507 (19%) __MEDTERM0_group __MEDTERM0_group and",
      "start_page": 144,
      "end_page": 144
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: lungrow lungrow 5: Road 6: eventrow eventrow 7: ____medeterM0_, ____medeterM0_, 22% (108/495) to to 12% (57/495) group group (Felip 2021). The __MEDTERM0(226 226 (39%) 84 84 (37%) steroids steroids (Gangulu Gangulu 2022). # Row 10: that Row 11: Row Row 12: studies. studies.' Row 13: ROW 14: equal. equal.",
      "start_page": 145,
      "end_page": 145
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: cancer cancer (__MEDTERM0_)? Row 2: Row 3: on on 23-01-2025 145/428 Row 4:",
      "start_page": 145,
      "end_page": 145
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: row 6: P:early-stage early-stage (to to IIIA) pathologically confirmed __MEDTERM0_; Row 7: I:adjuvant adjuvant (or both) other other treatment;Row 8: C:treat treat 9:",
      "start_page": 146,
      "end_page": 146
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: outcome outcome measure- where where disease/eligible eligible (IMpower010, IMpower010, PEARLS/KEYNOTE-091).' ROW 14: Row 15: and and Ovid/Medline. The querymentsheimer'ground. ground.",
      "start_page": 146,
      "end_page": 146
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Road 4: row 5: ROW ROW 6: Row Row 7: Results Row 8: the the literature: chemoimmunotherapy chemoimmunotherapy (Table 1), death. death.",
      "start_page": 147,
      "end_page": 147
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Trial (author year) STAGE STAGE (N) 7 7 WT(R-III) RockMate 816 (Felip Felip 2022)RCT (phase III)Neoadjuvant__",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: immunotherapy (perioperative treatment) Row 2: Row 3: on on 23-01-2025 148/428 Row 4:",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: Trial (author year)StudyInterventionContro Row 3: 816 816 (Felip Felip 2022)RCT (phase III)Neoadjuvant __",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: ol row 3: row 4: chemothe chemothe cycles) row 5: juvant nab- xel + platinum row 6: juvant __MEDTERM0_ (1500' row 7: row 8: ~ row 9: jaw mab' row 10: { row 11: row row 12:",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: row 2: Stage (N)TNM Row 3: Row 4: inum-erapyIB or II: 1277 Row 5: ROW 6 IIIA: 228row 7: - numIII A: 668 row 8: ~IIIB: 22row 9: 0 mgIA3: 127 row 10: − 14IIA: 10row 12: row/II:",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 3)",
      "text": "Row 1: Row 2: 148/428",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Road 4: ROW ROW 5: Row Row 6: (authordesign(N)Row 7 : mg mg ́Red(4-M)Radio-DemandRadiosyn.",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: StudyInterventionControlStageTNM Row 2: design(N)Row 3: PEARLS / KEYNOT-9091 (OBrien 2022)RCT (phase III)Adjuvant __MEDTERM0_(18 18 cycles) + adjuvant chemotherapyPlateletPlaceboIB: 1697 Row 4: (18 18 cycle(202) as as Rowd-III: row-III Red",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 1)",
      "text": "Row 1: Row Row 2: TrialStudyInterventionControlRow 3: (authordesignRovertRaw 4Row-Raw 5KEYNOTE- 671 (Wakelee 2023RCT (phase III)NeoadjuvantNEOadjuvant placebo (4 cycles)RiveterM0_ RiveterM0_ (200 mg) +(",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: Row 2: StageTNM Row 3: (N) Row 4: Row 5: oII: 2398 Row 6: IIIA: 442 Row 7: ~IIIB: 116Row 8: −Row 9: xelT1N2M0: 168 row 10: ≥Row 11:",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (column column 2)",
      "text": "Row 1: StageTNM Row 2: (N)Raw 3: IB: 1697 Row 4: antRow 5: II: 667ROW 6: ~IIIA: 339Row 7: −VI: 2Rrow 8: row row 9: {row 10: }IIA: 295ROW 11:",
      "start_page": 149,
      "end_page": 149
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: row 4: Last assessment: 01-01-2023 row 5: Last approved : 24-06-2024",
      "start_page": 150,
      "end_page": 150
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 150,
      "end_page": 150
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 150/428 Row 3:",
      "start_page": 150,
      "end_page": 150
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: 2023 2023 Oct;34(10):907-919. doi: 10,1016/17. 17. PMID: 37467930. Row 6: 1",
      "start_page": 151,
      "end_page": 151
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 151/428",
      "start_page": 151,
      "end_page": 151
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: ROW ROW 5: Raw 6: cancer cancer (stage I-III) for for ?IMD(A) or not? the the MAH'survival survival (EFS) versus versus 80% risk risk of",
      "start_page": 152,
      "end_page": 152
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: Row 2: Road 3: row 4: • ROW ROW 5: this this benefit/ risk/ Roally Roally ́s",
      "start_page": 153,
      "end_page": 153
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: row 4: carcinoma carcinoma (stage I-III), current current (anno 2023) adjuvant adjuvant chemotherapy; Row Row 5: ROW 6: Conclusions Row 7: ́ Row 8: Adjuvant __MEDTERM0_* early-stage early-stage (IB' ROW 9: to IIIA) pathologically confirmed;__METERM7_+___#",
      "start_page": 154,
      "end_page": 154
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 154/428 Row 2: Row 3: Row 4:",
      "start_page": 154,
      "end_page": 154
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: __EDTERM4_ __EDTERM4_ (7th TNM classification). receive_or_MDTERM0_ receive_or_MDTERM0_ (n=63) (times times daily) undergo_observation undergo_observation (fatigue vs.",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: He (2021) - EvidENCE",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Wu (2020) / Majem (2022) / Herbst (2023) / Tsuboi (2023), / John (2023 ) - ADAUR",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Zhong (2018/2021) - ADJUVANT",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 155/428'th Row 2: Row 3: row 4:",
      "start_page": 155,
      "end_page": 155
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: ROW ROW 6: __MEDTERM0_ versus cis/II-IIIA II-IIIA (7th TNM classification) {",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Kelly (2015) RADIANT",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Feng (2015)",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Li",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 156/428 Row 2: Row 3: Row 4:",
      "start_page": 156,
      "end_page": 156
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: __MEDTERM0_ __MEDTERM0_ (n=30) chemotherapy chemotherapy (500 mg/and and carpoplatin), group group + __MEDTERM15_. __MEDTERM15_.' ROW 14: Row Row 15: life_Row life_Row 17: T. T.",
      "start_page": 157,
      "end_page": 157
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: was was 89% (95% CI 85% to 92%) with with 52% (95% CI 46% against 92%) 20 20 (99.12% 0. 0.30). interval interval == consciousness average -> 50% -00% -0.1% -0.6% -0 % -0.9% - 7 7 (95% to to 12) Row Row 12: Row 13: in in 54/339 patients (16%) (95% CI, 12% to 20%) ___ ___ 39% five five (1%) the the __",
      "start_page": 158,
      "end_page": 158
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: Road 5: lung lung carcinoma' ROW 6: to to follow-up) and imprecision (e. e.? low. low.' Row 7: Row 8: low. low.' Row 13: Row 14: Row Row 15: ~ Row 16: Road Road 17: following following question:' Row 18: early-stage early-stage (Testage I-III) lung cancer:",
      "start_page": 159,
      "end_page": 159
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: I:gewetenM1_, gewetenM1_, •RoventerM2_, +RovderM2+, +BraderM3_, BRAF, _IMEDTERM4_alterations;Row 2: C:chemotherapy or placebo; Row 3: O:Row Row 4: Rovender's disease forerunner:",
      "start_page": 159,
      "end_page": 159
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: lung lung carcinoma' Row 5: • Toxicity (grade grade ≥3): groups. groups. ~ Row 6: ́Row 7: select select (Methods) Row 8: Zhao Zhao (2022) Zhao Zhao (2022). found found (Majem, 2022). mutation. mutation.'Row 14: Row 15: RCTs RCTs and&database. database.",
      "start_page": 160,
      "end_page": 160
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 160/428 Row 2:",
      "start_page": 160,
      "end_page": 160
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row Row 5: Row 6: References Row 7: Row 8: 1",
      "start_page": 161,
      "end_page": 161
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 161/428 Row 3:",
      "start_page": 161,
      "end_page": 161
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 1",
      "start_page": 162,
      "end_page": 162
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 162/428",
      "start_page": 162,
      "end_page": 162
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - row row 3: Row 4: is is 'stage III_MEDTERM4_' Row Row 5: row 6: these these (sub) Wow Wow 8: stage stage III-/MEDTERN4_ ~ WERE WERE DISCUSSED",
      "start_page": 163,
      "end_page": 163
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 163/228",
      "start_page": 163,
      "end_page": 163
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4: row row 5: row 6: patients patients __",
      "start_page": 164,
      "end_page": 164
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "ROW 1: NSCLC?Row 2: ROW ROW 3: Row 4: Undergoing Row 5: Row 6: Conclusions Row 7: Row 8: and and WHO-performance'-2 2 Gy/prolonged prolonged loco",
      "start_page": 164,
      "end_page": 164
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 164/428 Row 2:",
      "start_page": 164,
      "end_page": 164
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: rate rate (65%) radiotherapy radiotherapy (tumor tumor control) pragmatic pragmatic concerns: IMRT IMRT (Intensity Modulated Radiotherapy) regimen regimen (Row Row 6: on on 23-01-2025 165/428 Row 7:",
      "start_page": 165,
      "end_page": 165
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 108-59710776148514281",
      "start_page": 165,
      "end_page": 165
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 490-5383261",
      "start_page": 165,
      "end_page": 165
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 165126",
      "start_page": 165,
      "end_page": 165
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: of of chemotherapies- of of 23% versus 11% (p = 0.0066) CERETM0_s CERETM0_s 49% at distance (70%",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 1283",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 398-444357",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 491'89",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 496.53457755",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 282-28394",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: row 4: Lately authorised: 17-10-2014",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Oncol 8:543-555 Row 2: 6",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Phys Phys 27:507-516 Row 2: 8",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Chest 117:358-364 Row 2: 1",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Radiother Oncol 52:129-136 Row 2: 1",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 165 Row 2: 1",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: on on 23-01-2025 167/428 Row 2: Row 3:",
      "start_page": 167,
      "end_page": 167
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: (dose/volume) lung lung cancer: Cancer Cancer 41:Row Row 6: Cancer 41*207-214 Row 7: 1",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 20;28(36):5301-10. Row 2: 1",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Chest 117:358-364 Row 2: 2",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Oncol 15(Suppl 7):20-25 Row 2: 3",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 168/428 Row 3:",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: Row Row 4: row 5: Phys Phys 20131;85(2):444-50. [link] Row 6: 3",
      "start_page": 169,
      "end_page": 169
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: 5'0 - Oncol. Oncol. 2010;20(2):94-106. [link] Row 2: 5",
      "start_page": 169,
      "end_page": 169
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 169/428 Row 3:",
      "start_page": 169,
      "end_page": 169
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: 2003. Row 6: 6",
      "start_page": 170,
      "end_page": 170
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 170/428",
      "start_page": 170,
      "end_page": 170
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "carcinoma carcinoma - the the Roval-Meadwell-Radio-of of Row-10. 10.7%;68 68 (95% 0. 0.85). unknown unknown PD- Row Row 26: Row 27: 265 265 (",
      "start_page": 171,
      "end_page": 171
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: row row 4: placebo placebo (1 mg/ kg/ day). Raw Raw 5: are are €Road Road 15: Row 16: Row Row 17: outcomes outcomes (QALY) life-years life-years (LYG). follow-up. follow-up. ROWTERM% at 2 12",
      "start_page": 172,
      "end_page": 172
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "the the anti-tumour(s) control control and/ survival survival (status status 0-1), ROW ROW 7: Row 8: Recommendation-1 Row 9: Rationale/ Row Row 10: condition condition Row_M",
      "start_page": 173,
      "end_page": 173
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: radiotherapy radiotherapy (Formenti, 2018; Ngwa, 2018). stage stage III; provided by Rowter-Arcer-Raw 7: Conclusions Row 8: Row 9: Raw Raw 6: ~ survival survival rowterm(s) Rowster-Rovert",
      "start_page": 174,
      "end_page": 174
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: safety safety (and and toxicity) Rov Rov 6: very lowraw 7: grade Road 8: ́Sources: (Butts, 2014) • syndrome syndrome • imaging imaging • Sponsor: group. group. # Row 18: Row 19: field. field.",
      "start_page": 175,
      "end_page": 175
    },
    {
      "heading": "headed headed <Startpage - lung lung carcinoma> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: • ROW ROW 5: row 6: Results Row 7: Row Row 8: survival survival (critical outcome) Road 9: study study (Antonia, 2017; Antonia, 2018) 51 51 (95% 0. 0.63) Row Row 16: Row 17: ROW ROW 18: the the 24(%) baseline. baseline.",
      "start_page": 176,
      "end_page": 176
    },
    {
      "heading": "headed headed <of of life>",
      "text": "Row 1: Row 2: Row 3: Road 4: row 5: ROW ROW 6: (95% 1. 1.51)) . patients patients (4.4%) and and gezichtspunt; patients patients (6.0%) placebo placebo (74 74 (95% 1. 1.43) . Rov 7: Row_ 8: equal equal (22.2%) . Overall survival (critical outcome) Row 21: The START-study (Butts, 2014; Mitchells, 2014) median median __MEDTERM4(the the study) μths μths (95% 29. 29.4) months months (95% 25. 25.4%) 0. 0.0% ratio hr2 (24.6% ratio • kg/ kg/ day) • rob.",
      "start_page": 177,
      "end_page": 177
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: ROW ROW 5: Row Row 6: Road 7: 5. Safety (and and toxicity) Row 8: unit unit (respiratory distress syndrome) {MM-YY} {15 15 (1%) 5 5 (1%) group group (40 40 (95% 3. 3.82). Row 13: Row 14: patients patients (4%) patients patients (7%) placebo placebo (61 61 (95% CI 0.45) • velocity velocity • roar • east side • artery artery • region region • west",
      "start_page": 178,
      "end_page": 178
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: I:(intervention) adjuvant immunotherapy; Row 2: Row 3: on on 23-01-2025 178/428 Row 4:",
      "start_page": 178,
      "end_page": 178
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: C:(comparison) placebo or observation; Row 6: O:",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: making making process; safety safety (and and toxicity) Road Road 4: ROW 5: ratio ratio ===0.0) Rovijks: Overall risk-of-disclosure",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: select select (Methods) Row 3: Medline Medline (via OVID) between between (via Embase.com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS). contraindications. contraindications.",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 3- Brahmer, J., L. L., Boss, P., Crino, L., E. E., Poddubskaya, E., et al. (2015). __",
      "start_page": 179,
      "end_page": 179
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Medicine, Medicine, 373(2), 123-135. Row 6: 4",
      "start_page": 180,
      "end_page": 180
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 180/428",
      "start_page": 180,
      "end_page": 180
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "ROW 1: ROW ROW 2: • carcinoma carcinoma - Row Row 3: • ROW 4: • Radishing circumstances (ROW: • polycythaemia polycythaemia virus). • recommended. recommended. • Row 8: Recommendation Row 9: Row 10: ~ developing developing lymphoma",
      "start_page": 181,
      "end_page": 181
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: on on 23-01-2025 181/428 Row 2:",
      "start_page": 181,
      "end_page": 181
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: row 4: lung lung carcinoma' Row 5: tumor (subclavian subclavian vessels) a a pathologic-lung lung cancer/Row 5: chemo-Dummy: a a repeat-Rescue-Lung Lung Carcinoma/ROW 5: Tumour (were were 27% stage IIB, 8% stage IIIA, 42% and and 23% was was 39%. patients patients (66%) is is similar; surrogate surrogate sulcus-tumour",
      "start_page": 182,
      "end_page": 182
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: on on 23-01-2025 182/428 Row 2:",
      "start_page": 182,
      "end_page": 182
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row Row 5: Row 6: References Row 7: Row 8: 1",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 3- Cancer Cancer 30:Row Row 2: 4",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Biol Phys 48:347-354 Row 2: 7",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 9 Row 2: Chest 124:996-1003, Row 3: 1",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 2(7):603-612 Row 2: 1",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 183/428",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4: Row Row 5: Row 6: based based (May 2011) question worked out: Row 7: stage stage III",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: _____MEDTERM1_? Row 2: Row 3: module module 'sequential sequential chemoradiotherapy' guideline _________________May 2011). the the question: Row 4: radiotherapy radiotherapy treatment? Row 5: Road 6: ~ Row 7: Recommendation Row 8: − Row 9: patients patients ______",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: stage stage IIIA/ Row Row 3: Row 4: Recommendations consensus based(2013) Row 5: with with ≥ 10 mg/ kg/ day (5. 5.1). of of Row",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: _____MEDTERM0_? Row 2: Row Row 3: Row 4: Building Row 5: Row 6: Conclusions Row 7: Row 8: on on 23-01-2025 184/428 Row 9: Row 10:",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (column column 1)",
      "text": "Recommendation 1: ROW ROW 2: carcinoma carcinoma - Co-chemotherapy Row 3: Row 4: Raw Raw 6: Rrow Rrow 7: Rway Rway 8: __MEDTERM3_? Row 9: _MEDTERTM3__? ROW 10: RAY 11: module module 'Concomitant versus sewer' ROW: Row",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row 5: Row 6: ence based (May 2011) worked-up question: Row 7: Row Row 8: Row 9: Row 10: equemental chemoradiotherapy' ROW ROW 11: Row Row 12: Row 13: Row 14: Row 15: Row 16: adiotherapy vs. row:",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: um III",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (column column 3)",
      "text": "Row 1: Row 2: 2011). Row 3: eling? Row 4: row 5: row 6:",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (column column 3)",
      "text": "Row 1: a row 2: row 3: row 4: orcion too eling? row 5: eling row 6: row 7: row 8: row row 9: row 10: row 11: row 12: um III",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (column column 3)",
      "text": "Row 1: Iotherapy Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: 184/428",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: stage stage III",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: ___MEDTERM4_? Row 2: Row 3: Conclusions evidence-based(2011) Row 4: stage stage IIIA/Row Row 5: Auperin Auperin 2010( 10) row 6: row 7: Conclusions consensus based(2013) Rovter'to to ro",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Schwartz 2005(51) Row 2: Row 3: Row Row 4: Chen 2013(46), Uyterlinde 2013('41') Row 5: row 6: Row Row 7: - Row 8: stage stage III",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: evidence evidence based' Row 2: Row 3: Row Row 4: chemotherapy chemotherapy (radiation radiation therapy) Rod(A&M] at at 2%%%%.",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: ROW ROW 4: {ROW} Prior to ́s up-RowTerma RowTerma ́? ROWTER ́ ROWTler ROWTler RawTerm",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (column column 2)",
      "text": "Row 1: Row 2: Row 3: stage stage III",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Row 6: Row 7: at at __",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Row 6: Row 7: Row 8: stage stage III",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (column column 2)",
      "text": "Row 1: Row 2: ngcarcinomas Row 3: the the radiotherapy) confirmed confirmed [Auperin row 4: row 5: stage stage bell) [Furuse 1999(61); Curran 2003(59); Zatloukal row 6: 185/428",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Raw 3: row 4: Road 5: ROW ROW 6: 2004(68); Fournel 2005(60); Belderbos 2007(57); Ulutin 2000(67); Clamon 1994(58)]. declined declined [Auperin 2010(S) stage stage IIIA/IIIB {considered. considered.'Row 7: Row 8: combinationROW combinationROW 9: to to older's Row 10: on on 23-01-2025 186/428 Row 11: Row 12:",
      "start_page": 186,
      "end_page": 186
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Road 4: Role 5: daily daily (inter) para_MEDTERM0_ers para_MEDTERM0_ers [Palma 2013a(38), 2013b(39)]. Row 22: Row 23: et et al(37)2%)",
      "start_page": 187,
      "end_page": 187
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Row 5: lung lung carcinoma' ROW 6: survival survival [Salama 2013(40); Wang 2012(43); Vancinder 2013(42)]. #Row 7: Road 8: IMRT IMRT [dose dose 2010(49)]. scan scan (RCCT) the the lung'the the L",
      "start_page": 188,
      "end_page": 188
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW 5: carcinomaROW carcinomaROW 6: et et al(47). [2008] a a [",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Oncol 8:543-555 Row 2: 6",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Phys Phys 27:507-516 Row 2: 8",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: on on 23-01-2025 189/428 Row 2: Row 3:",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: lung lung cancer: 2010, 2010, 28(13):2181-90. Row 6: 1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Chest 117:358-364 Row 2: 1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Radiother Oncol 52:129-136 Row 2: 1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 165 Row 2: 1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Cancer 41:207-214 Row 2: 1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 20;28(36):5301-10. Row 2: 1",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Chest 117:358-364 Row 2: 2",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Oncol 15(Suppl 7):20-25 Row 2: Row 3: on on 23-01-2025 190/428 Row 4:",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 3",
      "start_page": 191,
      "end_page": 191
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 5'0 - Oncol. Oncol. 2010;20(2):94-106. [link] Row 2: 5",
      "start_page": 191,
      "end_page": 191
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 191/428 Row 3:",
      "start_page": 191,
      "end_page": 191
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Road 3: Row Row 4: row 5: of of non-Phys Phys 2005;62(2):561-70. [link] Row 6: 5",
      "start_page": 192,
      "end_page": 192
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 192/428",
      "start_page": 192,
      "end_page": 192
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Row Row 3: Row 4: Raw Raw 5: Road 6: chemoritherapy chemoritherapy (adjuvant adjuvant ~_MEDTERM0__) III-N2 III-N2 ? Row 7: • unit unit • Row Row 20: Row 21: Row Row 22: 26 26 trials",
      "start_page": 193,
      "end_page": 193
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Eberhardt Eberhardt (2015) in in tumors; / /higher higher risk/other other treatment",
      "start_page": 194,
      "end_page": 194
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Road 3: Row Row 4: Row Row 5: row 6: Rationale/ Role Role 7: III III - stage stage III-N2_MEDTERM[] on on Rowter-Arm]. since since ≥ difference difference between",
      "start_page": 195,
      "end_page": 195
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Veronica: Row 1: row 2: row 3: row 4: row 4: ROW ROW 5: Row Row 42: Row 43: on on 23-01-2025 196/428 Row 44:",
      "start_page": 196,
      "end_page": 196
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: group. group.' Row 7: Row 8: row row 16: Row 17: ratio ratio (HR) 47 47 (95% 0. 0.96), against against 20depend",
      "start_page": 197,
      "end_page": 197
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: Row Row 6: 16 16 (7.9%) after after pneumonectomy; to to diarrhea; 4 4 (2.1%) 748 748 1245",
      "start_page": 198,
      "end_page": 198
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: row 6: Row Row 7: Row Row 9: ~Row 10: secrecy. secrecy.",
      "start_page": 199,
      "end_page": 199
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: trial. trial. • Routine self-esteem • Slowly • Thrombophlebitis • Radishes • Artery • therapy therapy • pain pain • Lung disease • Hemorrhagic nerves • tables. tables.' Row 18: Row 19: on on 23-01-2025 199/428",
      "start_page": 199,
      "end_page": 199
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Responsible Row 4: row 5: Last assessed: 07/07-2020 Road 6: Last authorized: 07-07-2020",
      "start_page": 200,
      "end_page": 200
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 200,
      "end_page": 200
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 200/428",
      "start_page": 200,
      "end_page": 200
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "ROW 1: ROW ROW 2: cancer cancer - Row Row 3: Row 4: sub sub modules: row 5: ~ row 6: { row 7: =treatment treatment • Road Road 8: > 2dline treatment _________",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 836 Row 2: 3",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Clin Oncol 26:4617-4625 Row 2: 4",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Inst 95:362-372 Row 2: 5",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: 19:1336-1341 Row 2: 6",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 201/428 Row 3:",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: BMJ BMJ 311:Row Row 6: 1",
      "start_page": 202,
      "end_page": 202
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Oncol 15(Suppl 7):20-25 Row 2: Row 3: on on 23-01-2025 202/428",
      "start_page": 202,
      "end_page": 202
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: __EDTERM3_Row __EDTERM3_Row 3: Row 4: Row Row 5: Row 6: treatment treatment (primary treatment) of patients ___",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "ROW 1: rare mutation). Row 3: PD-L1 PD-L1 ≥50% primary__",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: ROW ROW 5: status status (_MENTERM39__ ≤1), of of >ROW ROW 8: Row 9: treatment treatment __MEDTERM15_'study study (Paz-Ares, 2018) on on a",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: the the study'trial-Raw trial-Raw 4: combination combination carbo- study study (Socinski, 2018), immunotherapy immunotherapy (Davies, 2017; Lazzari, 2017). Row Row 11: Row 12: on on 23-01-2025 205/428 Rod",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: ROW ROW 4: Row 5: the the patient'cell-celled cell-celled evidence- ROW 12: Row 13: non-squamous non-squamous cell-like;of of 1-49% both both immunotherapy/the the ke",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: Road 4: Row Row 5: Row Row 7: patients patients **of of {G] and {C] individual individual benefit/ Union Union (EU) Row Row 18: on on 23-01-2025 207/428 Row 19: Row 20:",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "This This includes: risk-benefit risk-benefit analysis",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: Row Row 4: Road Road 5: row 6: ROW ROW 14: Row 15: combination combination carboplatin-paclitaxel-_MED-_MEPTERN therapy- is slightly limited-rather-Administered-ROVED-ROWER-Divert-Live-Two-Mife-Towards-Over 1-Device-Boxed-Covator-Lead-Mivert/Soft-Wivent-Fiveth-Early-Paclizumab-Iive-Home",
      "start_page": 209,
      "end_page": 209
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: Row Row 4: Road 5: row row 6: Row 7: of of care;_",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: • ROW ROW 5: ratio ratio ≥50%, Row Row 6: ́România România Roww",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: pemetrexed) Row 2: nonsquamous nonsquamous non-Row Row 3: Low Row 4: GRADE ROW 5: Row 6: with row 7: •1, 1, •and and • Row.",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Veronica: Row 1: Row 2: Row 3: row 4: • ROW ROW 5: cancer. cancer. • Row 6: • Moderate-Row 7: − of of it; − Row 8:",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Veronica: Row 1: Row 2: row 3: Row 4: • ROW ROW 5: safety safety (and and toxicity) cancer. cancer. • Row 6: • Very low ~ ROW 7: −GRADEROW 8 • Row_ Comité-Row",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: ROW 3: row 4: Row Row 5: in in patients; burden burden ≥10 mutation/MbC. Row: Row 34: Lowrow 35: ~Row Row 37: −Row 38: •Reference: (Socinski, 2018) Row 39: ●Row 40: (2)Row Row 45: syndroom Row 47: A. A.",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: row 3: ROW 4: • cancer cancer • ROW 5: • carcinoma carcinoma • Row territory • row velocity • avoid avoid • haemorrhage • respiratory distress • gait instability • consciousness consciousness • flight risk • disease management • developmental disability • weakness • dystonia • peripheral neuropathy • disease disease • study. study. Row",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Row 5: carcinomaROW carcinomaROW 6: NSCLC_MCEDTERM0_ NSCLC_MCEDTERM0_ + chemotherapyChemotherapy Road 7: (KEYNOTE- 021)Raw 8: Row 9: ~ROW 10: Ghandi, 2018 (KEYNOTE- 02): •Rov",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "headed headed <of of life> (column column 1)",
      "text": "Row 1: Row Row 2: IV IV nonsquamous; RobsterM3_Row RobsterM3_Row 3: (KEYNOTE- 021)Row 4: non cow 5: Ghandi, 2018 (KEYNOYE- 189)Double- NSCLC_Row NSCLC_Row 6: ROW-MENG ROW-MENG SOCH",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "headed headed <of of life> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row 5: Row Row 6: ~Row 7: ́Row 8: −Row Row 9: -------------Row 10: ●Row 11: Row Row 12: Row Row 13: →Row 14: =chemo chemo N°2.20: SIFISO 29: Row-A1 ROW",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "headed headed <of of life> (column column 3)",
      "text": "Row 1: Row 2: Row Row 3: ROW 4: row 5: Row Row 6: ~ ROW 7: >METERM2_ + 2 2 2+ Row 3+ row 2+",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: survivorship survivorship (Reck, 2016) or or nonsquamous; lifeRow lifeRow 16: One study (Brahmer, 2017) unit. unit. (QLQ-C30) status status (GHS)/quality-of-life (frequently. frequently.' Row 20: Row 21: Row Row 22: ~ Row 23: on on 23-01-2025 217/428 Row 24:",
      "start_page": 217,
      "end_page": 217
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: of of evidence: II. II.' Row 20: Row 21: Gandhi Gandhi (2018) was 69.2% in the __MEDTERM1_+ 49. 49.4% in in the___",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Row Row 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: statical heterogeneity; CI: confident interva'l Row 7: ́Row 8: Ghandi (2018) Langer Langer (22), Group. Group.' Row 12: Row 13: 52 52 (95% 0. 0.62), death. death.",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Z: overall overall effect; df: degrees of freedom; I2: static heterogeneity; CI: Row Row 4: row 5: Gandhi (2018) with with (95% 0. 0.45) 0. 0.9% (Royal pain score:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Road 6: Row Row 7: Two studies (Gandhi, 2018; Langer, 2016) 48. 48.5% Five Five (26%) to to 49% and 16 (80%) of of 50% of of 49% (39%) greater greater (35) Row Row 16:",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: d Row 2: Row 3: Row 4: row 5: ROW ROW 6: (n=133) group group (RR 1.02; 95% 1. 1.15). In 6.7% (n=27) 5. 5.9% (n=2) Road Road 7: ́evidence. evidence.' Row 16: Row 17: inconsistentness inconsistentness (across across studies) clinical clinical relevance).",
      "start_page": 221,
      "end_page": 221
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Road 6: evidence. evidence. • Row 8: __MEDTERM0_with chemotherapy (carboplatin/paclitaxel) with with stave/PQQ-T-R-I-V-91 91 (95% 1. 1.06), favoring ipilimumab_(figure 5) Row Row 13: Row 14: Figure 5 Overallsurvival__azolamcm1; Row Row 15: ́Row 14: Overall Overall survivor(S)",
      "start_page": 222,
      "end_page": 222
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: survival survival (or or death) chemotherapy chemotherapy versus",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: chemotherapy Row 2: Row 3: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: 4 4 : RovMED 5 : 6 6 : comparing comparing ___ThenTERM0_+ rate rate (Govindan, 2017; patient patient ___",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: row 5: carcinomaRow carcinomaRow 6: 54. 54.2% evidence. evidence.' Row 14: Row 15: death. death.",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: industry industry (risk of bias), results results (stevigs stevigs studies) clinical clinical relevance) Hellmann Hellmann (2018) Burden Burden (TMB) ≥10 Mutations/Mb and ≥1% Expression Expression (PD PD -of of <1% to to receive;",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: confidence interva'l'Row 8: rateRow rateRow 9: One study (Carbone, 2017) approximately approximately 18% versus versus 41% group group (RR 0.43; 95% 0. 0.64) (Carbone, 2017; Hellmann, 2018), 10. 10.' Row 16: Row 17: Safety Safety (and and toxicity) __",
      "start_page": 226,
      "end_page": 226
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: carcinoma carcinoma convulsion' Row 5: Road 6: ́ Row 7: ~ Row 8: Z: overall overall effect; df: degrees of freedom; I2: static heterogeneity; CI: Row Row 9: − Rov 10: chemotherapy chemotherapy level: Overall survival (critical outcome) Row 23: study study (Hellmann, 2018) to to Row25-24:",
      "start_page": 227,
      "end_page": 227
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: row 4: Row Row 5: Road 6: survival survival 7: PD PD -least least 1% (62 62 (95% 0. 0.85) confidence confidence ratio: Row",
      "start_page": 228,
      "end_page": 228
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: of of evidence: Row Row 6: Row 7: of of evidence; Road 8: of of life--it wasn'consciousness. consciousness.",
      "start_page": 229,
      "end_page": 229
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: paclitaxel (BCP) Row 2: survivalRow survivalRow 3: 1 1 (Socinski, 2018). genotype genotype (WT population; expression expression (on on <50% and and <10% immune immune cells), BCP BCP (68 68 (95% to to .82). high high PD- L1 ratio: Row.",
      "start_page": 229,
      "end_page": 229
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: cancerRow cancerRow 5: Road 6: lifeRaw lifeRaw 7: life. life.'Row 8: ́Row 9: 5. Safety (and and toxicity)ROW 10: evidence. evidence.' Row 14: Row 15: evidence. evidence.' ROW 16: #Row 17: #equal. equal.",
      "start_page": 230,
      "end_page": 230
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: chemotherapy Row 2: Row 3: on on 23-01-2025 230/428 Row 4: Row 5:",
      "start_page": 230,
      "end_page": 230
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: lungrow lungrow 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: Row Row 7: − Row 8: selectingRow selectingRow 9: ~ Row 10: above. above.",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: I (intervention)immunetherapy with PD-1-, PD-L1- inhibitors inhibitors (without without chemotherapy); Row 2: C (comparison) platinum-based doublet chemotherapy; Row 3: Row 4: on on 23-01-2025 231/428 Row 5:",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed <of of life> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: Z: overall overall effect; df: degrees of freedom; 2I: statical heterogeneity; CI: confide Row 4: Row 5: Row Row 6: Row 7: accompaniing accompaniing PICO: Row 8: Row 9: neck. neck.",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed <of of life> (column column 1)",
      "text": "Row 1: I (intervention)immuneotherapy with PD-1-, PD-L1- inhibitors inhibitors (Row Row 2: C (comparison) platinum-based doublet chemotherapy; Row 3: Row 4: on on 23-01-2025",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed <of of life> (column column 2)",
      "text": "Row 1: Row 2: Roy 3: row row 4: row 5: ROY 6: ~Roy 7: g researchRaw 8: −Row 9: hibitors (andROW andROW 10:",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: row row 5: • O (outcome) • life, life, safety; • Row 6: − Raw 7: measures measures − Row 8: measure measure − difficulties difficulties − risk risk − factors factors − follow-up. follow-up.",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: select select (Methods) Row 3: Medline Medline (via OVID) and Embase (via Embase.com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS). contraindications contraindications ont(s) .",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: on on 23-01-2025 232/428 Row 2:",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 2",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: on on 23-01-2025 233/428 Row 2: Row 3:",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: 2018 2018 Nov/Dec;26(10):701-708. doi: 10.1097/PubMed PubMed PMID: 30095468. Row 6: 1",
      "start_page": 234,
      "end_page": 234
    },
    {
      "heading": "headed headed <of of life> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 234/428",
      "start_page": 234,
      "end_page": 234
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe>",
      "text": "ROW 1: Raw Raw 2: Row Row 3: Row 4: ROW ROW 5: ́ ROW 6: stage stage IIIB/C/IV_METERM26_? ~ ROW 7: Row 8: RecommendationROW 9: \\ ROW 10: verwarrenMETERTM26__BAR_ verwarrenMETERTM26__BAR_ (Raw Raw 17: Row 18: Row Row 19_: ROW ROW 21: M M <= 2 mg/ kg/ day.",
      "start_page": 235,
      "end_page": 235
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: row 2: Row 3: row 4: row row 5: IIIB/C/limitations limitations (_MEPTERM4_name selected indirectness) Row Row 6: Road 7: Row Row 8: __MEDTERM4_ __MEDTERM4_ PD-L1<1% alone alone + not not provide: Rower Rower CPMP: following following table: Rovello, 2023 (table 1). Row 10: rod -Row 11: Table 1: chemotherapyROW chemotherapyROW 12: Study Reference/year median ______month/11_ (PD-L 1 < 1%) Row-Raw 15 mg",
      "start_page": 236,
      "end_page": 236
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: ROW ROW 4: Road Road 6: Cost Row 7: treatment treatment __",
      "start_page": 237,
      "end_page": 237
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Overallsurvival (critical) PD-L1<1% Row 2: _MEDTERM0_% RowTERN1_ RowTERN1_ + or or recurr_METM4(RowTern): uncertain. uncertain.",
      "start_page": 237,
      "end_page": 237
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: ROW 3: row 4: • Row Row 5: / MEDTERM0_ + RowTERM1 combinatie: + or or recurr_rm; rowterM6+ with a PD-L1<1%, uncertain. uncertain. • Rowter: Rowster: • Rawter:",
      "start_page": 238,
      "end_page": 238
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Paz-Ares (2021) / Reck (2021 ) / Reck (2023) CheckMate 9L",
      "start_page": 238,
      "end_page": 238
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 238/428 Row 3: Row 4:",
      "start_page": 238,
      "end_page": 238
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: __MENTERM0_ __MENTERM0_ (3 3 weeks) week. week.",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Results Row 3: __MEDTERM0_+1 1 & 4: with with patient's with />METM6_ stage IIIB/C/therapy therapy (patients with caregivers) themselves. themselves.",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: of of 23% the the context; versus versus 13% PD-L1 PD-L1 <1% cohort (Carbone, 2023). the the \\hood ́Row Row 14: Row 15: ROW ROW 16: PD-L1 <1% Row 17: PD PD -of of <1%, rate rate (_MEDTERM6_) was 31.1% (42/135 patients, 95% CI: 39. 39.6) 20. 20.2% (26/129 patients, respectively; 95% facial rate: 28. 28.",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: cancerRow cancerRow 5: lifeRaw lifeRaw 6: life. life.'Row 7: for for EQ-2nd. 2nd.",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: patients patients (93%) Row Row 2: assay assay (Paz-",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Ares, 2021).' Row 2: Row 3: Row Row 4: vs. vs. rogue; 10 10 (to to 18-foot-four) . low. low.' Row 14: Row 15: limitations limitations (risk of bias: of of fund); applicationability (to to indirectness: reference treatment); involved involved patients-of-life: RoCuW-15. RoCuW-15.",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row Row 7: Row 8: Row Row 9: Row 10: following following question: the the chemotherapy:",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: I:immunotherapy immunotherapy (monoclonal monoclonal antibodies), chemotherapy chemotherapy involvement; Row 2: C:single single immunotherapy;Row 3: or or equal? • following following criteria: Row 18: row 19:the the PICO; row 20: the the PICOI; Row 21: ́Research type: Systematic review; RCT); Row 22: ~Articles written 26",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: ROW ROW 5: cohorts. cohorts.' Row 6: Row 7: table. table.' Row 13: Row 14: GRADE ROW 15: PD-L1 PD-L1 <1% Gandhi Gandhi (2018), Socinski (2018) and Garassino (2023).' ROW 16: rowd. rowd.",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Last evaluated: 01-01-2023 Row 4: Last authorized: 24-06-2024",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 244/428 Row 3:",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: 2021;24(8):29-34. Row 6: 1",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 245/428",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: __MDTERM3_Row __MDTERM3_Row 3: Row 4: Row Row 5: Row 6: line line (tertiary tertiary treatment) stage stage IIIB/C/IV___EDTERTM3_. Row 7: Row 8: Recommendation Row 9: Row 10: to to {months of age}",
      "start_page": 246,
      "end_page": 246
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Consider treatment;PD-L1 PD-L1 ≥50%. Road 4: row 5: Consider treatment 7_ELDERM5_~ disease. disease. Row",
      "start_page": 246,
      "end_page": 246
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: row 4: row row 5: However, However, HEAD-Road_M Road_M 6: Rod Rod 13: Row 14: The cost-Rod Rod 15: practice. practice. A",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: Raw Raw 4: row 5: a a (regional) Road Road 6: Row 7: implementationROW implementationROW 8: patients patients __MEDTERM7/ Row Row 20: Row 21: Conclusions ROW 22: ~ ROW 23: Row Row 24: row-",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Veronica: ROW 1: ROW 2: Row 3: row 4: lung lung ́ ROW 5: / MEDTERM0 ~ chemotherapy chemotherapy non-responder; line line chemotherapy",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Veronica: ROW 1: ROW 2: Row 3: row 4: • lung lung • ROW 5: / MEDTERM0 • chemotherapy. chemotherapy. •Row 7: •Moderate Row 8: − Row 9: ~GRADE • Rowter Rowter chemo",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: ROW 4: • lung lung • ROW 5 • •roid 6 • Row necessity • chemoradiance • row45. •Row Row 7: LowRow 8: ~GRADERaw 9: •Raw45 (Raw, Raw45) the the anti-PD-L1 antibody (_",
      "start_page": 251,
      "end_page": 251
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: CheckMate-017 CheckMate-017 (ReckMate 2-years, 2017), CheckMate-057 (Rekk, 2018) trials trials (Bordoni, 2018). Horn (2017) and Vokes (2018) 10 10 mg/ ROW ROW 22: regimens regimens (combination combination therapy) the provider(s) lung lung cancer_",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Row 6: docetaxel docetaxel (HR 0.73; 95% 0. 0.8%). subgroups subgroups 1-49% and ≥50%, 76 76 (95% 0. 0.96) 53 53 (95% 0. 0.70) respectively. Row 18: Row 19: ro. ro. (",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: 15 15 (_MEDTERM0_) 0. 0.81; 07_ 07_ verwarreneterM1_) (figure 3).' ROW 8: − Rov Rov 9: Row 10: 2 2 − Roval 2 mg/m2 − possible. possible.",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: squamous squamous (73 73 (95% 0. 0.98) disease disease (0.73 (95% 0. 0.89), Raw Raw 7: • Row 2 mg/ were were 10% versus versus <1% group group (Vokes, 2018: CheckMATE CheckMATE 057). Road 18: and Row 19: previous previous reporter'2x11. 2x11.",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Row 5: carcinomaROW carcinomaROW 6: 04 04 (95% 1. 1.27) 59 59 (95% 0. 0.74) nonively.Rov 7: Row 8: ratio ratio 0;13. 13.8% 13. 13.7% group group (RR 1.01; 95% 2. 2.59).' Row 14: Row 15: Row Row 16: ~ Row 17: on on 23-01-2025 256/428 Row 18:",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: Row Row 7: years years (Horn, 2017) years years (Vokes, 2018) arms arms (0. 0.034; 95% CI - 0. 0.076).' Row 16: Row 17: Bordoni (2018) Row Row 18: on on 23-01-2025 257/428 Row 19:",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: ROW ROW 5: Road 6: (OAK trial) EORTC EORTC Quality-alsookrcferfer alsookrcferfer (QLQ-C30). • Ventricular weakness; • Persistence rate • 94 94 (95% 1. 1.24), favoring @_MEDTERM0_. • control control • had had 83% chemotherapy chemotherapy (RR 0.17; 95% 0. 0.25), patients receiving *_EDTERM3___ had 59% by by chemotherapy(RR .41; 95% 0. 0.52) receiving receiving =< patients patients + 25 25 (RR 0.41) received received .",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: lungrow lungrow 5: Road 6: Z: overall overall effect; df: degrees of freedom; 2I: static heterogeneity; CI: Row Row 7: and Row 8: years years (Horn, 2017) later later (Two years): evidence. evidence.' Row 12: Row 13: __MEDTERM1_~Row 14: outcomes outcomes (clinical clinical relevance). Row 15: #Row 16: confidence. confidence.",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: blinding blinding (subjective outcome) outcomes outcomes (events events ). Road 6: level level .",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: I (intervention) immunotherapy with PD-1-, PD-L1- and CTLA4-inhibitors; Row 2: C (comparison) chemotherapy; row 3: O (outcome) Row Row 4: Row 5: ROW ROW 6: risk risk ratio:",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Quality of life: difference difference (MID) VAS VAS (Pickard, 2007). Row 2: Row 3: Row 4: on on 23-01-2025 260/428 Row 5:",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: select select (Methods) Row 6: Medline Medline (via OVID) and Embase (via Embase.com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS) other. other.",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: on on 23-01-2025 261/428 Row 2: Row 3:",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: 2018 2018 Aug;13(8):1156-1170. doi: 10,1016/PubMed PubMed PMID: 29777823. Row 6: 7:",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 262/428",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Treatment following (chemo-)ROW ROW 3: Raw 4: • chemotherapy-Roval chemotherapy-Roval toxicity-Raw: • a a second- and/ doublet doublet (or or sequentially) line line and/or second line? • Row 7: RecommendationRow 9: Row 10: patients patients (months, months, 95% 9 9 months) (The Langen, 2023) (Treatment Treatment incurable_>METERM22___~ *** RomeTrem5 RomeTrem5 (rarely) extensive extensive description). ROW 19: with with Ro",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: row row 4: row 5: the the benefit/ clinically clinically relevant",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Underbuilding Row 3: row 4: Background row 5: Road 6: chemotherapy chemotherapy (ChT) with immunotherapy (ICI) mutations mutations (for for ICI). rate. rate.",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Veronica: row 1: cow 2: row 3: row row 4: Row 5: chemotherapy chemotherapy (without without treatment) themselves. themselves. Rowwter-",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: I:docetaxel; Row 2: C:",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: O: Row Row 2: Row 3: Row Row 4: decision decision making; and progression- oflife oflife questionnaire: Row necessity:",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: clinically clinically (patient) other other (regardless of difference): docetaxel+_MEDTERM0_or docetaxel___medTERM1_) Row Row 25: Row 26: Results Row 27: literature. literature.' Row 28: ~ Row 29: Responsible Row 30: - Row 31: Last assessed 01-01-2023 Row 32: Last authorized",
      "start_page": 266,
      "end_page": 266
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 266,
      "end_page": 266
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 266/428 Row 3:",
      "start_page": 266,
      "end_page": 266
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 28;28(15):OF1-OF7. doi: 10,1158/1078-0432. CCR-print. print. PMID: 35762926; PMCID: PMC96622947. Row 5: 2",
      "start_page": 267,
      "end_page": 267
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 267/428",
      "start_page": 267,
      "end_page": 267
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - preferable preferable to:limited limited to: RowTERM9_Raw 3: 4 4 Rawter's response to: RovterRovter'__MENTERM0_astases __MENTERM0_astases (1 to 5_MEPTERM0_antibodies) local local therapy;aberration aberration (_MEDTERM6_ or __MDTERM7_), therapy therapy (radiotherapy or surgery) Gomez Gomez (2019), 8 8 months), placebo placebo (4. 4.4).",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: In guidelines (ESMO, NCCN) Gomez Gomez (0-6) and Iyengar (2018). Row 5: Row 6: ROW ROW 7: ROW 8: oligo_METERM0_astases oligo_METERM0_astases (lymph lymph node_MEPTRM0+total, total, well/driver driver aberrations), treatment treatment (concurrent );therapy therapy . survival survival (_MEDTERM7_) Row Row 15: on on 23-01-2025 269/428 Row 16: Row 17:",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: Gomez Gomez (2019) 0 0 (39. 39.8) Raw Raw 12: Row Row 16: the the benefit/ treatment treatment rod",
      "start_page": 270,
      "end_page": 270
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: ROW ROW 5: not not ge_medterM0(Row Row 22: Low Row 23: ́GRADE ROW 24: ~Row 25: -Sources: (Gomez, 2016; Iyengar, 2018) Row 26: 'Row 27: −of of (chemo)uiteen. uiteen. Roww",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: Row Row 6: group (n=24) ____MEDTERM2_ ____MEDTERM2_ (96% each each patient). regimen regimen (Gomez, 2016) 10 10 : Rong/ Lymph Nodes 1) RT RT + 11 11 : 2 Spleen2",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: ROW 2: Row Row 3: group (n=24) synchronous synchronous oligometastatic;_MEDTERM1_(96% in patients), Roworgan ́ Row",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: row 3: and and 92% 2 2 R-R-A-R) 1 1 R-E-R (5 5 R-Trower)",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: Row 2: Row 3: h h p). Row Row 4: Row 5: Row 6: Row 7: platinum row 8: Row 9: Row 10: row row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: platinum Row 18: Row 19: Row 20: Row 22: Row 23: py) Row 24: Row 25:caties Row 27:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Row 6: Row 7: n Row 8: Row 9: Row 10:cites Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: n row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: s Row 26: Row 27: Row 28: ns Row 29: Row 30:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Veronica: Row 1: Row 2: ROW 4: row 5: • carcinoma carcinoma • Rov 6: 141) Two brain lesions*1) Row Row 7: 2) Lung/lymph nodes2) 8 8 • 15 (7-11) Lung nodules • Lung (0) Lung Lung sp)",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: 141) Two brain lesions* Row 3: 2) Lung/Row Row 4: 151) Lung: Row/Row Row 5: (2) Adrenal Row 6: 3) Bone (L4) Row 7: 131) Liver Row 10: 171) Bone(S1) Row 11: ́2 Lung / 12 12 ) L-L. L-L.",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: * Row 3: s Row 4: s Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: es Row 12: Row 13: es row 14: es ROW 15: Row 16: Row 17: les Row 18: Row 19: es ROW 20: Row 21: ) Row 22: Row 23: es Road 24: Row 25: Row Row 26: Row 27: es Row 28: Row 29:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 3: row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row Row 26: Row 27: Row 28: Row 29: Row 30: Row 31: Row 32: Row 34:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 3: row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: metasta Row 26: Row 27: Row 28: Row 29: Row 30: Row 31: Row 32:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 5)",
      "text": "Row 1: Row 2: 1) Row Row 3: 2) Row Row 4: 14, 14, G) 4, 4,",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 6)",
      "text": "Row 1: Row 2: s Row 3: ns Row 4: Row Row 5: Row 6: Row 7: s Row 8: nce Therapy: erlot Row 9: ns ROW 10: nes RT + pemetre Row 11: t (Row Row 12: nts RT + Paclitax Row 13: nls RT + pemetre Row 14: Row Row 15: Row 16: ions Row 17: slow 18: row.",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: Row 6: Row 7: Row 8: __",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: Raction Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: bopla Row 11: rapy) Row 12: platinum Row 13: bopla Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22:poside Row 23: Row 24: Row 25: Row 26: Row 27: Row Row 28: Row 29:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 9)",
      "text": "Row 1: Row 2: Row 3: Row 3: Row 4: row row 5: Row 6: Row 7: Row 8: Row 9: Row 10: atin row 11: Row 12: n Row 13: atin row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: e Row 23: Row 24: Row 25: Row 27: x 5) Row 28: Row 29: Row 30:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: row 5: • carcinoma carcinoma • LOW 6: 311) 7 7 • 2 Lung (Primary site) • Row 8 • 321) Brain*9 9 2) Lung disease. • Nung/ 1, 1, Sp",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: 311) Brain* Row 3: 2) Lung (primary site) Row 4: 321) BRAIN 5: 2 Lung/ROW ROW 6: 331) Rung/ Row Row / L. L.",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: ns (Hu row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: row row 25: row 26: row 27: n row 28: nz* row 29: row 30: row 34:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: umeru row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: 3) row 25: row 26: row 28: row 29: row 30: row 31: row 32: row 27:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: row 2: Peme Row 3: Row 4: peme row 5: Row 6: ́Peme row 7: ~Row 8:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 5)",
      "text": "Row 1: Row 2: etrexe Row 3: Row 4: etrexee row 5: Row 6: etrexEE row 7: Row 8: emetrete row 9: Row 10: etice row 11: Row 12: ervatio row 13: Row 14: __MEDTERM0_ROW 15: Row 16: ervatio row 17: Row 18: row row 19: Row 20: emtrexe row 21: Row 22: t_EDTERM02: Row 25:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 6)",
      "text": "Row 1: Row 2: ed Row 3: row 4: row 4: ed row 5: row 6: od row 7: row 8: ed row 9: row 10: ED row 11: row 12: on row 13: row 14: row 15: row 16: on row 17: row 18: rod row 19: row 20: row 21: row 22: row 24: on cow 25: row 26: row 27: row 28:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 3: Road 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 28: Row 29: Row 30: Row 31: Row 32: 35 row 33:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 14)",
      "text": "Row 1: Row 2: Row 3: Row 3: Road 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 27: Row 28: Row 29: Row 30: Row 31: Row 32: 35 row 33:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: ROW 3: row 4: Road 5: Row Row 6: 481) Brain*Pemetrexed Row 7: 2) and 3) Row Row 8: 491) Lung/Raw Raw 9: −Row Row 10: ~3) node node − ROW 11: *disease disease ** 6 6 (30. 30.2) months. Row 14: Row 15: regimen regimen (Iyengar, 2018) Row 16: Row Row 17: 11) Right upper lobe1) 18 18 2) right hilum2) 19 19 ): 3000 3) cm cm 4* Row",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: 481) Brain* Row 3: 2) and 3) Rowwijk- Lwaich- to to Rowijk: 727 727 Rawijk- l45 Ravijk ́ 347 347 ) 24 24 Rockest",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: row 2: Pemet Row 3: esionsrow 4: esPemet Row 5: Row 6: mph noderow 7: tion.Raw 8: ~Row 9: disease disease (30. 30.2) MONTHS: Row 10: Row Row 11:",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Rofract 1: Row 2:trexed Row 3: Row 4:trexed' Row 5: row 6: ́ Row 7: ~ Raw 8: • or or (1) MEDTERM1_ ARY) circl circl ́ arm 15,",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: and Row 12:tion Row 13:tions Row 14: tions Row 15: etaxel Row 16:tions ROW 17: IONS ROW 18: __MEDTERM0_ ROW 19: ION ROW 20: plications ROW 21: cw 24:",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 5)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: row 26: row 27: row 28: row 29: row 31: row 30: row 25: row 34:",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Veronica: Row 1: row 2: row 3: row 4: row 4: row 5: 7, 7, 2) LEFT lung2) 10, 10, 2) Mediastinum ́2) 16, 16, 24",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: 8 row 3: Row 4: 9 row 5: Row 6: 10 row 7: Row 8: 11 row 9: Row 10: 12 row 11: Row 12: 13 row 13: Row 14: 14 row 15: Row 16: 15 row 17: 16 row 18: Row 19: 17 row 20: Row 21: 18 row 22: 19 row 23: 20 row 24: Row 25: 21 row 26: Row 27: 22 row 28: Row 31:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row Row 2: 1) Liver Row 3: 2) Row Row 4: Row 5: lobe lobe 6: − 2) 7 7 − 28 28 − 9 9 − essentieel essentieel − Rowsti2) Rowsti) 6 6 − 4 4 − 5 5 − Love.",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 4: e row 6: row 7: row 8: e row 9: row 10: row 11: row 12: row 13: be row 14: be row 15: e row 16: row 17: be rod 18: row 19: row 20: row row 21: row 22: be Row 23: row 24: be cow 26: row 27: e Row 28: row 29: be bow 32:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 3: row 4: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row Row 21: Row 22: Row 23: Row 24: Row 25: Row 27: Row 28: Row 29: Row 30: Row 31: Row 32:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 5)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: diastin row 21: row 22: row 23: row 24: row 25: row 26: row 27: row 28: row 29: row 30: row 31: row 32: row 35: row 36:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 6)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: num row 21: row 22: row 23: row 24: row 25: row 26: row 28: row 29: row 30: row 31: row 32: row 27: row 47:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 3: row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 28: Row 29: Row 30: Row 31: Row 32: 35 row 33:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 11)",
      "text": "Row 1: Row 2: 1) Row Row 3: 2) Row Row 4: Row Row 6: Row Row 7: − 8 8 − 9 9 − 2) 10 10 − 3 − 2, 2600 − 12, −2500 − 1, 1,",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 12)",
      "text": "Row 1: Row 2: ns Row 3: us Row 4: rexed Row 5: n Row 6: us Row 7: exed Row 8: us row 9: ne Row 10: ns row 11: n row 12: __",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 13)",
      "text": "Row 1: Row 2: Row 3: Row 3: Road 4: d Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25: Row 26: Row 28: Row 29: Row 30: Row 31: Row 32: Row 33:",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: Road 5: ROW ROW 6: 241) Row Row 7: 251)Row Row 8: 2)Right hilumRow 9: •loBERaw loBERaw 10: 26)Rowwinde Rowwinde (Rovert) the the (chemo)group group (RR 2,30; 95% 5. 5.56).raw 29: row 30: Iyengar (2018) Rov-R. Rov-R.",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: ew 3: row 4: Row Row 5: Row 6: Row Row 7: Gomez (22) baseline baseline (visit visit (16 16 weeks), treatment treatment (Iyengar, 2018) 6x12 6x12 24* rod rod lP",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Veronica: Row 1: Row 2: Row 3: row 4: ROW ROW 5: Road 6: blinding blinding (risk of bias) level level (Row Row 31: Row 32: select select (Methods') Row 33: Medline Medline (via OVID) and Embase (via Embase. com) reviews reviews (SRs), trials trials (RCTs) studies studies (OBS). tab tab ́ at at 23/ 4.",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: Raw Raw 6: following following criteria: oligometastatic oligometastatic non-therapy therapy . avoid avoid .",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 280/428",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Raw Raw 8: Row Row 2nd",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 3: References Row 4: Row 5: 1 - advanced advanced non-small- Row 6: Row 7: on on 23-01-2025 281/428 Row 8:",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: row 4: cell lung cancer: Oncol Oncol 2005;23:2926-2936. Row 5: 2",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 282/428",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: cell lung cancer: Row Row 5: 2",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row 2: on on 23-01-2025",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row Row 6: Row 7: 5",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: row 2: Row 3: row 4: Oncol Oncol 2005;23 Row 5: Cancer Cancer 2005;49:289-Raw 6: 2005, 2005, 49:289-Row 7:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: 3:2926-2936. Row 5:Row Row 6: -298 Row 7: Row 8:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: . Row 5: eatme Row 6: Row 7:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: advanc Row 6: Row 7:",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7: 282/428",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4: Row Row 5: Row 6: be be considered?Row 7: Recommendation Row 9: Raw 10: be be combined;Row Row 26: on on 23-01-2025 283/428 Row 27: Row 28:",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: ROW ROW 5: and and 20%. is is 6% (95% CI., 2-10%) agents agents (2). the the carboplatin/paclitaxel/ carboplatin carboplatin / paclitaxel-arm (HR 0.79; 95% 67-0. 67-0.92; p=0.003). respectively respectively (HR 0.66; 95% 57-0. 57-0.77; p<0.001), was was 35% and 15% (P<0.001), a a placebo-naïve",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Rov 5: Raw Raw 6: __MEDTERM0_ __MEDTERM0_ (36% versus 29%, p=0.012), seen seen (months, months, p=0.04). patients patients __",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: 21:3016-3024, Row 2: 6",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Clin Oncol 2009;27:3217-3224 Row 2: 7",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: 2005;47:69-80 Row 2: 8- Clin Clin 122; Row Row 3: 9N EnglJ",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: on on 23-01-2025 285/428 Row 2:",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 1 Row 5: C",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: N, N,Manegold",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 286/428",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Row Row 3: Row 4: • Row Row 5: Road 6: STAMP STAMP ROWTER_Study: • score score (PS) 2? Rov 8: monochemotherapy monochemotherapy (6) (7). Row 26: (7 Row 27: Row 28: Responsible Row 29: - Row 30: Last assessed 22-05-2011 Row 31: Last authorized: 22/05-2011",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: Row 5: on on 23-01-2025 287/428 Row 6:",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: 1",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Clin Oncol 26:4617-4625 Row 2: 4",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 288/428",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: lung lung carcinoma' Row 2: NSCLC_ NSCLC_ __METERM21__~_______# a patient'of of self-retardation/disability/disordering/disappearance-of-disability-disorderedness/distress/distention-displacement:ROWER-disease-display-discussing-discussion-discretion-discomfort-disposition-diskus/disk-dis pneumonia/__MEDTERM10_ __MEDTERM10_ (7 7 study) the the 3rd-months",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: row 4: Row Row 5: lung lung carcinoma/The The {between between first-generation-_MEDTM29_-TKIs and {the the second-lined-disordered- of of __EDTERM29_-TKI's. ROW 9: studies studies ___METERM30________>__MENTERM29_ __MENTERM29_ TKI'S. For _MEPTERM1_~ better self-effic",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: lung lung carcinoma' ROW 5: trial trial (Janne, 2023). __MENTERM0_ __MENTERM0_ + chemotherapy arm (n=279) or the _SERM_0_%Q. IMPROVED: by by ___mg/ the the AMI+the the patient'Road Road 7: Row 8: patients patients (their their caregivers) ROW 9: patients patients {specific specific risk/Row Row 13: on on 23-01-2025 291/428 Row 14: Row 15:",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: row 2: Row 3: row 4: row row 5: Road Road 6: Row 7: ROW ROW 8: survival survival (_",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: TKIs TKIs (ROW ROW 22: ROW 23: ~ ROW 24: ́LowRow 25: =GRADE_ROW 26: -Source: Wu, 2017; Ramalingam, 2020; ROW ROW 27: − ROW 28: }TKI TKI (___MEDTERM3_ or _",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: lonrow lonrow 2: row 3: raw 4: row 5: lowrow 6: ~GRADErow 7:",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: ngcarcinoma' Row 2: TKIs TKIs (_ Row 26: Row 27: ~Row 28: ́Row 29: −Row 30: vermijdenRow 31: =Row 32: ----------------source: Nakagawa, 2019; Hosomi 2020; Saito, 2019); Row Row 33: >Row 34: (thereafter. thereafter.",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Veronica: Row 1: ROW 2: Row 3: row 4: Row Row 5: TKI TKI (___METERM0_ or __MEDTERM1_) + other treatment (Row Row 35: Row Row 36: (Row Row 37: Year)Row 38: 2nd/TKIROW TKIROW 39: III III studyRD_",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: Rowmet ́ R ROWLET ́ ROW ROW 6: naive naive patients(s) metastatic metastatic * ROWMETERM9 (L858R. L858R. 21% daily. daily. ~ C__mg ___Rowmet 2",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "ROW 1: ROW ROW 2: or or metastatic(L858R. L858R. 21% metastases. metastases. / / daily. daily. C1: daily daily n=183 Row 3: (Rowster-B. Rowster-B.",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: row 4: Road 5: b row 6: row 7: ~ row 8: {row 9: }",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: Row 2: Row 3: _MEDTERM0_ROW 4: %EDTERM1_ (Row Row 5: /%EDterM2_%: Row 6: ~AEs Row 7: ≥Row 8: >ROW 9: ________________MEDTERME0_(primaryoutcom Row 10: ===",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: y me)Raw 5: Row 6: ~Row 7: ́Row 8:",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Veronica: Row 1: Row 2: Row 3: Road 4: row 5: ROW ROW 6: relapsed relapsed nonsquamous; X-ray X-ray 13M-M-D-R-T-I-S. (",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: (Row Row 4: Miyauch 2022) Row 5: Row 6: NEJ026 Row 7: (Row Row 8: Row 9: Road Road 10: (row row 11: Row 12: Row 13: Row 14: Row Row 15: (Piccirillo 2022) Road 16: Row 17: Row 18: PDF on",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row Row 2: Row Row 3: mi,Row 4: hi,Row 5: ROW 6: Row Row 7: 2019)Raw 8: ~Row 9: −Row 10: IS- Row Row 11: 2021)row 12:",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: inoma Row 2: row row 3: Row 4: row 5: 3 3 study'row row 6: Road 7: EG8 EG8 : andimized, andimized, nti",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "ROW 1: ROW 2: utations utations (and and L861Q)_",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 5)",
      "text": "Row 1: Row 2: Row Row 3: 3 row 4: Row 5: Row Row 6: 4 row 7: Row 8: ni b g/day Row 9: 4 Row 10: Row 11: Row 12: Row Row 13: Row 14: Row 15: Row 16:",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 6)",
      "text": "Row 1: row 2: Row 3: Row 4: Row 5: ROW 6: ~Row 7: −Row 8: 4)Row 9: ●Row 10: ♦Row 11: ↔Row 12: yrow 13: grofRow 14: →Row 15: ________________Row 16: adequaat 17: ATCROW 18: 57/Row 19: phenoxyRow 20: Рrow 21: SIFISO 22:",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 7)",
      "text": "Row 1: Row 2: row 3: _MEDTERM0_ (Row Row 4: /EDTERM1_ (row row 5: ~_MEPTERM2_ : ROW 6: AES ROW 7: ___MEPTERN3_ Row 9: ́ROW 10: ________________MEPTRM1_ ~omvat omvat MEPTern>MEPTIR: Row(MEPTORM2) Row 9:",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 8)",
      "text": "Row 1: Row 2: Low row 3: y me) Row 4: Row 5: y ME) ROW 6: Row 7: ~Row 8: ́Row 9:",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: OS: Overall Survival; __ELDERM1_: Progression free survival; ____ELDERM2_: Objective response rate; AEs: Adverse events;",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: _____MEDTERM0_: LifeRaw LifeRaw 2: Roy 3: Wu (2017) / Mok (2018) /Patty (2021) /Mok(2021) - ARCHER 1050",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Soria(2018)/Ramalingam (2020)/Leighl (2020). FLAURA",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Park (15)/Paz-Ares- LUX-Lung 7",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Nakagawa (2019) / Nadal (2021) / Yoh (2020) - RELAY",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Hosomi (2020)/ Miyauchi (2022) - NEJ009",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Saito (2019) - NEJ026",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: on on 23-01-2025 297/428 Row 4: Row 5:",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Zhou (2021) - ARTEMIS-CtronG1509",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Piccirillo (2022) - The BEVERLY study",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Results Row 3: Row 4: Overall survival - ROW ROW 5: survival. survival. #Row 6: #Raw 7: #Three trials (and and LUX-7) study study (Nakagawa 2019). occured. occured.' Row 11: Row 12: ~ Row 13: on on 23-01-2025 298/428 Row 14: − Row 15:",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: versus versus first",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: TKI TKI + ROW ROW 2: Row 3: survival survival (_MEDTERM0_) - Row Row 4: on on ____",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: versus versus first",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "ROW 1: TKI TKI + ROW ROW 2: Row 3: survival survival (_MEDTERM0_) - Row Row 4: on on __",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: tion",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: row row 3: Row 4: Row 5: 299/428",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: third third generation",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: TKI TKI + generation generation TKI' Row 2: Row 3: rate rate (___ 39%eral M___) - Imported outcomeRow 4: from from 56% to 84%.' Row 5: Row 6: Three studies (and and LUX-Lung-7) and and 10*.",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: or or third",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: TKI TKI + ROW ROW 2: Row 3: Adverse events (AEs) grade ≥ 3- Row Row 4: from from 34% to 57%. Row 5: Road 6: Three studies (and and LUX-Lung-7) genesis. genesis.",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: row 6: events events grade≥or or third",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: TKI TKI + generations generations TKI' ROW 2: Row 3: life life (_MEDTERM13_) - Row Row 13: Three studies (and and LUX-7) 77 77 (SE=0.01) 80 80 (SE = 0.01) with__EDTERM1_ with__EDTERM1_ (p=0.14). Road 5: Row 6: Four studies (RELAY RELAY study) Row Row 7: on on 23-01-2025 302/428 ROW:",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: TKI TKI + Generation Generation TKI",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: study study (NEJ026) on on patients' Row Row 3: row 4: the the literature' Row 5: of of evidence: evidence. evidence. # Row 6: ROW 7: __MEDTERM0 % cm. cm.",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Row Row 5: Road 6: limitations limitations (risk of bias: the the sponsor); imprecision (relevant relevant effect). Row Row 7:level level (Row 13) low. low.' Row 16: Row 17: Row Row 18: ~ Row 19: following following question:'Row 20: inhibitors inhibitors (_",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: I:treatment treatment with: Row 2: 1) inhibitors inhibitors (_MEDTERM0_, _>MEPTERM1_, Row 3:_",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: cancerRow cancerRow 5: Overall survival: >16 weeksandHR<0.7Raw 6: − Progression-free survival: <=16 week & −HR<Row Row 7: + Objective response rate: absolute difference >10%ROW 8: Adult events: absolute differences <5% for lethal complications- 1x22. 1x22.",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Updated search' Row 3: and and Obsid/analysis. analysis.' Row 8: Row 9: following following criteria:' Row 10: ~ Row 11: on on 23-01-2025 305/428 Row 12: =",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: ROW ROW 5: phase phase III; row 6: −stage stage IIIB/___MEDTERM0_ ___MEDTERM0_ mutation; −Row 7 −line line treatment;language. language. −Row 37: opposite, opposite,",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: on on 23-01-2025 306/428 Row 2: Row 3:",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 8",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: on on 23-01-2025 307/428 Row 2: Row 3:",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: with with __",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 308/428",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: ROW ROW 2: NSCLC_____METERM2_ NSCLC_____METERM2_ (rarely) mutations Row 3: Row 4: Row Row 5: ~ ROW 6: Which (new) Row Row 26: Row Row 27: ROW 28: to to *by by Ro",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "ROW 1: ROW ROW 2: __MEDERM2_ __MEDERM2_ (rarely) mutations Row 3: Row 4: Row Row 5: Road 6: Which (new) an an incurable_>>METM34_## Row Row 28: Row 29: ROW ROW 30: ~ ROW 31: BRAF, BRAF, _METER",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: EGFRRow EGFRRow 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: ___EDTERM2___, or nen: ________________",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: lung lung carcinoma' ROW 5: tumor-specific tumor-specific abnormalities: and and fusion/rearrangements in ~Road Road 12: Raw 13: patients patients (their their caregivers) ROW 14: __MENTERM5_: drip drip 15_METER2",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: ROW ROW 4: patients patients __MEDTERM0_% Boards Boards (MTB)Row 5: Raw 6: Rationale/the the ROWTER",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: arrow 5: Row Row Rway: Search Search period: stabilised stabilised randomised;fusions. fusions. A: ___ 39%",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: Row Row 5: Row 6: PDF on",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: Row 5: 9 RCTs (ROW 6: ́A:eXALT Road 7: ~B:ALTA Row 8: ≥C:CROW Row 9:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: Row 2: paralysis. paralysis. period: Row Row 3: Road 4: row 5: (phase III): Row 6: Row Row 7: Road Road 8: Row Row 9: row row 10: row row 11: FILE1029 row 12: row row 13: row row 14: ILE1014:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: ~ row row 3: Row 4: Row 5: Row 6:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 5)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row 5: Row 6:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 6)",
      "text": "Row 1: Row 2: mentally anced LKA: Row 3: row 4: I: bid bid N=172H: Row 5: I: Pemetrexed 500 mg/m2 + cisplatin 75 mg/ mg mg / m2 + carboplatin (AUC 5 6) N=171 Row 6:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 6)",
      "text": "Row 1: B: bid bid N=138 Row 2: C.",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 7)",
      "text": "Row 1: row 2: Row 3: Row 4: Row 5: ROW 6: ~Row 7: −Row 8: 4)Row 9: 0 5ROW 10: 0587Raw 11: =Row 12: =0:0 5row 13: ↔ -Row 14: ----------------Row 15:",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 8)",
      "text": "Row 1: Row 2: row 3: _",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: ROW 2: Row 3: row 4: Road 5: Raw Raw 6: aged aged ≥ with with KRASG12C- mutant advanced;platinum-based platinum-based platinum- mg mg • Row",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: Gerber, Row 5: 2018 Row 6: Row 7: NCT013 Row 8: Row 9: __MEDTERM0_ROW 10: Row Row 11: BRAF Row 12: Row Row 13: ____MEDTERM1_Row 14: Row Row 15: _________________EDTERM2_Row 16: ROW 17: PDF on.",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row Row 2: countries countries ́ Rowforcer' Rowracer'Rowager'A randomization ́",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: Row 2: nous xel (row row 3: Row 4: Row Row 5: Row 6: Row 7: Row Row 8: Row 9: row row 10: Row 11: ettherap row 12: Row 13: Row 14:",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: 3 Row 3: _MEDTERM0_Raw 4: ___MEDTERM1_Row 5: Row Row 6: ~Row 7: ́Safety Row 8: −PROs Row 9: -------------raw 10: ----------------Row 11: =_MENTERM0_ROW 12:",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row_s 1: Row 2: Row 4: row 5: ROW ROW 6: a a _",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: Her2 Row 5: Row Row 6: Row 7: __MEDTERM0_ Row 8: Row Row 9: NRG Row 10: Row 11: PDF on",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row Row 2: Row Row 3: row 4: row 4; row 5: Search period: Row 6: ́Included Included studies: 2RedRRMC 2RedRRMC RowR-R",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 3)",
      "text": "Row 1: Row 2: a a __",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11:",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11:",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11:",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 7)",
      "text": "Row 1: row 2: Row 3: Row 4: Row 5: ROW 6: ~Row 7: −Row 8: 4)Row 9: ●Row 10: ♦Row 11: grofRow 12: ↔Row 13: (2)Row 14: py and 3)Row 15: extreemRow 16: PPARow 17:",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 8)",
      "text": "Row 1: Row 2: row 3: _",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: ROW ROW 6: or or __",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: C:Control)= or or __",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: measure measure Row: row: Row Row 4: Row 5: asthma asthma (r) .",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "ROW 1: ROW ROW 2: Row Row 3: Uncommend≤M27_ mutation /______",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: decision decision making; measure. measure. # Row 4: Row 5: factors factors (ROW:",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (column column 2)",
      "text": "Row 1: Row 2: ment Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11: Row 12: b; Row Row 13: Row 14: nd Row 15: Row 16: Row 17: Row Row 18: Row 19: Row 20: Row 21: Row 22: Row 23: Row 24: Row 25:",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Rowschleel 1: Row 2: Row 3: Road 4: row 5: ROW ROW 6: Objective response rate: available available (non-randomized non-randomized studies)-Row 7: absolute difference <5% or or <25% for serial complications' Row 8: ́life life self-reported: excluded. excluded.' Row 16: Row 17: excluded excluded (tab tab methods). penguin, penguin, 2022; Xu, 2022). other. other.",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: on on 23-01-2025 316/428 Row 2:",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 2",
      "start_page": 317,
      "end_page": 317
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: on on 23-01-2025 317/428 Row 2: Row 3:",
      "start_page": 317,
      "end_page": 317
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Mar Mar 15;28(6):1117-1126. doi: 10,1158/1078-0432. CCR-21-2733. PMID: 34789481; PMCID: PMC9365370. Row 6: 1",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "headed headed <immunotherapy. immunotherapy. Severe> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 318/428",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading <_MEDTERM0_:>",
      "text": "ROW 1: Row Row 2: __MEDTERM12_fuses Row 3: Row 4: Row Row 5: ROW 6: Which (new) to to ____MEDRM12_fusions? ~ ROW 8: row row 10: better better outcomes;_",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: Row Row 7: generation generation ~_",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: row 4: Row Row 5: Road 6: analysis. analysis.' Row 7: ~ Row 8: Row Row 9: Peng (2023)",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "# Row 1: published/unpublished phase 2/advanced advanced (III/IV/recurrent) # Peng Peng (2023). Row 2: Row 3: StudyStudy designPatientsInterventionControlReported-Follow-upRow 13mg: Österreich Rowd-Mead Otherwise-Med(S-M-D-Q-Ten)(n-Two-",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: ROW 5: Raw Raw 6: or or ≥20 years_MED_",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 1)",
      "text": "Row 1: lung lung cancer' Row 2: or or ≥20 years (local local regulations) advanced advanced __MEDTERM3_- Row Row 3: Row 4 : 5 5 : N=149 cm Rowterm1",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 2)",
      "text": "Row 1: Row 2: bid bid N=147 Row 3: Row 4: ROW 5: N N =151 Row 6: row 7: ~Row 8: o___MEPTRM0___ + Row Row 9: =N=62 Row 10: −Row 11: ≥Row 12:",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 3)",
      "text": "Row 1: Row 2: ___",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 3)",
      "text": "Row 1: __MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4: Safe Row 5: __ELDERM3_",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 3)",
      "text": "Row 1: __MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4: AEs",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 3)",
      "text": "Row 1: __MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4: Safe",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 4)",
      "text": "Row 1: Row 2: Row 3: S Row 4: Row 5: R Row 6: ety Row 7: L Row 8: Row 9: Row 10: S Row 11: Row 12: R Road 13: s Row 14: Row 15: Row 16: S row 17: R row 18: Row 19: ew 20: Row 21: Row 22:",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 5)",
      "text": "Row 1: Row 2: Row Row 3: row 4: Row 5: I: 7 7 C: 13 13 Produto) investigator-assessed investigator-assessed 15(M) 24 24 . Row 12 Comité",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: • ROW ROW 6: trial. trial. • of of life",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 1)",
      "text": "Row 1: row row 2: row row 3: Row 4: J2-ALEX row 5: Row 6: row row 7: Row 8: PROFILE row 9: Row 10: Row 11: PDF gem",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 2)",
      "text": "Row 1: Row Row 2: _MEDTERM2_ _MEDTERM2_ inhibitor- advanced advanced non-were were chemotherapy- regimen regimen ); {MMD] Row",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 3)",
      "text": "Row 1: Row 2: bid bid N=1 Row 3: row 4: arrow 5: mg mg + cispla 75 mg/ mg mg + carbopl (AUC 5 N=103 Row 6: Road 7:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 4)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: rexed g/m2 atin /m2 rexted g/ m2 latin 56) Row 5: Row 6:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 5)",
      "text": "Row 1: Row 2: __",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 5)",
      "text": "Row 1: __MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4: Row Row 5: Safe",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 5)",
      "text": "Row 1: __MEDTERM0_ROW 2: __EDTERM1_ROW 3: __MDTERM2_Row 4: AEs Row 5: __ELDERM3_",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 6)",
      "text": "Row 1: Row 2: Row 3: S Row 4: Row 5: R Row 6: QOL ( row row 7: ety row 8: Row 9: Row 10: S row 11: Row 12: R row 13: s row 14: L row 15: Row 16: Row 17:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 7)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Row 5: I: 12·0 (IQR 6·5 15·7)Raw 6: ~Row 7: (will ted ly)ROW 8: 126/ 2 (1/ 4 17·4)Rov 9: −Row 11: rod rod -4 (95% row 47): row 48*. Row 24; row 24 *24(0)Row 24: row 14, row",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: Road 5: ROW ROW 6: recurred, recurred, or/_MEDTERM0(bid bid N=172Pemetrexed 500 mg/m2 + cisplatin 75 mg/ m2 ? mg mg / m2 for) {MM-YY} was was 78% group. group.' Row 33: Row 34: vs. vs.>METM3_# Row Row 35: on on 23-01-2025 Row 36:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: died died (30% and and 37% in the_ verwarreneterM1( 35 35 (33.7%) 37 37 (35.9%) monthmeters monthmeters (95% CI: 26.4not reached) rate against the",
      "start_page": 325,
      "end_page": 325
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: or or __MEDTERM0_",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "ROW 1: (generation generation TKI)' ROW 2: survival survival (___MEDTERM22_) equal equal to% the the ,45m- a a __",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "ROW 1: ROW 2: ROW 3: ROW 4: Row 5: ROW ROW 6: analysis (in in the__METERM1_group). evaluable evaluable (95% CI 20·3NE) versus versus 10·2 months (8/212·0)with _MEPTERNIM1_ (HR 0·34 [99 rapportages ratio%%% powder/kg/day.",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: crizotinib (generation generation TKI' Row 2: rate rate (___EDTERM9_) - Row Row 3: Peng Peng (2023) __MENTERM9_ __MENTERM9_ (Figure 3). and and //CEDTERM1+.",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: row 6: - Row 7: response response rate-chemotherapy chemotherapy or",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "ROW 1: __MEDTERM0_ (generation generation TKI' Row 2: Row 3: Adverse events (AEs) Grade-≥3 - Imported outcomeRow 4: Peng Peng (2023) grade grade ≥events events graded_",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: __MEDTERM0_ __MEDTERM0_ (when",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "ROW 1: generation generation TKI) of of grader/Row Row 2: life life (by by partner'reported. reported.' ROW 10: ROW 11: study, study, Solomon",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Row Row 5: Road 6: Peng Peng (2023). ~ Row 7:",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 330/428",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading <_MEDTERM0_:>",
      "text": "Row 1: Row Row 2: Row Row 16: Row 17: Consideration ROW 18: ~ ROW 19: necessityM8_ necessityM8_ (radiomegaly) mutationsRow 20: incurable__ VNEDTERM12____(radio geëlimineerd) prednisone. prednisone. Roww",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: row row 5: Road 6: ~ with with nonsmall- stage stage IIIB/ a a tar_",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "ROW 1: ROW 2: NCT01395758 Gerber (2018) arm arm (HR Row 11: Row 12: on on 23-01-2025 332/428 Row 13:",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Row 5: • carcinomaROW carcinomaROW 6: 1.20; 95% CI: 0.761.88; P=0.44). relevant. relevant. • Rome 7: survival survival - Imported outcomeRaw··5: survival survival (_MEDTERM14) row row 20: row 21: Adverse events - Imported outcomerow 22: Events Events (AEs).'Row 23: ́Row 24x26 Rovracht-Rovert-Row",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: row 4: Row Row 5: Road 6: following following outcome: status status (HR 0.69; 95% CI: 0.530.91), physical functioning (0.59; 0. 0.92), dyspnea dyspnea (0.63; 95%CI: 13, 13,",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 334/428",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading <_MEDTERM0_:>",
      "text": "ROW 1: ROW ROW 2: __MEDTERM1_fuses Row 3: Road 4: Raw Raw 5: Row 6: Which (new) at at ____MEDRM1_fusions? arrow arrow 8: row row 10: incurable incurable ~_________Row_rm3 _________Row_rm3 Rawd-Meier",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading <_MEDTERM0_:>",
      "text": "ROW 1: 2023), Row Row 2: of of __ELDERM7_+__. Both {MEDERM00] and {IMDERM1+] received a {MMD]-naïve to Rodder'Netherlands, Netherlands, ___EDTERTM% was {mgD = 2] available. available. {",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: row row 3: row 4: row row 5: trials trials (RCTs) Road Road 6: ROW 7: 8 8 : ~ Late Late ≥ 12",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 336/428",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: Row Row 4: Row Row 5: row 6: row row 7: __MEDTERM0_ __MEDTERM0_ (rarely) mutations. Row 9: (rasle) mutations(sleep)-Raw 10: * Row 11: Ridge Row 12: Late 13 ROW-12:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 2)",
      "text": "Row 1: Row 2: Road 3: row 4: trials trials (RCTs) Row Row 5: row 6: − Row 7: ~ Row 8: Row Row 9:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 2)",
      "text": "Row 1: Row Row 2: Row 3:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: Row Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: row row 15: Row 16:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: aber __MEDTERM0_ROW 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row Row 15: Row 16:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6: Row 7: Row 8: C __MEDTERM0_",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7: 336/428",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading <_MEDTERM0_:>",
      "text": "ROW 1: Row Row 2: Row Row 3: Row 4: Row Row 5: Raw 6: Which (new) patients patients met____MEDERM13_+enrolled enrolled (treated treated __MElderM15;__METERM0_), was the ___MEderM46_67%, obtained obtained (Fan, 202463). well. well. {months/months-",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row 2: row row 3: row row 4: row 5: row row 6: trials trials (RCTs) Road Road 7: ROWTER-MEPTER-8 Lately Rowter-9",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 338/428",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: Row Row 5: Row Row 6: row 7: row row 8: 14__MEDTERM0_ 14__MEDTERM0_ (rarely) mutations. Road 10: (raswolf) mutations arrow 11: ~ row 12: selection selection 14_",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 2)",
      "text": "Row 1: row 2: Row 3: Row 4: Row 5: trials trials (RCTs) ROSRaw ROSRaw 6: ROW 7: ~Row 8: −Row 9: Row Row 10:",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 2)",
      "text": "Row 1: Row Row 2: Row 3:",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row Row 16: Row 17:",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row 9: abble____MEDTERM0_ Road 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row Row 16: Row 17:",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7: Row 8: Row 9: C met",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <___MEDTERM0_:> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7: 338/428",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "headed headed <Which (new) HER2 HER2 mutations?>",
      "text": "Row 1: row row 2: row row 3: Row 4: row row 5: row 6: Which (new) HER2 HER2 Mutations? ROW 8: arrow arrow 10: the the following:",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "headed headed <Which (new) HER2 HER2 mutations?>",
      "text": "ROW 1: 2023), Row Row 2: outcomes outcomes (Jebbink, 2020). __MENTERM3_% of of 28% (95% CI 19% - 38%), a median ___",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "headed headed <Which (new) HER2 HER2 mutations?> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: row 4: analysis. analysis.' Row 5: Road 6: Row Row 7: Wu (2022)",
      "start_page": 340,
      "end_page": 340
    },
    {
      "heading": "headed headed <Which (new) HER2 HER2 mutations?> (from previous page)",
      "text": "Row 1: Row 2: row row 3: row 4: and and select;_",
      "start_page": 340,
      "end_page": 340
    },
    {
      "heading": "headed headed <Which (new) HER2 HER2 mutations?> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 340/428",
      "start_page": 340,
      "end_page": 340
    },
    {
      "heading": "headed headed <NRG:>",
      "text": "ROW 1: Row Row 2: __MEDTERM2_/ Row Row 3: Row 4: • wish wish • Raw Raw 6: • Which (new) spp spp • 2nd use • Worse • Who cares? • Raw 8: raw raw 10: incurable incurable ~_MED_Wors",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "headed headed <NRG:>",
      "text": "ROW 1: 2023), Row Row 2: by by program-",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "headed headed <NRG:> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: row row 5: 2021). @around around 25%, months months (Drilon, 2021): Row 7: Undergoing Row 8: Road 9: Conclusions ROW 10: ~ ROW 11: ́Resistance with TAR(S)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed <NRG:> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 342/428",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed <NRG:> (column column 1)",
      "text": "Row 1: Row 2: row row 3: 2021). around around 25%, months months (Drilon, 2021).Row 4: Row 5: Undergoingrow 7: Vertel 8: Conclusionsrow 9: −Row 9: -version version Rowver'other. other.",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed <NRG:> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed <NRG:> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: othera row 10: Row 11: Row 12: Row 13: Row 14: tment . Row 15: Row 16: Row 17: Row 18: incura row 19: Row 20: Row 21: Row 22: Row 23: Row 24: produ row 25: Row 26:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed <NRG:> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11: Row 12: Row 13: Row 14: Row Row 15: Row 16: Row 17: Row 18: abble__MEDTERM0_ROW 19: Row 20: Row 21: Row 22: Row 24: Row Row 25: Row 26:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed <NRG:> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row Row 10: Row 11: Row 12: Row 13: Row 14: Row Row 15: Row 16: Row 17: Row 18: C __MEDTERM0_",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed <NRG:> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row 7: 342/428",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "headed headed <Which (new) ____MEDTERM0_ ____MEDTERM0_ mutations?>",
      "text": "ROW 1: Row Row 2: Row Row 3: ROW 4: Raw Raw 5: Row 6: Which (new) at at ____METM1_fusions? ~ ROW 8: row row 10: module module treatmentnummer_",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "headed headed <Which (new) ____MEDTERM0_ ____MEDTERM0_ mutations?>",
      "text": "ROW 1: 2023), Row Row 2: goal-directed goal-directed ___",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "headed headed <which (new) ____MEDTERM0_ ____MEDTERM0_ mutations?> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: Conclusions Row 4: row 5: -with with __",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "headed headed <which (new) ____MEDTERM0_ ____MEDTERM0_ mutations?> (from previous page)",
      "text": "Row 1: Row 2: row row 3: row 4: Which (new) at at __MEDTERM0_% mutations? row 5: incurable___ELDTERM2____ incurable___ELDTERM2____ __QDTERM1-1_(rarely) mutations.",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "headed headed <which (new) ____MEDTERM0_ ____MEDTERM0_ mutations?> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 344/428",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "headed headed <BRAF V600:>",
      "text": "ROW 1: ROW ROW 2: Row Row 3: Row 4: Raw Raw 5: Row 6: in in BRAF? ROW 7: ́ ROW 8: WW WW 10: WW_M15_ WW_M15_ (zeildworm) a a __MEDTERM0_//study study (59 patients) a a ~from from 63% months months (Planchard, Besse, 2016).' ROW 29: ROW 30: review review plus",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "headed headed <BRAF V600:> (from previous page)",
      "text": "Row 1: Row 2: Row 3: ROW ROW 4: Road 5: Raw Raw 6: the the short__",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "headed headed <BRAF V600:> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 346/428",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "headed headed <BRAF V600:> (from previous page)",
      "text": "ROW 1: ROW ROW 2: mutations mutations /Pharmacy Pharmacy Rawder-Mothers-Personal Retardation Rowter-Mateler-Wadeler-Two-Doseler-Sider-Rawter-Line Rawter-Line . Raw",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "headed headed <BRAF V600:> (from previous page)",
      "text": "ROW 1: 2023), Row Row 2: concerning concerning first-and and __EDTERM16__Study: concern concern first-",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "headed headed <BRAF V600:> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: lung lung carcinoma' ROW 4: chemotherapy chemotherapy (for __EDER_M0_0.25) was reported (Jänne, 2023);Row Row 5: Road 6: Undergoing Row 7: ~ Row 8: Conclusions ROW 9: ́Row 10: − with with tar_",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "headed headed <BRAF V600:> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 348/428",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading <board board __MEDTERM0_>",
      "text": "ROW 1: ROW ROW 2: Row Row 3: ROW 4: Raw Raw 6: board board (MTB) are: ROW 2 mg/ used used instead? MTB MTB managed? 3 3 mg/ Roy Roy 25: Raw Raw 26: ~Row Row 27: betreffende - row 28: r aw 29: network network for:Roow 30: rod- to to ROW-",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 2: Raw 3: RAY RAY 4: Row Row 5: a a (regional) row row 7: Row Row 8: the the following: nurse nurse (Basse, 2018; Rofo, 2018). DNA DNA technology",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: situation situation (Velden, Velden, 2017). sequencing sequencing (WES) sequing sequing (WGS) a a (molecular) patient'Row Row 7: Row 8: well well as",
      "start_page": 351,
      "end_page": 351
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Raw Raw 7: demonstrate demonstrate case-cancer cancer (Lindeman, Lindeman, 2018; Garinet, 2018). frequent frequent (mean >5%) domains domains (__MENTERM2_exon19del, __MENTERM2_exon19del, _",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: non-useable row 4: cancer cancer ́ Row 5: Tsao, Tsao, 2016;timally, 2013). MTB-mediated MTB-mediated mutation-",
      "start_page": 353,
      "end_page": 353
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Road 4: ROW ROW 5: therapy therapy (not not registered/off-label) melanoma melanoma (than than V",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: findings. findings.",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: Boards (MTB) Row Row 6: Rrow 7: Row Row 8: ~ Row 9: row row weekly",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: on on 23-01-2025 355/428 Row 2: Row 3:",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: Kinase Kinase Inhibitors: Diagn Diagn 2018;20: 129-159. Row 6: 1",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: 23 - Oncol Oncol 2016;11: 613-638. Row 2: 2",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 356/428",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma -Rrow Rrow 3: Row 4: the the care/ Rod Rod 18: Row 19: treatable treatable risk-significant significant risk/ benefit",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: • cancer cancer • Row 4: • efficacy. efficacy. • as as follows: • areas areas • care care • community community • Row Row 23: Row 24: Care Care (PSURs) as as follows: pharmacovigilance pharmacovigilance activities",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: lungrow lungrow 5: arrow operation 6: row row 7: Adamson Adamson (and and 2011)Row 9: − Row 10: • Row 11: and and Row",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: Row 5: Row 6: on on 23-01-2025 359/428 Row 7:",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: 1- Palliative Palliative care: The The Hague: 2007. Row 4: 2",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: 3- IKNL Pallialine URL: https://www.pallialine.nl/ Row Row 2: 4",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: 12 - The The Hague: 2011. Row 2: 1",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 360/428",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: ROW ROW 2: Row Row 3: Row 4: Row Row 5: Row 6: therapy therapy : ROW: condition condition ~_METM0_ THORCULAR COMPLICATIONS: to to Row'Row Row 21: dose dose (3 3 Gy) considered considered and;discussed discussed (sheared decision making). Row-",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: row row 5: row row r/ high-grader high-grader R/ very very low- grade 3R/ Rov Rov 21: Row 22: of of <ROW ROW 23: 3; rod. rod. r/ radiotherapy radiotherapy (in in maintaining",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: Row 2: ROW 3: row 4: Road 5: Raw Raw 6: of of {mg/kg/day}",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: arrow 3: row 4: Row Row 5: 6 6 201420082006(Gy Gy (1fx) Gy Gy (10vx)studies. studies.' Row 39: of of 3/and and 2/Row Row 40: Row 41: on on 23-01-2025 364/428 Row 42:",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: 2014 Row 4: Row 5: Gy Gy (1fx) Gy Gy (10vx)x Row 6: cattle cattle 7: Gy Gy (2fx): vs.-30 Gy (10fx), Gy Gy (2vx/ gx) • Rowx 12 grx",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 2)",
      "text": "Row 1: Row 2: row row 3: 2008 row 4: row 5: x row 6: ~ Row 7: {row 8: }Row 9:",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 3)",
      "text": "Row 1: Row 2: LesterRadiatestec Row 3: (maximal row 4: 2006(maximum row 5: Row Row 6: Row Row 7: rod 8: x-2D Row 9: row 10: Raw Raw 11: ~ Row 12: + 2arrow 2arrow 13: − Row 14: 2arrow 2arrow 22:",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 4)",
      "text": "Row 1: Row 2: chnic",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 4)",
      "text": "Row 1: Row 2: Row 3: row 3: row 4: row 5: row 6: row 7: row 8: row 9: row 10: row 11: row 12: row 13: row 14: row 15: row 16: row 17: row 18: row 19: row 20: row 21: row 22: row 23: row 24: row 25: row 26: row 27: rotation. row 28: row 29: row 30: row 31: , it. it.",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Road 4: ROW ROW 5: complaints complaints (0. 0.89; 95%67-1. 67-1.18) symptoms symptoms (1. 1.00; 95%89-1. 89-1.12) ongebruikteRow 19: symptoms symptoms (17 Gy: 83.3%; 20 Gy: 79.6%; 30 Gy: 87)EKEN Row 20: Row 21: HemoptoeRaw 22:",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Road 4: • ROW ROW 5: Row 6: 7 7 : rate rate (1. 1.28; 95% 03-1. 03-1.60), survival survival (1. 1.38; 95%94-2. 94-2.04) dose dose (dose dose (<30 Gy) combinations combinations ___MEDTERM0_/ improvement improvement (obstructive obstructive pneumonia) Road Road 19: Row 20:metrie -Roy -20: Roy-2-20:",
      "start_page": 366,
      "end_page": 366
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 366,
      "end_page": 366
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 366/428 Row 3:",
      "start_page": 366,
      "end_page": 366
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: lung lung carcinoma' Row 3: Row 4: Oncol. Oncol. 2008;26(24):4001-11. [link]Row 5: 2 - Reviews. Reviews. 2006;4(4):CD002143. [link]Row 6: 3 M-M-K-C-H-G.",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: Oncol. Oncol. 2008;26(24):4001-11. [link] Row 5: 2 - Reviews. Reviews. 2006;4(4):CD002 1443. [link]' Row 6; 2014 c-",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 2)",
      "text": "Row 1: Row 2: row 3: Row 4: Row 5: ne DatabaseRaw 6: locallyRrow locallyRrow 7: nd lowerROW 8: raneRown 9: hedule of 1(4):348-53.'Row 10: 189-202. 189-202. [link]'ROW 11: link]Row 12: row row 13: ~Row 14: 367/428",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "carcinomaROW carcinomaROW 2: communicationRaw communicationRaw 3: Row 4: Use Use (CHMP) Row Row 6? the the benefit/their their notification: https://isbg.nl/lung cancer-by-asbestos/. Row 31:",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: Recommendation row 5: row 6: • on on diagnosis? Road 7: ● occupational occupational disease? − Row 8: ------------- informed informed ___~ Diergeneeskunde Diergeneeskunde Nijde-Jedschappelijk-Diaanwerk Intensie Tel: +99 99 België/ Belgique/ Belgien Raw-Targaal-Row-Raw-this this medicine",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: row 4: row 5: row 6: row 7: row 8: row 9: __SCLC? Row 10: row 11: row 12: row 13: row 14: row row 15: row 16: row 17: row 18: row row 19: row 20: row 21: row 22: row 23: no row 24: row 25: row 26: row 27: row 28: row row 32:",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "the the benefit/ Row Row ́Row Row 18: Row 19: Raw Raw 21: MEDTERM MEDTERM 0/ 2",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 2: row 3: row 4: Rav 4: arrow arrow 5: Row Row 11: Row 12: Road Road 13: work work (Baars, 2005). and and asbestos",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: ROW 2: Row 3: • cancer cancer • ROW 4: • excluded excluded • claim. claim. • 13 13 • Draw-assessed Draw-assessed • disease disease • Working Group • pregnant pregnant • claim claim • Raw Raw 16: Row 17: this this risk/ cancer cancer (Lexces, 2022). foetus foetus and",
      "start_page": 371,
      "end_page": 371
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row Row 3: Row 4: • cancer cancer • the the treatment/ risk/ benefit/ ROW ROW 7: treatROW treatROW 8: an an option; whether whether he/ Row Row 15: Row 16: Undergoing Row 17: Row 18: Background Row 19: ~ Row 20: with with the",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: group. group.",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: 2- patients. patients. Tilburg: Row Row 2: 3",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 373/428",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "for for human",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 374/428",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "important important (risk risk minimisation) ng ng • activities activities • years years • Row Row 17: Row 18: Considerations Row 19: - Row 20: Road Road 21: ~ Row 22: Undergoing Row 23:",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 375/428",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: ROW ROW 2: cancer cancer - communication communication - Rrow Rrow 3: Raw 4: Row Row 5: Road 6: contact contact ~patients patients {>others others ́ patient patient ́patients patients ́ Cancer Cancer Foundation;_EDERTERM0_volunteers. Row 21: Row 22: Responsible Row 23: ~ Row 24: Last assessed: 07/07-2020 Row 25: Last authorized: 07-07-2020",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 376/428 Row 3:",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: Row Row 5: Professional. Assen: Row Row 6: cancer. cancer. Tilburg: Row Row 7: Row 8: on on 23-01-2025 377/428",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: pro.Asses: 175-1Row 175-1Row 4: row row 5: Row 6: on on 23-01-2025",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 2)",
      "text": "Row 1: Row 2: row 3: Row Row 4: Row Row 5: Road 6:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: row row 5: Row 6:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: otenco Row 5: Row 6:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: nkerpat Row 5: Row 6:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row 6:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 8)",
      "text": "Row 1: Row 2: Row 3: Row 4: urg: Row Row 5: Row 6: 377/428",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Row Row 3: Row 4: Baseline questionRow 5: Road 6: cost-effective cost-effective ---therapy therapy (tumor tumor recurrence) ?Row 7: ́Row 8: RecommendationROW 9: ~ROW 10: ___ROW a &Row Row 22: Row 23: unknown. unknown.",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: carcinomaROW carcinomaROW 5: whereas whereas FDG-PET/from from Row-Tr(s) Raw Raw 14: Row 15: groups, groups, Row-in in patients",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: thorax thorax (contrast contrast administration). Row 6: Row 7_: scan scan 16: Row 17: Undergoing Row 18: Row 19: Background Row 20: Row 21: carcinoma carcinoma (___EDTERM12_) intention intention (SBRT, surgery and/or chemodiation): or or FDG-curative curative treatment? the the patient's condition?",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row Row 4: PET-CT Row 5: using using FDG-PET/FDG FDG -PET/18 18 . survival survival (Crabtree, 2015; Karzien, 2016; Reddy, 2017).' Row 33: Row 34: of of FDG-PET/36 36 :",
      "start_page": 381,
      "end_page": 381
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: lung lung carcinoma' ROW 6: examinations and (follow-up) diagnostic imaging. ́Row 7: Row 8: surgery surgery (Chiu, 2003; Crabtree, 2015; Onshi, 2011; Takenaka, 2010); Row Row 21: Row Row 22: Row 23: ~ ROW 24: −ROW ROW 25: postoperativeations postoperativeations ~_",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: ROW ROW 6: resection resection (stage I-IIIA) 1.FDG-PET/CTpathological (if feasibility) examinationsRow examinationsRow 7: exams exams (incl non-contrast CT) CT CT (n=46) Row 28: Row 29: ́ Row 30: \\disease Row 31: surgery surgery (n=33),radiotherapy radiotherapy (n=10) therapy therapy and/or chemotherapy (n=2)CTpathologyRow CTpathologyRow 32: 'Row 33: ~T. T.",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: ROW ROW 5: Road 6: consciousness consciousness (the the test) . for for FDG-PET/38. 38. Nakajima",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: ROW 3: row 4: row row 5: I I ́R. R. 0",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: Row Row 2: Row Row 3: Row 4: Row Row 5: Row Row 6: Row 7: FDG-PET/Row Row 8: Row Row 9: ́ Row 10: Row Row 11: Onishi 2011**121 Row 12: Row necessity:",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 2)",
      "text": "Row 1: Row 2: assessed assessed (04%) (0* Methode-(0))(0*)(0)20*(0)(0)1(0)2(0)2)(0)4(0)? Row.0*, 10*, 12*, 20*, 13*, 19*, 28*, 30*, 17*, 31*, 16*, 24*, 08*, 9*, 14*, 49*, 48*",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 3)",
      "text": "Row 1: Row 2: ve results PET/CT Row 3: row 4: Road 5: Row Row 6: ~ Row 7: {row 8: } Row Row 9:",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: lungarrow lungarrow 6: 73 73 (0.43- 0.090)0.91 (0.83- 0.96)Row Row 7: Row 8: surgeryraw surgeryraw 9: 21 21 (0.04-0.0)-(0.49)-Row 10:",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: (Number FP + number TN) Row 2: **) many data reported; here results from: assessed assessed FDG-PEGT/CT Row 3: ***) TN, TN, TP; these acrachy",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: data fit FN=1, TN = 21 (total n=44) Row 2: **) treatment, treatment, SUVmax>Row Row 3: *** late late images; SUVmax 4.'and and 5: Results: and and Karzien(0) months. months.' Row 13: Row 14: Row Row 15: accuracy accuracy / limitations limitations (risk of bias: physician. physician.",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: row 3: Row 4: ROW ROW 5: Road 6: limits limits (risk of bias; retrospective observational studies) and uncertainty (imprecision; following following criteria: investigating investigating FDG-PET/CT, CT and/Rodwell Rodwell ́ Tel:",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 387/428 Row 3:",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: Row 5: lung lung cancer? Surg. Surg. 2015;149(1):e1-3. e1-3. doi: 10,1016/Row Row 6: 3",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 388/428",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: cancer cancer - Row Row 3: Row 4: of of \"organization and care\" modules. modules.' Row 5: these these (sub) modules. row 6: row 7: Responsible row 8: ~ row 9: Last assessed: 22-05-2011 row 10: Last authorized: 20.05-2011",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 389/428",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: Row Row 2: cancer cancer - Row Row 3: Row 4: of of \"organization and care\" row row 5: this this (sub row 6: row 7: Responsible row 8: ? row 9: Last assessed: 22-05-2011 row 10: Last authorized: 20.05-2011",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: odules Row 5: b)mod Row 6: Row 7: Row 8: Row 9: Row 10: vervain Row 11: Row 12:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 3)",
      "text": "Row 1: row 2: Row 3: Row 4: s.'Row 5: duels.'Row 6: ROW 7: ~Row 8: {Row 9: }Row 10: ante prow 11:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 4)",
      "text": "Row 1: row 2: row 3: row 4: row 5: . row 6: row 7: row 8: row 9: row 10: produ row 11: row 12:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: row 4: row 5: row 6: row 7: row 8: row 9: row 10: guess row 11: row 12:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 7)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row 6: Row 7: Row 8: Row 9: Row 10: Row Row 11: Row 12: 389/428",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Raw Raw 2: carcinoma carcinoma - Row Row 3: ROW 4: weeks weeks . ROW: for for patients? Level Level 2: 2002 2002 (7), Jones), 1994 (20), Rapoport 1993 (23), 1976-77 1976-77 (24) Grade Grade 2: 1994 1994 (4), Bozcuk 2001 (9), Billing 1996 (10) treatment treatment (dose dose radiation) Level Level 3: 2000 2000 (8) Row 29: PDF",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "following following procedures: Row 3: row 4: the the test: patient patient ́Consultation Consultation ( etc, etc, collaborating), proposed proposed (see table below) (1). Table: Care Care (2) Row 18: Row 19: on on 23-01-2025 391/428 Row 20:",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "given given to: patient patient ́at at 25°weeks weeks (5). to to be: (a) pulmonologist. pulmonologist. (b) week. week. (c) hours hours (of of maximum) s s symptoms",
      "start_page": 392,
      "end_page": 392
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: (g) begin begin (is is acceptable) (6). table table (see Appendix) (7) (8) (10) (11) (12) . the the radiotherapist'days days (median: 44). of of 0-373% (median : 56) In In 21% Row Row 7: on on 23-01-2025 393/428 Row 8:",
      "start_page": 393,
      "end_page": 393
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row-Raw Row-Raw 3: Row 4: row 5: Raw Raw 6: treatment treatment (high-dose high-dose ventilation) in in patients;differences differences between",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: database. database. ́ Row 2: Row 3: referring Row 4: row 5: 1 - c. c. • lilly lilly Tlf: • Row-Raw-Rac-Rav-Rov-Ra-Rad",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 1",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Medicine 152;2714-2717 Row 2: 1",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 395/428",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4: row row 5: Row 6: consultation consultation (MDO) met_ met_ __ELDERM2___? Row 7: Row 8: Recommendation Row 9: Row 10: III III );",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: a a (eventual) medical medical counselor'a a physician'compassionate compassionate care/patients' a a doctor'the the patient'the the physician'the the decision-to-be-therapist'to to continue",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: Road 5: row row 6: the the discussion: row 7: − row 8: • physical physical examination; further discussion: assessment assessment are: be be re-evaluated:",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Responsible Row 3: row 4: Previously assessed: 22-05-2011 Row 5: Last authorized: 12-05-2011",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 397/428",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4: Road Road 5: Row 6: met met (suspected on) ~Pulmonary: #Roval: #Tolerating the lung'lung. lung. #Row 7: Row 8: Considerations Row 9: Row 10: described. described. #Row 12: Building Row 13: Row 14: Control Control (June 2010) rate rate (73 73 (95% CI., 0.64 - 0.84, p<0.001) survival survival (93 93 (95%84-1. 84-1.03; p=0.16) (4) rate, rate,",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: row 4: Road 5: of of thoracic/ NSCLC NSCLC (period 2001-2006). specialists specialists (\"Row Row 8: Row 9: Responsible Row 10: ? Row 11: Last assessed: 22-05-2011 Row 12: Last authorized: 22.05-2011",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: 3 Row 2: JAMA 280:1747-1751 Row 3: 4",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Oncol Oncol Suppl1: s83-92 Row 2: 6",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 399/428 Row 3:",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 8",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: 11 - 'care. care. Utrecht:' Row 2: Row 3: on on 23-01-2025 400/428",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: Row Row 2: 8",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 1)",
      "text": "Row 1: 11 - 'care. care. Utrecht:' Row 2: Row 3: on on 23-01-2025",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 2)",
      "text": "Row 1: Row 2: Row Row 3: Row Row 4: Row Row 5: Row 6: Row 7:",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (column column 3)",
      "text": "Row 1: Row 2: Row Row 3: geal resection: Row Row 4: Row Row 5: Row 6: Row 7: 400/428",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Rov 1: Rov Rov 2: cancer cancer - Row Row 3: Row 4: given given to: Raw Raw 5: Row 6: This This includes: Row 7; as as follows: Rov 8: Row Row uc",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: on on 23-01-2025 401/428 Row 2:",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "a a centre: Row 16: − Row 17: care care − Care Care − of of dual-agent/ therapy therapy . Examples Examples are: techniques, techniques, (adjuvant) Row Row 21: Row Row 22: on on 23-01-2025 402/428 Row 23:",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: arrow 5: Row Row 6: ~ of of Row",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: 6 Row 2: JAMA 280:1747-1751 Row 3: 7",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 403/428",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: Row Row 2: carcinoma carcinoma - Row Row 3: Row 4: Row Row 5: Row 6: met_ met_ __MENTERM6_? Row 7: Row 8: Considerations Row 9: Row 10: Row Row 11: Row 12: Building Row 13: Row 14: Row Row 15: Row 16: the the patient'of of patients;protocols protocols (Surgeons Surgeons database) of of text",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: cancerarrow cancerarrow 5: COPD COPD (1). trials, trials, co- independent independent prog",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: length (in cm); Row 3: weight (in kg); row 4: performance-score performance-score (Karnofsky/ WHO), see table ( 8) ( 9) Row 5: circulation: venegraphy venegraphy (superior superior syndrome) lymph node stations; row 6:",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Road 3: row 4: row row 5: row row 6: row 7: status-Raw status-Raw 8: Row Row 10: up up to",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Red chest X-ray; Row 3: Bronchoscopy; Row 4: CT; Row 5: mediastinoscopy (these these glands); Row 6: ~FDG-PET or FDG- PET-CT; Road 7 MRI; PA PA testing; Laboratory Laboratory examination; 13 13 ROB: UV UV Rob:",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: Roy 3: row 4: ROY 5: lungRaw lungRaw 6: Wow 7: ?vital capacity (VC)); Row 8:",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: date of surgery; Row 3: type of operation; Row 4: radiation radiation therapy; Row 5: dose (in Gy) radiation radiation radiotherapy; Row 6: • dose dose adjustment; Row 7: ● of of chemotherapy; Row 8: ecombinant chemotherapy type; Row 9: − chemotherapeutic chemotherapeutic agent; Row 10: adequaat: Row 13 − weight weight adjustment; Row 15 − platelet",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: or or progression; Row 3: death date; row 4: Row Row 5: Road 6: Responsible Row 7: ~ Row 8: Last assessed: 22-05-2011 Row 9: Last authorized: 20.05-2011",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 407/428 Row 3:",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: row 3: row row 4: 5- cancer. cancer. 'Laryngoscope 110:593-602', 2000. Row 5: 6",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Criteria. Criteria. 'Version 2.0'. Row Row 2: Row 3: on on 23-01-2025 408/428",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "is is 1: ROW ROW 2: cancer cancer - Row Row 3: Row 4: Oncoline Oncoline - Row Row 5: row 6: breast breast cancer; pain pain severity",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: row 5: 1- 2008 2008 Feb;24(1):57-67. Row 6: 2",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 409/428",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "ROW 1: ROW ROW 2: cancer cancer - Row Row 3: Row 4: Outpatients' Raw Raw 5: row 6: patients patients met__________READERM14_? raw raw 8: RecommendationROW 9: ~Row 10: patients patients ___>patients patients __MDTERM0; lung cancer, 37% problems problems (4). anorexia anorexia (1). Row 26: Row 27: Responsible Row 28: ~ Row 29: Last approved 2205-2015:",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading <board board __MEDTERM0_> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: on on 23-01-2025 410/428",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "headed headed <References>",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: row 5: 1- cancer. cancer. In: Holland JC (ed). Psycho-Oncology. New York: Row Row 6: 2",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References>",
      "text": "Row 1: 3 Row 2: Psycho-oncology 10:19-28 Row 3: 4",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References>",
      "text": "Row 1: Row 2: on on 23-01-2025 411/428",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (column 1)",
      "text": "Row 1: Row Row 2: Row 3: Row Row 4: row 5: 1- Row Row 6: 2",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (column 1)",
      "text": "Row 1: Oncol Oncol 18: Row 2: 3- Row Row 3: Psycho-oncology 10:1 Row 4: 4",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (column 1)",
      "text": "Row 1: Row 2: at at 23-0",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (column 2)",
      "text": "Row 1: inoom Row 2: Row 3: Row 4: Row 5: cer. In: Holland JC (ed). Psycho-Onco Row 6: lu lu :Row Row 7: .893-903 Row 8: Row Row 9: 19-28 Row 10: bikka bikka Utrecht: Row Row 11:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (column 3)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5:ology. New York: Oxford row 6: ung cancer: row row 7: Row Row 8: row row 9: Row 10:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (column 4)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: Row Row 7: Row Row 8: Row Row 9: Row 10:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (column 5)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: 340-34 Row 6:Row Row 7: Row Row 8: oblet Row 9: Row 10:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (column 6)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row 5: Row Row 6: row row 7: Row Row 8: Row Row 9: Row 10: 411/428",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "ROW 1: ROW ROW 2: cancer cancer - Rrow Rrow 3: Row 4: the the nurse'during during treatment? child child Discontinuation;support support ____",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: advanced advanced __",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: on on 23-01-2025 413/428 Row 2: Row 3:",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: life life (6). study study (n=59) chemotherapy chemotherapy and/therapy therapy (7). the the patient'chemotherapy chemotherapy (10). study study (n=471) nurse nurse (11). following following symptom",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Use Use (CHMP) of of any",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: References Row 4: Road 5: 1- care, care, http://www.oncoline.nl/2010 Row 6: 2",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: 2011; ANNONC-2010-0749 Row 2: 7",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 415/428 Row 3:",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 8",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: 10 - lung lung cancer: approach. approach. 'Row Row 2: 1",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row Row 2: 13 - work. work.http://www.oncoline.nl/cancer-Row Row 3: 14 - 2010, 2010, http://nl nl / Roy 4: 1",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: 2011; ANNONC-2010-0749 Row 2: 16 - cancer. cancer. '2008 2008 Feb;24(1):57-67'. Row 3: 1 Row 4: http://www.stivoro.nl/Professionals/Setting/Care/Guideline_Treatment_of_tobacco dependence/Road Road 5: Row 6: 2301-2025. 2301-2025.",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "ROW 1: ROW ROW 2: carcinoma carcinoma - Organization Raw 3: Row 4: Level Level 3: 1992 1992 (1) Caregivers Caregivers (mental mental caregivers) Level Level 3: c Schrameiwer (1) Row 22: row row 23: row 24: row row 25: - row 26: 27 27 - 4:25 - 4:35PM.",
      "start_page": 417,
      "end_page": 417
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 2: this this risk/ complaints complaints and/refer refer (1) (2). as as (medical) Room Room 9",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 3: References Row 4: Row 5: 1 - Row Row 6: Row 7: on on 23-01-2025 418/428 Row 8:",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: NcGv series: 92-22. Utrecht: Row Row 5: 2",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: ESF. ESF. 'Guideline Oral Cavity/ Oropharyngeal Carcinoma(concept). Row 2: Row 3: on on 23-01-2025 419/428",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed <References> (column column 1)",
      "text": "Row 1: Row 2: Row Row 3: Row 4: NcGv series: 92-22. Utrecht: Road Road 5: 2",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed <References> (column column 1)",
      "text": "Row 1: ESF. ESF. -Guideline Row 2: Roy 3: on on 23-01-2025",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed <References> (column column 2)",
      "text": "Row 1: Row 2: Row 3: Row 4: Row Row 5: Row Row 6: n Oral cavity/Orop Row 7: Row 8:",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed <References> (column column 3)",
      "text": "Row 1: row 2: Row 3: Row 4: Row 5: help? In: in in oncology; manual Row 6: pharyngeal carcinoma(concept). Row 7: row 8: 419/428",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "ROW 1: ROW ROW 2: small small - Rrow Rrow 3: Row 4: Row Row 5: row 6: performance performance status? Raw 8: Road Road 10: tumors tumors > but but ≤ of of > Row Row 22: Row 23: partial partial atelectasis/ TNM7 TNM7 . T4 T4 (was previously T",
      "start_page": 420,
      "end_page": 420
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: row 5: Road 6: lung lung setting: the (maximum length), directions directions (or or coronal) Raw Raw 7:",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: row 3: row 4: row row 5: c) lesions lesions {lesion lesion *for for multiplicity; row 6: d) tumour tumour (similar SAE-M0/ b (see above)) defined defined as",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: invasive adenocarcinoma. (Bron: Travis, 2016) Row 2: t-statusCategorie Row 3: AISTis Row 4: MIAT1mi Row 5: ≤Row Row 6: >1-2cm'T1b Row 7: >2-3cmT (1c Row 8: 13 PL1/PL2T2 ROW 9: >3-4cm 'T2a Row 10: >4-5cm Tow 11: PL3T3 Road 12: >557* Rowwind in the",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Road 3: Row Row 4: row 5: Raw 6: N-status Row 7: invasion invasion (Table 2). area area .",
      "start_page": 423,
      "end_page": 423
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Row 3: ROW ROW 4: classification classification (Bron: Raw Raw 5: Rrow Rrow 6: hilar hilar and/ Road Road 8: N2 Gland metastasis",
      "start_page": 424,
      "end_page": 424
    },
    {
      "heading": "headed headed <References> (column column 1)",
      "text": "classification classification (Bron: Asamura, 2015) 45 45 mg/ view view of",
      "start_page": 424,
      "end_page": 424
    },
    {
      "heading": "headed headed <References> (column column 2)",
      "text": "Row 1: row 2: Row 3: Row 4: ROW 5: ROW 6: ~Row 7: −Row 8: 4)Row 9: ●Row 10: e-d, grofRow 11: ♦Row 12: inRaw inRaw 13: →Row 14: ↔Row 15:",
      "start_page": 424,
      "end_page": 424
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Raw 3: ROW ROW 4: • metastases metastases • ROW 1/ Trough Trough 18B- IIIR-IIIR- Trough 15B-8B- or 8B-L-III. • Rough Rough 7: M1bSolitary M1bSolitary extrathoracic(s) Row Row 33: Row 34: Rod Rod 35: - Row 36: on on 23-01-2025 425/428 Row 37:",
      "start_page": 425,
      "end_page": 425
    },
    {
      "heading": "headed headed <References> (column column 1)",
      "text": "Row 1: Row Row 2: metastasesRow metastasesRow 3: rod, rod, o/o, o, c",
      "start_page": 425,
      "end_page": 425
    },
    {
      "heading": "headed headed <References> (column column 2)",
      "text": "Row 1: row 2: row 3: row 4: rod rod 1/ rod rod 1/ rod rod 1/ row row 7: row 8: row 9: IVB IVB (see table 4). row 10: 2. 2.",
      "start_page": 425,
      "end_page": 425
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: arrow 3: Raw Raw 4: row 5: 3Wot 3Wot 1: rodY rodY rod",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed <References> (column column 1)",
      "text": "Row 1: Row Row 2: Row 3: aa aa (Detterbeck, 2016). Row 4: Row 5: Row Row 6: Row Row 7: Row Row 8: Row Row 9: Row 10: Row Row 11: Row Row 12: Row Row 13: Row Row 14: Stage ROW ROW:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed <References> (column column 2)",
      "text": "Row 1: Row 2: Row 3: row row 4: Row 5: row row 6: Row 7: Row 8: Row 9: Row 10: Row 11: Row 12: Row 13: Row 14: Row 15: Row 16: Row 17: Row 18: Row 19: Row 20: Row 21: Row 22: Row 24: Row 25: Row 26: Row 27: Row 28:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed <References> (column column 3)",
      "text": "Row 1: Row 2: row 3: arcinomas_",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed <References> (column column 4)",
      "text": "Row 1: Row 2: row 3: are are cT1a(2)N0 Row 4: row 5: 16) Row 6: N0 row 7: −N0 Row 8: =N0arrow 9: >N0 Road 10: phenoxyN0 Raw 11:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed <References> (column column 5)",
      "text": "Row 1: Row 2: row 3: kt kt __MEDTERM0/ or or cT1b(m)N0M0. Row 4: arrow 5: row 6; M0 Row 7: ́M0 row 8: Row 9:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: row 3: row row 4: classification classification (8th) row row 5: row 6: selectingrow selectingrow 7: −row 8: age. age.",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row Row 2: Row 3: Row 4: Row 4: 1",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: on on 23-01-2025 427/428",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "headed headed <References> (from previous page)",
      "text": "Row 1: Row 2: Row 3: Row Row 4: 8",
      "start_page": 428,
      "end_page": 428
    }
  ]
}